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Abstracts 
Chapter 1: Affinity-Cleaving Studies Examining the Orientation and 
Specificity of the DNA-Binding Domain from y8 Resolvase 
The DNA binding domain of gd resolvase, residues 141-183, is thought 
to bind DNA by the helix-turn-helix motif based on sequence similarities 
with other known DNA binding proteins. Incorporation of the DNA 
cleaving moiety, EDTA•Fe at the amino and carboxy termini of y8 (141-183), 
allows the positions of these residue relative to the DNA bases at three 
resolvase binding sites, each consisting of inverted copies of an imperfectly 
conserved nine base pair consensus sequence, to be mapped by high-
resolution gel electrophoresis. Cleavage data for EDTA-y8(141-183) reveal 
that the NH2 terminus of the DNA binding domain of y8 resolvase is 
bound proximal to the minor groove of DNA near the center of the 
resolvase binding sites. Cleavage by EDTA•Fe attached to a lysine side chain 
at (Asn183_Lys183) at the COOH terminus of y8 (141-183) reveals that the 
putative recognition helix is in the adjacent major groove on the same face 
of the helix, oriented towards the center of the inverted repeats. Subsequent 
studies utilized affinity cleavage to analyze the effects of changes in amino 
acid composition of the recognition helix on the binding characteristics of 
y8 (141-183). In a systematic helix-switch experiment, the DNA contact 
residues of the putative recognition helix were exchanged for the DNA 
contact residues from another putative helix-turn-helix protein, Hin 
recombinase. Substitution of the amino acid in the putative recognition 
helix of y8 resolvase resulted in five proteins that showed no DNA binding 
specificity, six proteins that showed no significant alterations in DNA 
vi 
binding specificity, and four proteins that showed altered DNA binding 
specificity. 
Chapter II: Design of a Sequence-Specific DNA-Cleavage Metalloprotein 
Ni(II) GGH-yo (141-183) 
A forty-six residue chymeric protein that combines the cuperic binding 
domain of serum albumin, GGH, with the DNA binding domain of yo 
resolvase (residues 141-183), was synthesized. This protein, in the presence 
of Ni(II) and monoperoxyphthalic acid, cleaves DNA sequence specifically at 
one nucleotide adjacent to each of the six yo resolvase binding sites 
contained within res. Cleavage occurs at the center of each of the dimeric 
binding sites, indicating that the position of the Ni(II) GGH is proximal to 
the minor groove. The characteristics of the DNA products created by 
Ni(GGH-yo 141-183) cleavage of DNA indicates that cleavage is produced by 
some time of non-diffusible oxidizing species. ESR studies indicate that 
cleavage is not mediated by Ni(III)•GGH. Mechanistic studies indicate that 
DNA cleavage likely results from abstraction of the hydrogen atom at the 
C4' position of the deoxyribose backbone by some high valent, nickel-oxo 
species. Protocols for the synthesis of deuterated thymidines are included. 
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Chapter 1: 
Affinity Cleaving Studies Examining the Orientation and Specificity of the 
DNA Binding Domain from y8 Resolvase 
Introduction 
DNA-binding proteins interact with DNA to perform a wide range of functions 
necessary to living organisms. These interactions could be divided into three 
categories: structural, synthetic, and regulatory. Proteins and DNA interact 
structurally on two levels, locally and globally. Examples where DNA 
structure is affected on a local level, through protein interactions, include 
modification at specific sites, as in the case of site-specific DNA methylases, or 
cleavage at specific DNA sequences, as in the case of endonucleases. Examples 
where DNA structure is affected on a global level by protein interactions 
include packing by nucleosome proteins to form chromatin, or changes in the 
superhelical characteristics of DNA mediated by topoisomerases. Cases where 
proteins interact with DNA to serve synthetic functions include the actions of 
DNA polymerases that mediate replication, or RNA polymerases that mediate 
transcription. The interactions of enzymes responsible for the repair of 
damaged DNA, either by the excision of lesions like thymine dimers or 
correction of base pair mismatches, would also fall into this category. The 
category of regulatory interactions between proteins and DNA involves a series 
of interactions that can affect gene expression. In some cases, these interactions 
can be as simple as the binding of a protein, for example, in the case where the 
protein may bind adjacent to a promoter and block transcription, or a different 
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protein could bind adjacent to the same promoter and enhance or potentiate 
transcription. Other cases are more complicated in which a gene can be 
removed from the physical proximity of its promoter as in the case of site-
specific recombinases. The one thing all these different types of interactions 
have in common is a requirement for an association, or binding, to take place 
between the protein and DNA. Within a cell, DNA contains all the information 
needed for the cell to grow, divide, respond to its environment, and to 
differentiate. The management of this huge data base, as well as the conversion 
of its information into useful cellular functions, is mediated by the interaction 
of proteins with DNA. Transcription, replication, restriction, and genomic 
regulation are but a few of the cellular activities that are under the control of 
DNA binding proteins. The studies described herein will focus on the sub 
problem of regulation and investigate the nature of the DNA-protein 
interactions responsible for the sequence-specific binding of a regulatory 
protein. For regulation to occur, the regulatory sequences associated with a 
specific gene must be identifiable in the presence of thousands or hundreds of 
thousands of other genes (Schleif, 1988). The question remains: How do 
proteins recognize the specific sequences of DNA? 
Principles of Sequence-Specific Recognition of Double Helical DNA. B-DNA, which 
exists under physicological conditions, is probably the dominant form of DNA 
in vivo (Ollis and White, 1987). The important helical parameters that define B-
DNA are the presence of approximately 10.3 to 10.6 base pairs per turn, with a 
rise per base pair of approximately 3.4A and an overall diameter of 22A for the 
duplex (Saenger, 1984). This form of DNA contains two distinct grooves 
positioned on opposite sides of the helix, a large major groove with a 11.7 A 
3 
width and 8.5A depth and a smaller minor groove with a 5.7 A width and a 
7.5A depth. 
Structural, biochemical, and molecular genetic studies have identified two 
sources of sequence specificity in the interactions between proteins and B-DNA 
(Steitz, 1990). The first of these is direct hydrogen bonding and van der Waals 
interaction between the protein side chains and the exposed edges of base 
pairs, in the major, and to a lesser extent, the minor groove of B-DNA. The 
second form of interaction is based on the sequence- dependent bendability, or 
deformability, of the DNA duplex, which provides selectivity through the 
ability of certain nucleic acid sequences to adopt a particular structure that is 
required for protein binding at a lower free energy cost relative to other DNA 
sequences. 
Role of the Major Groove of B-Form DNA in Sequence-Specific Protein Recognition. 
The floors of both the major and minor grooves of B-form DNA have specific 
patterns of hydrogen bond donors and acceptors, in addition to sites for 
potential van der Waals interactions. Seeman, et al (1976) have examined these 
patterns and have observed that the pattern of hydrogen-bond donors and 
acceptors, in combination with the location of potential van der Waals contacts 
is unique for all four possible base pair combinations in the major groove 
(Figure 1). Therefore, in the major groove it is possible to distinguish between 
TA, AT, GC, and CG base pairs. Additionally, Seeman, et al (1976) observed 
that there were fewer features presented by the base pairs in the minor groove 
that allow for discrimination between the different base pairs (Figure 1). In the 
minor groove the hydrogen-bond acceptors (N3 on guanine and adenine and 
02 on cytoseine and thymine) occur at almost identical positions regardless of 
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the base pairing. Only the exocyclic amino group of guanine, N2, exists to 
differentiate AT from GC . The end result is that direct minor groove 
recognition can distinguish only a binary code of GC or CG versus AT or TA. 
Major Groove 
• • * • * • • 
• * • • • 
Minor Groove 
Figure 1 The hydrogen bond donors and acceptors presented by Watson Crick 
base pairs to the major and minor groove (adapted from Lewis, et al., 1985). * 
represents hydrogen bond donors and+ represents hydrogen bond acceptors. 
e represents a methyl group capable of providing van der Waals interactions. 
The varied pattern presented by the base pairs to the major groove 
demonstrates that it is possible to distinguish among AT, TA, CG, and GC base 
pairs. The pattern of hydrogen bond donors and acceptors in the minor groove 
demonstrate that it is possible to distinguish only between AT and GC 
containing base pairs. 
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The ability of the two different grooves of B-DNA to provide sites for hydrogen 
bonding and van der Waals interactions is not the only consideration in 
examining potential determinations for DNA-binding specificity. The minor 
groove is not only limited by potential hydrogen bonding patterns, but it is also 
limited sterically. The minor groove of B-form DNA is too deep and too 
narrow to allow direct contact by amino acid side chains alone (Steitz, 1990). 
The situation for the major groove is quite different, however. As pointed out 
by Zubay and Doty (1959), the major groove of B-form DNA can readily 
accommodate a protein a-helix. In their model, hydrogen bonding contacts 
could occur between the amino acid side chains on one face of the a-helix and 
the DNA base pairs in the floor of the major groove. 
The predictions and observations of Seeman, et al (1976) and Zubay and Doty 
(1959) have been borne out by the high-resolution crystal structures of several 
DNA-protein complexes (Aggarwal, et al., 1988; Jordan and Pabo, 1988; 
Wolberger, et al., 1988; McClarin, et al., 1986; Kissinger, et al., 1990). These high 
resolution crystal structures have shown extensive hydrogen bonding and 
shape complementarity between the major groove of DNA and the surfaces of 
the sequence-specific DNA-binding proteins. Generally, the structural 
complementarity between a protein and a specific DNA sequence occurs in an 
idiosyncratic manner, and there does not appear to be a defined code for 
nucleic acid sequence recognition by a given type of protein (Pabo and Sauer, 
1984; Matthews, 1988). In the initial model proposed by Seeman, et al (1976) 
there was a series of preferential interactions that were thought to occur 
between specific amino acid side chains and specific base pair combinations. It 
does not appear that this model is entirely correct, although there does appear 
to be some degree of preference for the types of interactions produced by 
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certain amino acids. One of the interactions proposed by Seeman, et al (1976), a 
bidentate interaction between the N7 and 06 of guanine and the guanidium 
group of arginine, has been observed in the DNA cocrystals of EcoRI 
(McClarin, et al., 1986) and Trp repressor (Otwinowski, et al., 1988). However, 
other interactions with the side chain of arginine and DNA have also been 
observed. In the cocrystal structure of EcoRI, the guanidium group of arginine 
was found to interact with the N7's of two adjacent adenines (McClarin, et al., 
1986). Additionally, the cocrystal structure of the homeodomain protein, 
engrailed, has shown that arginines can interact with the phosphodiester 
backbone (Kissinger, et al., 1990). Examination of the interactions that the side 
chain of glutamine makes with DNA shows that it also possesses the ability to 
form several different types of hydrogen bonding patterns. This amino acid 
side chain was originally proposed to interact with the hydrogen bond donors 
and acceptors of a single adenine (Seeman, et al., 1976). In some cases, the 
glutamine side chain does interact with the hydrogen bond donors and 
acceptors of a single adenine (Aggarwal, et al., 1988; Jordan and Pabo, 1988). In 
other cases the glutamine side chain interacts with the 06 and N7 of guanine 
(Aggarwal, et al., 1988). This side has even been observed to form a van der 
Waals interaction with a thymine methyl group (Kissinger, et al., 1990). An 
interesting and unexpected bidentate interaction was observed for another 
amino acid side in the cocrystal of EcoRI. In this structure a glutamic acid side 
chain simultaneously interacted with the N6's of two adjacent adenines 
(Frederick, et al., 1985). Seeman, et al (1976) originally pointed out that the 
ability of amino acid side chains to form bidentate interactions with DNA 
greatly enhanced their ability to provide sequence-specific recognition. 
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The number and type of interactions that could be used to provide sequence-
specific recognition of DNA were tremendously expanded when it became 
apparent that the amino acid side chains could mediate their interactions with 
the DNA through solvent molecules, and could modify their interaction by 
simultaneously interacting with other amino acid side chains or solvent 
molecules and the DNA. In 1 repressor, glutamine 44 interacts simultaneously 
with an adenosine and with glutamine 33, which in turn is also interacting with 
the backbone of the phosphate (Jordan and Pabo, 1988). The crystal structure of 
Trp repressor shows an interesting variation in which hydrogen-bond contacts 
between the protein and the major groove are mediated through water 
molecules (Otwinowski, et al., 1988). In the Trp repressor DNA complex, two 
water molecules appear to make hydrogen bonds between the protein and 
specific bases in the DNA operator. The crystal structure of 434 repressor 
shows that a water molecule is used to orient the carboxamide side chain of 
glutamine 33 so that it is directed towards the 04 of a thymine (Aggarwal, et 
al., 1988). In addition to the hydrogen-bonding contacts involving more than a 
single amino acid side chain, van der Waals contacts of this type have been 
observed. The cocrystal of the homeodomain protein, engrailed, contains a van 
der Waals interaction that involves the simultaneous interaction between the 
side chain of isolusine 47, a portion of the a-carbon backbone, and the methyl 
group of a thymine in the operator sequence. 
Role of the Minor Groove of B-Form DNA in Sequence-Specific Protein Recognition. 
Just as x-ray crystallographic studies have demonstrated some unexpected 
findings in major groove recognition by proteins, they have also demonstrated 
some unexpected findings in terms of minor groove recognition. The initial 
model predicted that there would be few sequence-specific interactions 
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between the amino acid side chains of proteins and the base pairs in the floor of 
the minor groove (Seeman, et al., 1976). It appears, however, that sequence-
specific interactions can also occur in the minor groove. The crystal structure of 
the homeodomain protein engrailed identified two arginines that contact DNA 
bases in the floor minor groove (Kissinger, et al., 1990). The side chain of 
arginine 5 in this protein reaches directly into the minor groove and hydrogen 
bonds with the 02 of thymine. The side chain of arginine 3 is also positioned in 
the major groove; however, its exact hydrogen-bonding pattern is uncertain. It 
could potentially hydrogen-bond with the 02 of thymine and/ or hydrogen 
bond with a sugar oxygen from an adjacent adenosine base pair. Water-
mediated interactions between arginine guanidinium groups and AT sequences 
in the minor groove have been observed for the 434 repressor (Aggarwal, et al., 
1988). It is interesting to note that the enzyme DNAse I, a protein that is 
considered to bind DNA "nonspecifically," exhibits preferences for cleaving 
DNA that are thought to arise from interactions in the minor groove (Suck, et 
al., 1988). 
The Role of B-Form DNA Conformation and Protein Binding. While the role of 
hydrogen bonding and van der Waals interactions in sequence-specific 
recognition of DNA was predicted, the extent to which the sequence-dependent 
conformational variability of B-form DNA would be involved in nucleic acid 
sequence recognition was not anticipated. This conformational variablity 
appears to play an extremely important role in most, though perhaps not all, 
protein DNA complexes (Steitz, et al., 1990). Significant distortion of DNA 
structure has been observed in the crystal structures of DNA complexes with 
EcoR I (Frederick, et al., 1985; McLaren, et al 1986), 434 repressor (Aggarwal, et 
al., 1988), Trp repressor (Otwinowksi, et al., 1988), and DNAse I (Suck, et al., 
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1988). The changes in duplex DNA structure that havebeen observed in these 
complexes include changes in twist (Aggarwal, et al., 1988), alterations of 
groove width (Suck, et al., 1988), and kinking of the DNA (McClarin, et al., 
1986; Otwinowski, et al., 1988; Aggarwal, et al., 1988). These crystal structures 
suggest that when a protein binds DNA in solution, the DNA is not always a 
passive partner. The conformational flexibility that has been observed for B-
form DNA is dependent on the nucleic acid sequence in the region. Generally, 
AT sequences have a narrower minor groove than GC sequences (Saenger, 
1984), and AT sequences typically favor bending into the minor groove (Drew 
and Travers, 1984). GC rich sequences, however, tend to favor the formation of 
kinks that tend to narrow the major groove (Drew and Travers, 1984). 
Examination of the types of contacts that form between proteins and DNA and 
the types of conformational changes that DNA can undergo has demonstrated 
that the process by which proteins recognize specific DNA sequences is not a 
simple one. It involves more than the recognition of a simple code of 
hydrogen-bond donors and acceptors found in the major groove of B-form 
DNA. The amino acid side chains of DNA binding proteins can interact with 
the base pairs at the floor of the minor and major grooves in a wide variety of 
ways. The interactions can be mediated through water molecules, or even by 
other amino acid side chains found on the protein. The result of this is that 
there is no simple code for sequence-specific recognition, in which a given 
amino acid will always recognize a specific DNA base pair. To complicate the 
situation, it has become apparent that the conformational flexibility of DNA can 
also play a role in the sequence-specific recognition of DNA by proteins. The 
result of this is that the selective binding of a protein to a particular DNA 
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sequence requires not only recognition by the protein of an ensemble of steric 
and chemical features, but also the accommodation of the DNA to the protein. 
Protein Structural Motifs Used in DNA Binding. Many DNA-binding proteins 
contain small discrete domains, which they use to recognize DNA in a 
sequence specific manner. In several cases, a specific type of domain, or motif, 
is used by several different proteins to bind to DNA. Examples of some of the 
structural motifs used by proteins to bind DNA in a sequence-specific manner 
are the a-helical structure of EcoRI, the zinc finger, the leucine zipper, the ~­
ribbon, and the helix-turn-helix. Each of these motifs possesses its own unique 
mode of DNA recognition. The characteristics of these different motifs will be 
discussed below. 
EcoRI-DNA Co-crystal. The DNA sequence recognized by this restriction 
endonuclease is centered on a diad axis of symmetry, which contains the 
palindromic sequence 5'-GAATTC-3'. EcoRI binds to the palindromic sequence 
as a dimer of two identical sub-units, and in the presence of magnesium, 
catalyzes the cleavage of the palindromic sequence between the GA resulting in 
a 5'-phosphate. In the absence of magnesium, the EcoRI endonuclease 
apoprotein was co-crystallized with a DNA sequence containing its 
palindromic recognition site (McClarin, et al., 1986; Frederick, et al., 1984). It is 
important to note that the DNA sequence used to form the cocrystal was 
identical to the deodecamer originally crystallized by Dickerson and Drew 
except for the addition of a thymidine overhang at the 5'-end (Dickerson and 
Drew, 1981; Dickerson, 1983). Figure 2 contains a schematic representation of 
the cocrystal structure of EcoRI bound to its palindromic binding site. 
Comparison of the DNA structure in the EcoRI co-crystal with that of the 
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Dickerson deodecamer (Dickerson and Drew, 1981) shows that there are two 
distinct kinks, or distortions, in the DNA (Frederick, et al., 1984; McClarin, et al 
1986). The first kink occurs at the center of the dyad axis of symmetry. The 
Figure 2 A schematic representation of one subunit from the dimeric EcoRI 
DNA co-crystal (McClarin, et al1986). The sequence of the DNA oligomer is 5'-
TCTCGAATTCGCG-3'. The other subunit of the complex would be rotated 
180° about the horizontal line through the center of the first subunit in the 
plane of the page. 
second kink is observed three base pairs from the dyad axis on both sides of the 
diad. When the structure of the EcoRI protein itself is examined, it is found to 
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contain a five-stranded 13 sheet surrounded on either side by a helices 
(McClarin, et al., 1986). In the co-crystal, the amino ends of the a helices bind 
to the center of the major groove of DNA. This positions the positive end of the 
helix dipole in contact with the DNA. Three amino acids, two arginines, and 
one glutamic acid emanate from these a-helices to form hydrogen bonds with 
DNA bases on the floor of the major groove (McClarin, et al., 1986). Arginine 
200 forms a hydrogen bond with the N7 and 06 of guanine. This pattern of 
hydrogen bonding is consistent with the model originally suggested by 
Seeman, et al (1976). Arginine 145 forms hydrogen bonds with the N7's of two 
adjacent adenines, while glutamic acid 144 from the other subunit accepts 
hydrogen bonds from the N6 amino groups located on the same two adenines. 
It has been suggested that while this hydrogen-bonding pattern may account 
for much of the sequence-selectivity of the enzyme, it may not be sufficient to 
account for its low rate of cleavage at incorrect sequences (Steitz, 1990). It is 
possible that the low rate of cleavage at incorrect sequences is not a result of the 
binding specificity of this enzyme. This notion is supported by the binding 
characteristics observed by another restriction endonuclease, EcoRV (Vermote, 
et al., 1992; Vermote and Halford, 1992). EcoRV was found to bind many 
different DNA sequences with equal affinity. However the enzyme was able to 
cleave DNA at only one particular sequence, 5'-GATATC-3'. This indicates that 
it is possible that the sequence-selectivity, in DNA cleavage, exhibited by 
restriction endonucleases may not result soley from the protein's ability to 
recognize and bind one specific sequence of DNA. The sequence-selectivity in 
DNA cleavage may result from a combination of the protein's ability to 
recognize a DNA sequence and the ability of that sequence to adopt a 
conformation suitable for strand scission to occur. 
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Zinc Finger DNA Binding Domains . The zinc finger motif was originally 
identified as a 30-residue repeating sequence in the transcription factor IliA (TF 
IliA) (Miller, et al., 1985). The motif was christened the "zinc finger" because it 
was found that the coordination of a zinc ion to a set of invariant cysteines and 
histidines, within each repeating unit, was vital to determining the protein's 
tertiary structure (Diakun, et al., 1986; Evans and Hollenberg, 1988). 
Subsequently, a second type, or subclass, of zinc finger proteins was identified 
(Evans and Hollenberg, 1988; Beato, 1989). This class is exemplified by the 
yeast GAL 4 transcriptional activator and mammalian steroid receptors. In this 
class of zinc fingers, the zinc ion is coordinated with four invariant cysteine 
residues. Mutagenesis experiments have shown that replacement of one pair of 
cysteins, with a pair of histidines, completely abolishes the DNA-binding 
activity of the GAL 4-like proteins (Evans and Hollenberg, 1988). 
Recently, the DNA co-crystal of a TF IliA-type protein, Zif268, has been solved 
to 2.1 A resolution (Pavletich and Pabo, 1991). A schematic representation of 
the structure is shown in Figure 3A. Crystallography confirmed the structure 
originally predicted by 2D NMR measurements (Parraga, et al., 1988; Lee, et al., 
1989) in which each zinc finger consisted of two antiparellel P-sheets and an a 
helix surrounding centrally bound zinc ion. In the co-crystal, the zinc finger 
wraps around the DNA double helix, making contacts in the major groove 
through the use of the amino terminal portions of the a helices. It appears that 
each of the three zinc fingers in this protein act as independent units, each 
recognizing a three base pair subset of the consensus recognition sequence. 
Figure 3B shows a summary of the base pair contacts made by Zif286 with its 
DNA-binding sequence. The five arganines that contact DNA in the major 
groove form hydrogen bonds with the N7 and 06 of guanines in a manner that 
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was consistent with the original predictions of Seeman, et al (1976). An 
additional interaction occurs between histidine 49 and a guanine in the major 
groove. Currently, no detailed, three-dimensional structures are available for 




Figure 3 a) A schematic representation of the Zif 268-DNA complex solved by 
x-ray crystallography. The terminal residues of each a helix and j3 sheet and 
the DNA base pair numbers are indicated, adapted from Pavletich and Pabo 
(1991). b) A schematic summary of the base pair contact observed in the co-
crystal of the Zif 268 zinc finger domain, adapted from Kaptein (1991). 
The Leucine Zipper Motif. This type of DNA-binding element was originally 
identified by its dimerization motif, an a-helical segment referred to as the 
leucine zipper (Landshultz, et al., 1988). The dimerization domain of these 
peptides is a 30 amino acid segment comprising the carboxal terminal half of 
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the protein, which forms an ampiphilic a helix containing a leucine at every 
seventh residue. The amino terminal portion of these proteins contains a basic 
region that is thought to be responsible for DNA binding. Members of this 
class of proteins include the GCN4 transcriptional activator, and the jun and fos 
ocoproteins (Landshultz, et al., 1988). These proteins are proposed to bind to 
DNA, using a "scissor-grip" model in which the ampiphilic helices of two 
monomers join to form the base of a Y -shaped dime ric molecule. The basic 
amino terminal regions of the monomers form the bifurcating arms of the "Y," 
which are thought to bind to DNA by tracking in opposite directions along the 
major groove (Vinson, et al., 1989). Currently, this structural motif has not been 
characterized by crystallographic techniques. However, solution studies 
employing footprinting (Vinson, et al., 1989) and affinity-cleaving (Oakley and 
Dervan, 1990) have found the protein to bind to DNA in a manner consistent 
with the scissor-grip model shown schematically in Figure 4. 
The {3-Ribbon Motif. Two types of procaryotic proteins that contact DNA 
through a 13-ribbon motif have been identifed (Phillips, 1991). The first type of 
13-ribbon proteins includes the protein HU, the E. coli integration host factor, 
IHF, and the B.sbutilis phage-transcription factor, TF I. HU forms the 
condensed nucleo-protein structures observed in many procaryots. It binds to 
DNA in a non-specific manner through interactions with the minor groove 
(White, et al., 1989; Yang and Nash, 1989). Crystallography has shown the core 
structure of a dimer of the protein HU to contain two a-helices, and two 
projecting ribbons that originate from each monomer (Tanaka, et al., 1984). The 
13-ribbons are formed by the carboxal terminal third of the polypeptide chain, 
and are thought to be responsible for forming the protein-DNA contacts. 
Structural information for the other two members of this group of 13 ribbon 
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proteins, IHF and TF I, is limited. However, it is known that these two 
proteins, unlike HU, bind to DNA in sequence-specific manners (Phillips, 1991). 
5' 3' 5' 3' 
5' 3' 5' 
Figure 4 A schematic representation of theY-shaped model for the dimer of 
the DNA-binding domain of GCN4 bound to its recognition sequence of DNA. 
The views represent side and front views of the complex. The leucine zipper 
dimerization domain is represented by a pair of cylinders projecting out of the 
major groove of DNA. Adapted from Oakley and Dervan (1990). 
The second type of ~-ribbon protein includes the met j repressor from E. coli 
and the arc and MMT repressors from salmonella phage P22. The structure of 
met j has been determined by crystallography (Rafferty, et al., 1989). The 
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protein is a dimer with a core comprised of four a-helices, two from each 
subunit. In met j an adjacent carboxy terminal helix protrudes from each 
monomer. An anti-parallel ~-ribbon is formed from the end terminal segment 
of each monomer and protrudes from the core. In a DNA complex of met j that 
has been determined crystallographically, the ~-ribbon lies in the major groove 
of the DNA (Phillips, 1991). The structure of the Arc repressor has been 
examined by 
CAP ci 
Figure 5 A schematic representation of the DNA operator 0R3 in the right-
handed B-form together with representations of the dimeric crystal structures 
of Cro, the carboxy terminal domain of cap, and the amino terminal domain of 
A.-repressor (ci). The location of the carboxyl terminus of the proteins is 
designated by the letter C; the location of the amino terminus of the proteins is 
designated by the letter N. Letters in parentheses indicate that the termini are 
disordered. The helix-turn-helix units of the proteins are <X.2-<X3 or ae-af. The 
circled phosphates and guanines on the 0R3 operator are sites where 
ethylation or methylation inhibit cro binding. Adapted from Ohlendorf and 
Matthews (1983). 
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NMR (Breg, et al., 1990) and found to be consistent with the structure 
determined from met j, except that there is an absence of the C-terminal a-
helices. 
The Helix-Turn-Helix DNA-Binding Motif. The helix-turn-helix DNA-binding 
motif is perhaps the best characterized of all the protein motifs known to bind 
DNA. Originally, this structure was identified by comparisons of the crystal 
structures of CAP and A.-Cro (Steitz, et al., 1982). The existence of this motif 
was subsequently confirmed by comparison with the crystal structure of 
another DNA-binding protein, A.-repressor (Pabo and Sauer, 1984; Ohlendorf 
and Matthews, 1983). Figure 5 shows a schematic representation of these 
proteins based on their x-ray crystal structures. Currently, the DNA co-crystals 
of at least seven proteins that use this motif to bind to DNA have been solved 
to high resolution (Harrison, 1991). Comparison of protein-sequence homology 
has identified at least thirty more DNA-binding proteins that could potentially 
recognize DNA, using the helix-turn-helix motif (Sauer, et al., 1990). A 
sequence alignment of several of these proteins is shown in Figure 6. Initially, 
this DNA-binding motif was thought to be used only by procaryots; however, 
structural studies on the eukaryotic homeodomain proteins, antenapedia 
(Antp) and engrailed, have demonstrated the existence of this motif in 
eukaryots (Qian, et al., 1989; Kissinger, et al., 1990). 
The helix-turn-helix motif is defined by several common structural features. 
The core of this domain generally consists of twenty amino acids (Harrison, 
1991). This region contains two a-helices linked by a three amino acid turn. 
The a -helices lie across one another at approximately a 120° angle (Harrison, 

























































































































































































































































































































































































































































































































































































































































































































































































































































hydrophobic residues that occur at invariant positions along the a-helices 
(Figure 6) (Sauer et al., 1990). A comparison of the a-carbon backbones for a 
series of these proteins shows that the backbones are superimposable on each 
other with a root mean-square difference in positions of the atoms ranging 
from 0.4 to LOA (Zhang, et al., 1987; Brennan and Matthews, 1989; Qian, et al., 
1989). 
Proteins using the helix-turn-helix motif to bind DNA should share common 
features in the sequence-specific recognition of DNA. Initially, sequence-
specific recognition of DNA by these proteins was thought to be achieved 
solely by the second helix of the helix-turn-helix domain, which was termed the 
recognition helix (Wharton, et al., 1984). In the initial model, this helix was 
postulated to lie in the major groove of DNA and to form sequence-specific 
hydrogen-bond contacts between the amino acid side chains, on one face of the 
helix, and the bases in the floor of the major groove. The high-resolution 
crystal structures of several protein-DNA complexes have shown that protein-
DNA contacts of this type do occur (Kissinger, et al., 1990; Aggarwal, et al., 
1988; Jordan and Pabo, 1988; Wolberger, et al., 1988). In the original model the 
first helix of the helix-turn-helix domain was to anchor the recognition helix in 
place by making a series of non-specific contacts with the phosphate backbone 
of DNA. These types of interactions have also been observed in the co-crystals 
of helix-turn-helix proteins. 
As the structures of more co-crystals of helix-turn-helix proteins became 
available, it became evident that the original model was not entirely correct and 
that the amino acid composition of the recognition helix might not be the sole 
determining factor in DNA-binding specificity of the protein (Pabo, et al., 1990). 
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While the positions proposed for the two helices in the model were correct, it 
underestimated the importance of the contacts with the DNA made by the first 
helix of the motif. It considered these contacts to be non-specific and placed 
little importance on their ability to influence sequence specificity of the protein. 
Subsequently, the phosphate contacts, which are formed by the first helix and 
turn of the helix-turn-helix domain, were found to determine the alignment of 
the recognition helix with respect to the DNA major groove (Pabo, et al., 1990). 
The exact nature of this alignment is thought to be a determining factor in the 
type of hydrogen bonds that can occur between the recognition helix and the 
floor of the major groove, and as a result of this influence, the specificity of the 
DNA-binding protein (Pabo, et al., 1990; Harrison and Aggarwal, 1990). This 
has led to the idea that a series of subfamilies of helix-turn-helix proteins may 
exist. Members of the same subfamily would share common orientation of the 
recognition helix relative to the DNA. An example of helix-turn-helix proteins 
that share a common recognition pattern, and as a result would belong to the 
same family, are 434 and A.-repressors (Pabo, et al., 1990). In these proteins, 
their relative positions with respect to the DNA are very similar, and so are the 
patterns of hydrogen bond contacts that form between the recognition helices 
and the DNA. This is exemplified by the DNA contacts formed by the 
glutamine residue that is present at the amino terminus of the recognition helix 
in both of these proteins. In the operator sequences for both of these proteins, 
there is an adenine located towards the 5'-end. A virtually identical hydrogen-
bonding pattern was observed in the co-crystals of these proteins between this 
similarly positioned adenine and the conserved glutamine located in the 
recognition helix. An example of a different and unrelated family of helix-turn-
helix proteins would be the homeodomains. The positioning of the 
homeodomain helix-turn-helix on DNA as observed in crystal structures and 
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by NMR in solution (Otting, et al., 1990; Kissinger, et al., 1990) is quite different 
from that found in the complexes of prokaryotic helix-turn-helix proteins such 
as 434 and A.-repressors (Brennan, 1991; Pabo, et al., 1990). In the homeodomain 
proteins the entire motif is shifted and reoriented with respect to the DNA. 
Another factor not initially considered in the binding model for helix-turn-helix 
proteins, was the DNA conformation itself. In many of the protein-DNA co-
crystals of helix-turn-helix proteins, the DNA is highly distorted (Harrison and 
Aggarwal, 1990; Brennan, 1991). This bending, or distortion, of the DNA at and 
adjacent to the binding site has been suggested to play a role in determining the 
binding specificity of these proteins (Harrison and Aggarwal, 1990; Brennan, 
1991). 
High-Resolution X-Ray Crystal Structures of Selected Helix-Turn-Helix Protein-DNA 
Co-Crystals. A schematic representation of A.-repressor bound to its DNA 
operator site is shown in Figure 7a (Jordan and Pabo, 1988). An examination of 
the general structural features of the protein-DNA complex shows that the 
protein binds as a dimer with one helix from each subunit positioned in the 
major groove. The overall complex is approximately symmetrical. The 
position of the twofold axis of symmetry from the protein dimer corresponds 
with the position of the twofold axis of symmetry from the DNA-binding site, 
or operator. The operator was found to be a relatively straight segment of B-
form DNA with an average helical twist corresponding to 10.5 base pairs per 
turn. This is extremely close to the average parameters predicted for B-form 
DNA (Saenger, 1984). As observed in the crystal structure of the A.-repressor 
alone, (Pabo and Lewis, 1982) the protein in the co-crystal contained five a-






Figure 7 A schematic representation of the helix-turn-helix regions of proteins 
bound to their operator sequences taken from protein DNA co-crystals. The 
proteins represented are (a) A.-repressor (Jordan and Pabo, 1988), (b) 434-
repressor (Aggarwal, et al., 1988), (c) TRP-repressor (Otwinowski, et al., 1988), 
(d) CAP (Schultz, et al., 1991), and (e) the homeo domain protein engrailed 
(Kissinger, et al., 1990). In these representations, the a-helices are represented 
as cylinders. 
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helix, was positioned in the major groove. The protein-protein contacts 
responsible for the dimerization of the proteins were formed between the fifth 
helix of each monomer. Specific hydrogen-bonding interactions were observed 
between the major groove of DNA and the side chains of two amino acids 
located near the 
amino terminus of helix 3, the recogntion helix. Glutamine 44 was observed to 
form a bidentate hydrogen bond between the N7 and N6 of an adenine. This 
type of bidentate hydrogen-bonding pattern was predicted to be a determinant 
of protein-DNA binding specificity (Seeman, et al., 1976). The interaction 
between glutamine 44 and the adenine appears to be stabilized by a hydrogen 
bond that occurs between glutamine 33, from helix 2, and glutamine 44. Serine 
45, which is also located at the amino end of the recognition helix, formed a 
hydrogen bond with the N7 of a guanine contained in the operator sequence. 
Other sequence-specific hydrogen-bonding, involved asparagine 55, which is 
found just past the carboxyl end of helix 3, and lysine 4, which is present in the 
amino terminal segment of the protein. In this interaction asparagine 55 and 
lysine 4 combined to recognize a guanine near the dimeric center of the 
operator sequence. Asparagine 55 simultaneously formed a hydrogen bond 
with the N7 of guanine and lysine 4, which in turn formed a hydrogen bond 
with the 06 of the same guanine. Sequence-specific hydrophobic interactions 
were observed to occur between the B-carbon of alanine 49 and the terminal 
carbon of isoleucine 54 and the methyl groups of two different thymines in the 
major groove. For each monomer a series of five hydrogen bond interactions 
were observed with the phosphate sugar backbone. These interactions flanked 
the 5'- and 3'- edges of the point in the major groove that was occupied by the 
recognition helix. The amino terminal end of this protein was observed to track 
along the major groove. 
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Figure 7b contains a schematic representation of 434 repressor bound to its 
operator sequence (Aggarwal, et al., 1988). 434 repressor, a protein containing 
5 a-helices, binds as a dimer to its operator sequence with an approximate two-
fold axis asymmetry. The DNA in this complex is B-form; however, it is 
distorted by bending, creating an arc of 65A in radius (Aggarwal, et al., 1988). 
The width of the minor groove changes throughout the operator sequence. At 
the edges of the operator sequence, it is approximately 14A. Towards the 
middle of the operator sequence, near the axis of pseudosymmetry, the width 
narrows to 8.4A. These are significant alterations in groove width when 
compared with the normal 11.7A width of the minor groove of B-form DNA 
(Saenger, 1984). Comparison of the structure of 434 repressor from the co-
crystal (Aggarwal, et al., 1988) with the crystal structure of the protein alone 
(Mondragon, et al., 1989) shows that no large conformational changes occur in 
the protein upon DNA binding. However, this comparison reveals that 
significant adjustment in the positions of some amino acid side chains occurs 
coincident with DNA binding. The protein-protein contacts in the dimer are 
mediated by a series of hydrophobic interactions that occur between helices 4 
and 5 of the monomers, in addition to a salt bridge in this region. Helices 2 and 
3 form the helix-turn-helix unit, with helix 3 serving as the recognition helix. 
Helix 3 lies in the floor of the major groove, with the amino termini of the 
adjacent helices, helices 2 and 4, lying in close proximity to the sugar phosphate 
backbone of the DNA. In this co-crystal, as in the one of A.-repressor, the amino 
end of the recognition helix makes specific contacts with DNA bases in the floor 
of the major groove (Pabo and Lewis, 1988; Aggarwal, et al., 1988). Hydrogen-
bonding contacts between the recognition helix of 434 repressor and the major 
groove of DNA are mediated by glutamines 28 and 29. Glutamine 28 forms a 
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bidentate hyrodgen bond with an adenine located at the 5'-end of the 
recognition sequence, and glutamine 29 hydrogen bonds to the guanine of the 
adjacent GC base pair. A non-polar interaction is observed between the methyl 
group of a thymine and a hydrophobic pocket formed by a portion of the side 
chain from glutamine 29 and from threonine 27. Hydrogen bond contacts 
between the protein and the DNA sugar phosphate backbone occur at the 5'-
edge of the recognition sequence with the amino acid side chains found at the 
amino end of a-helix 2. Contacts between the protein and the sugar phosphate 
backbone of the DNA are also observed between the amino acids in the loop 
between a-helices 3 and 4, and the phosphate groups at the 3'-edge of the 
recognition sequence. It is interesting to note that some of these contacts were 
mediated by solvent molecules. An additional solvent-mediated protein-DNA 
contact is observed between arginine 43, which is located in the loop between 
helices 3 and 4, and the minor groove. In this contact arginine 43, through three 
bridging water molecules, simultaneously contacts an AT base pair and two 
sugar phosphates. 
A schematic representation of the helix-turn-helix region of Trp repressor 
bound to its operator sequence is shown in Figure 7c. Initially, this structure 
was solved to 2.4A resolution (Otwinowski, et al., 1988) and later it was more 
highly refined to 1.9A resolution (Luisi and Sigler, 1990). The protein binds to 
its operator DNA as a dimer with a pseudo C2 axis of symmetry. The 
structure-bound Trp repressor contained 6 a-helices (A-F). Helices D and E 
form the helix-turn-helix unit of the protein. In the co-crystal, the amino end of 
the recognition helix, helix E, and the loop between helices D and E point into 
the major groove, with helix D positioned across the major groove. The 
structure of the DNA operator is approximately B-form (Otwinowski, et al., 
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1988). While the DNA structure does not exhibit a large bend, as was observed 
in the case of 434 repressor (Anderson, et al., 1987), it does show some 
structural differences from normal, uncomplex B-form DNA (Otwinowski, et 
al., 1988; Luisi and Sigler, 1990). In the structure of the protein-DNA complex, 
the phosphates that are involved in protein-DNA contacts show marked 
deviations in position relative to unbound DNA (Otwinowski, et al., 1988). 
Some of these phosphates have moved by as much as 9.6A The adjustments in 
the positions of these phosphates give the appearance of the DNA reaching and 
grabbing the protein as if to hold it in place (Luisi and Sigler, 1990). When the 
structure of complex Trp repressor is compared with that of uncomplex Trp 
repressor, some interesting differences are observed (Otwinowski, et al., 1988). 
The amino region of complex Trp repressor representing helices A through C 
shows no significant conformational differences from the structure of unbound 
repressor. However, the region of Trp repressor, which is involved in DNA 
binding, containing helices D and E, the helix-turn-helix unit shows a major 
reorganization upon binding to the DNA. When the protein-DNA co-crystal is 
examined for sequence-specific contacts, only one direct contact is observed to 
occur between the protein and the major groove. In this contact, arginine 69, 
located near the amino terminus of helix D, forms a bidentate hydrogen bond 
with a guanine at the 5'-end of the operator sequence. This interaction is 
stabilized by a water molecule that bridges from the arginine to an adjacent 
phosphate. While there are no other direct contacts between the protein and 
the major groove of the operator sequence, there are three contacts mediated by 
six water molecules (Luisi and Sigler, 1990). Two of the water-mediated 
contacts involve the protein-amide backbone and the third involves the side 
chain of lysine 72. Eleven hydrogen-bonding contacts were observed with the 
sugar phosphate backbone (Otwinowski, et al., 1988; Luisi and Sigler, 1990). 
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The Trp repressor operator complex provided new insights into the 
determinants of protein-DNA recognition. In the co-crystal structures of A.- and 
434 repressor there were a significant number of sequence-specific interactions 
formed between the protein and the DNA bases in the floor of the major 
groove. Only one interaction of this type was observed in the Trp repressor 
DNA complex. This raises the question of what factors determine the binding 
specificity of Trp repressor? Luisi and Sigler, et al. (1990) have postulated that 
the sequence-specific recognition of the Trp repressor operator by Trp repressor 
is mediated by a combination of bridging water molecules, DNA 
conformational plasticity, and protein conformational plasticity. They 
postulated that the hydrogen-bonding interactions mediated by the water 
molecules would play the largest single role in determining protein-binding 
specificity, with the shape-selectivity of the protein and DNA for one another 
providing the balance. They noted that the Trp repressor protein would be 
unable to contact simultaneously the phosphates on each side of the major 
groove unless the DNA was able to bend and conform to the protein. 
A schematic representation of CAP bound to its DNA operator sequence is 
shown in Figure 7d (Schultz, et al., 1991). CAP binds to its DNA operator as a 
dimer with a pseudo dyad axis of symmetry. There is a single molecule of 
cyclic AMP found between each CAP monomer and the DNA operator 
sequence. The overall structure of the DNA operator sequence shows a 90° 
bend, which results from two 40° kinks between base pairs 5 and 6 on each side 
of the dyad axis of symmetry. In the co-crystal, the amino terminal end of helix 
D, the recognition helix of the helix-turn-helix unit, penetrates the major groove 
with its axis parallel to the plane of the bases. In other helix-tum-helix proteins, 
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the recognition helix is parallel with the plane of the groove. In this complex, 
three amino acid side chains emanating from the recognition helix appear to 
hydrogen-bond directly to three base pairs in the major groove. Arginine 180 
forms a bidentate hydrogen bond with the N7 and 06 of a guanine at the center 
of the recognition sequence. Arginine 185 hydrogen bonds to a guanine from a 
GC base pair at the 3'-end of the recognition sequence. Glutamic acid 181 forms 
a hydrogen bond with the N4 of the cysteine from the same GC base pair. As 
with other helix-turn-helix proteins, a significant number of hydrogen bonding 
interactions were observed between the phosphate backbone and the protein 
on either side of the portion of the major groove occupied by the recognition 
helix. In the case of CAP, sequence-specific DNA binding is thought to be a 
result of a combination of hydrogen bond interactions between the protein and 
the floor of the major groove and the sequence-dependent bendability or 
deformability of the DNA duplex (Schultz, et al., 1991). 
A schematic representation of the last protein-DNA complex to be discussed, 
the homeodomain protein engrailed, is shown in Figure 7E (Kissinger, et al., 
1990). Unlike its prokaryotic brothers, the eukaryotic protein engrailed binds to 
its DNA recognition sequence as a monomer. The protein contains three a.-
helices and an amino terminal arm. Helices 2 and 3 form the helix-turn-helix 
unit. Helix 3, the recognition helix, is positioned in the major groove, with 
helices 1 and 2 lying across the major groove perpendicular to helix 3. The 
DNA duplex in the co-crystal is a relatively straight segment of B-form DNA 
with an average helical twist of 34.2° and approximately 10.53 base pairs per 
turn. The only distortion appears to be a slight widening of the major groove in 
the region where helix 3 binds (Kissinger, et al., 1990). Extensive sequence-
specific contacts occur between the floor of the major groove and the side 
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chains of amino acids located near the amino end of helix 3. In the crystal 
structure, a bidentate hydrogen bond is observed between asparagine 51 and 
the N7 and N6 of an adenine located at the 3'-end of the binding site. A 
hydrophobic interaction is observed to occur between isoleucine 47 and the 
methyl group of the thymine in the adjacent AT base pair. Glutamine 50 also 
forms a van der Waals contact with the methyl group of a thymine in the major 
groove. As in the prokaryotic proteins, extensive hydrogen-bonding 
interactions are observed between the protein and the sugar phosphate 
backbone on either side of the portion of the major groove that is occupied by 
the recognition helix. Unlike the prokaryotic proteins, the homeodomain 
protein engrailed makes multiple sequence-specific contacts with DNA bases in 
the adjacent minor groove. The amino terminal arm of the protein lies along 
the minor groove. The side chains of two arginines, located in the amino 
terminal arm, reach into the minor groove and form sequence-specific 
hydrogen-bonding interactions with thymines. When the structure of 
homeodomain is compared to the structure of the prokaryotic protein A-
repressor, the a-carbon backbones from the helix-turn-helix portions of these 
proteins superimpose with a root mean square difference in atomic positions of 
only 0.84A (Kissinger, et al., 1990). Although the structure of the helix-turn-
helix units in A-repressor and engrailed are very similar, examination of the 
protein-DNA co-crystals reveals that they are used in very different ways to 
recognize the DNA. If the A-repressor operator complex is used as a starting 
point and the helix-turn-helix units of the proteins are superimposed, it appears 
that the DNA in the homeodomain complex has been shifted towards the C-
terminal end of the second helix in the helix-turn-helix unit. This difference in 
positioning shifts the register of amino acids in the recognition helix that are in 
position to make critical contacts with DNA base pairs. While the helix-turn-
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helix motif is similar in engrailed and prokaryotic proteins, it appears to be 
used in a different manner to recognize DNA. 
Comparison of the DNA co-crystals from several helix-turn-helix proteins 
reveals that there are several potential mechanisms used by this class of 
proteins to recognize DNA. There is direct hydrogen bonding, as in the case of 
A-repressor or engrailed, direct hydrogen bonding in combination with 
alternations in DNA conformation, as in the case of 434 repressor and CAP, and 
water-mediated hydrogen-bonding in combination with changes in structural 
conformation of both the protein and DNA, as in the case of Trp repressor. It 
has become apparent that even if the same mechanism of sequence-specific 
recognition is used, for example, direct hydrogen-bonding in the case of A-
repressor and engrailed, variations in the relative positioning of the protein and 
DNA can significantly alter the amino acid side chains that are positioned to 
interact with the DNA. A more graphic example of differences in the relative 
positioning of helix-turn-helix proteins and DNA is provided by lac repressor. 
The orientation of the recognition helix of this protein is opposite with respect 
to the recognition helices of A.-repressor and the other helix-turn-helix proteins 
that have been discussed (Boelens, et al., 1987; Lehming, et al., 1987; Shin, et al., 
1991). While a large body of structural information exists on binding of DNA 
by helix-turn-helix proteins, our understanding is limited because a great 
number of these proteins are uncharacterized. Since the determination of 
crystal structures can be problematic for some proteins, and because multi-
dimensional NMR can require a large time investment, a need for techniques 
that can rapidly provide information about protein-DNA complexes is obvious. 
To meet this need, a series of solution-phase techniques that can rapidly 
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provide information on the nature of protein-DNA complexes have been 
developed. 
Analysis of Protein and DNA Binding in Solution. Three solution techniques 
frequently used to examine the nature of protein-DNA interactions are 
chemical or enzymatic footprinting (Galas and Schmitz, 1978; Dervan, 1986; 
Tullius, et al., 1987), interference experiments (Siebenlist and Gilbert, 1980), and 
affinity cleavage (Dervan, 1991). The first two techniques are extremely useful 
in describing the DNA binding site for a given protein. Footprinting maps the 
region of DNA that is protected by a bound protein. If a chemical agent is 
used, it can be mapped to nucleotide resolution. Interference experiments 
using methylation and ethylation can identify specific bases, in the case of 
methylation, and specific phosphates, in the case of ethylation, which are 
involved in protein binding. However, neither of these techniques provides 
information on the orientation of the protein with respect to the DNA. In order 
to obtain information about the protein's orientation with respect to the DNA, a 
technique called affinity-cleaving has been developed (Dervan, 1991). The 
affinity-cleaving technique involves incorporation of the DNA-cleaving moiety, 
EDTA•Fe, at discrete amino acid residues within a protein (Sluka, et al., 1987). 
The cleavage pattern generated following chemical activation, with a reducing 
agent such as dithiothreitol (OTT), allows the position of the protein relative to 
the DNA to be mapped to nucleotide resolution (Sluka, et al., 1987). EDTA•Fe 
localized at a specific DNA-binding site cleaves both DNA strands, typically 
over a four to six base pair region, via a diffusible species (Figure 8) (Shultz, et 
al., 1982; Taylor, et al., 1984; Dervan, 1986). The central point of the cleavage 
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Figure 8 A schematic representation of the high-resolution assay used to 
interpret affinity-cleavage patterns. 
acid at which the EDTA has been covalently attached (Sluka, et al., 1987). Due 
to the right-handed nature of double-helical DNA, the groove in which the 
EDTA iron is located can also be identified by analysis of the cleavage patterns 
(Dervan, 1991). An EDTA•Fe located in the minor groove generates an 
asymmetric cleavage pattern with the maximal cleavage loci shifted to the 3' 
side on opposite strands (Figure 9) (Taylor, et al., 1984; Dervan, 1986). When 
the EDTA is located in the major groove, the maximal cleavage loci are 5' 
shifted; in addition cleavage of lower efficiency occurs on the distal strands of 
the adjacent minor grooves (Moser and Dervan, 1987; Griffin and Dervan, 1989; 
Oakley and Dervan, 1990). This results in a pair of 3' shifted asymmetric loci of 
unequal intensity on opposite strands (Figure 9). This pair of patterns is 
consistent with a diffusible species, generated by an EDTA iron located above 
the major groove, that reacts in the major and minor grooves of DNA with 
unequal rates, preferentially (although not necessarily exclusively) in the minor 
groove. Tullius and Dombrowski (1985) obtained a cleavage pattern that was 
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Figure 9 Cleavage patterns produced by a diffusible oxidant generated by 
Fe(II)•EDTA located in the major and minor grooves of right-handed DNA. 
Filled circles represent points of cleavage along the phosphodiester backbone. 
The sizes of the circles represent the extent of cleavage. Beneath each helical 
representation is the type of densitometric cleavage pattern observed when 
EDTA is positioned in the respective groove. 
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sinusoidal in intensity when DNA, bound to a precipitate of calcium 
phosphate, was allowed to react with EDTA iron. This sinusoidal cleavage 
pattern was a direct result of the differences in reactivity of the major and 
minor grooves of DNA towards the oxidative species generated by the EDTA 
iron. The studies described in this section detail the use of affinity cleavage to 
elucidate the mechanism by which y8 resolvase binds to DNA. 
Previous Studies of the Interactions Between y8 Resolvase and DNA. y8 resolvase is a 
183 amino acid protein encoded by the transposable element, gamma delta, a 
member of the TN3 family of bacterial transpons (Grindley and Reed, 1983). 
Resolvase is both a site-specific recombinatorial protein and a repressor. y8 
resolvase interacts with 120 bp site named res, which lies within the region 
between the divergently transcribed TNP A and TNP R genes of the y8 
transposon. Resolvase protects all three of the dimeric binding sites within res 
from nuclease digestion (Grindley, et al., 1982; Kitts, et al., 1983). Each binding 
site consists of a pair of inverted repeats of nine base pairs (Figure 10). The 
consensus sequence for these binding sites is TGTCYNNTA (where Y is 
pyrimidine and N is any base) (Grindley, et al., 1982). The binding sites are 
separated by a variable spacer of 7, 10 or 16 base pairs. Site I, which has a 10-bp 
spacer, contains the recombination, or crossover point. y8 resolvase has been 
shown to induce a structural change corresponding to a bend in the DNA at 
site I (Hatfull, et al., 1987; Salvo and Grindley, 1988). 
All three dimeric binding sites contained in res are required for recombination 
(Grindley, et al., 1982; Kitts, et al., 1983; Wells and Grindley, 1984). When two 
identically oriented copies of the res site are present on a superhelical plasmid, 










Figure 10 The DNA sequences contained within res that are recognized and 
bound by y8 resolvase and y8(141-183). In all cases, the DNA sequences are 
written in the 5' to 3' direction. The consensus sequence was derived from 
comparison of the sequences that are recognized by the proteins. In the 
consensus sequence Y = a pyrimidine and N = any base. 
produce two caternated circular pieces of DNA (Reed and Grindley, 1981; 
Reed, 1981). Recombination proceeds via a staggered mechanism in which 
DNA cleavage occurs at site I (Reed and Grindley, 1981). During 
recombination the DNA between sites I and II is bent, or looped out, due to 
interactions between the different resolvase dimers within the complex (Salvo 
and Grindley, 1988). The unique structure obtained by this complex was 
termed a "resolvasome". In the absence of magnesium, the DNA is cut but not 
religated and an intermediate can be isolated in which the resolvase protein is 
covalently linked to the 5' phosphate of the DNA via serine 10 (Reed and 
Grindley, 1981; Reed and Moser, 1984; Hatfull and Grindley, 1986). 
The interactions between the 183 amino acid protein y8 resolvase and DNA 
have been examined by methylation and ethylation interference studies (Figure 
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11) (Falvey and Grindley, 1987). Major groove methylations within the 9 bp 
recognition sequence, as well as ethylation of phosphates within and adjacent 
to this region were found to inhibit resolvase binding. Minor groove 
methylations of adenine at and adjacent to the 3'-end of the recognition 
sequence also inhibited resolvase binding. Resolution was inhibited by 
methylation of adenine at the center of site I, suggesting that minor groove 
contacts near the crossover may be required for this activity. 
l l• 0 0 0 0 ol l 
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Figure 11 A consensus of inhibitory modifications displayed relative to the 9 
base pair consensus sequence. R = purine, Y = pyrimidine, N or n = any base. 
(n is used for positions outside the 9 bp-conserved segment.) Arrows indicate 
inhibitory ethylated phosphates, asterisks indicate major groove inhibitions 
(i.e., methylations where a guanine occurs in this position), and open circles 
indicate minor groove inhibitions (i.e., inhibitory methylations where an 
adenine occurs at this position). Adapted from Falvey and Grindley (1987). 
y8 resolvase can be cleaved by chymotrypsin into two fragments, one 140 
amino acids long and one 43 amino acids long (Abdel-Meguid, et al., 1984). 
The 140 residue amino-terminal domain does not bind DNA, but does contain 
residues known to be important for catalysis (Newman and Grindley, 1984) 
and to be responsible for protein-protein interactions (Abdel-Meguid, et al., 
1984). Recently, the crystal structure of the catalytic domain of y8 resolvase has 
been solved at 2.7 A resolution (Figure 12) (Sanderson, et al., 1990). The 
resolvase catalytic domain is an a~ structure consisting of a central ~ sheet 
made up of one antiparallel and four parallel ~ strands surrounded by four a 
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helices. The serine at position 10, which becomes covalently linked to the DNA 
during the recombinational event, is located in a loop between J3 strand 1 and a 
helix a. It was surprising to find this active site serine present on the surface of 
the protein. Enzyme-catalytic residues are usually positioned in an enzyme-
active site pocket and not on the surface of the protein. A mutational study has 
identified four resolvase residues, within this 140 amino acid domain, that are 
responsible for the protein-protein interactions required for recombination 
(Hughes, et al., 1990). Mutations at residues 2, 32, 54, and 56 produce a 
phenotype that is characterized by an inability to catalyze recombination, and 
that shows a loss of cooperative binding to the res DNA sequence. The side 
chains from these four residues are clustered on the surface of the protein that 
mediates the interactions between resolvase dimers in the crystal structure. 
Figure 12 A schematic representation of the 140 residue amino terminal 
domain resulting from chymotrypsin cleavage of yo resolvase. Adapted from 
Sanderson, et al. (1990). 
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The 43 amino acid carboxyl terminal domain, yo (141-183), binds specifically to 
each half site contained within res. However, unlike the native resolvase, 
which binds to all the sites with equal affinity, yo (141-183) binds each of the six 
half sites with different affinities (Abdel-Meguid, et al., 1984). Ethylation 
interference experiments reveal that the phosphate contacts made by the 
carboxyl terminal, DNA-binding domain are similar to the intact resolvase, 
with the exception of a single phosphate at 3' edge of each contact region 
(Rimphanitchayakit, et al., 1989). Phosphate contacts extend across adjacent 
major and minor grooves on one face of the DNA helix. The DNA is contacted 
over a 12 base pair sequence that includes the 9 base pair inverted repeat. 
s·-TGTCCGATAT ATN-3• 
I I I I 
CRITICAL CRITICAL 
Figure 13 The optimum DNA-binding sequence for yo (141-183) determined 
from mutagenesis experiments. Portions of the sequence that are contacted in 
the major and minor groove of the protein are indicated. Nucleotide 
substitution at positions that are labeled critical can result in a 100-fold increase 
kD of the protein. Adapted from Rimphanitchayakit and Grindley (1990). N = 
any base. 
Saturation mutagenesis of the DNA site bound by yo (141-183) has defined the 
sequence requirements for binding of yo resolvase to its recognition site 
(Rimphanitchayakit and Grindley, 1990). Saturation mutagenesis provided 31 
of the possible 36 single base mutations within the twelve base pair minimum 
binding sequence. Binding assays in vitro with yo (141-183) show that 
substitutions at eight of the twelve positions strongly inhibit complex 
formation, increasing the dissociation constant by 100 times or more. The 
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critical positions fall into two groups: positions 1-6 towards the 5'-end of the 
binding site and positions 9-10 towards the 3'-end of the binding site (Figure 
13). These positions correspond to regions where the DNA domain spans the 
major and minor grooves of its respective binding site (Falvey and Grindley, 
1987; Rimphanitchayakit, 1989). Base substitutions at the intervening positions, 
7 and 8, have modest effects on binding, less than a 20-fold increase in KD. 
Substitutions at positions 11 and 12 corresponding to the 3'-end of the DNA 
sequence have no effect on binding. The results of this study have identified an 
optimal sequence for y8 resolvase binding, 5'-TGTCCGAT(A/T)ATN-3' (where 
N equals any base) (Rimphanitchayakit, 1990). 
y8 (141-183) contains a high degree of sequence similarity with the helix-turn-
helix regions of several DNA binding proteins (Pabo and Sauer, 1984). Given 
sequence similarities with other DNA binding proteins, it has been proposed 
that resolvase uses the helix-turn-helix motif in the major groove for sequence-
specific DNA-binding (Abdel-Meguid, et al., 1984). The proposed orientation 
of the DNA binding protein y8 (141-183) is one in which the carboxyl end of the 
protein lies in the major groove, and the amino terminus is oriented toward the 
center of each dimeric binding site (Abdel-Meguid, et al., 1984; 
Rimphanitchayakit, et al., 1989). 
The Orientation of y,8 (141-183) Determined by Affinity Cleaving. 
Synthesis. Four 43 amino acid proteins based on the DNA-binding domain of y8 
resolvase (residues 141-183) were synthesized by a combination of automatic or 
manual, solid-phase techniques using tBoc-protected amino acids (Kent, 1988; 
Sarin, et al., 1981; Tam, et al., 1979; Merrifield, 1969). One of the proteins was y8 
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(141-183) with no modifications; it was a synthetic protein corresponding to the 
natural fragment produced by chymotrypsin cleavage of native y8 resolvase 
(Abdel-Meguid, et al., 1984). Two of the peptides .contained one EDTA 
molecule located at a discrete position within y8 (141-183) (Figure 14A). The 
first of these, EDTA-y8 (141-183), had EDTA derivatized to the amino terminus 
of the protein (Figure 14B). The EDTA was attached to the amino terminus of 
the protected resin-bound peptide using tribenyzl EDTA-y-aminobuteric acid 
(BEG) as described by Sluka, et al (1987; 1990). The second peptide containing 
one EDTA molecule, y8 (141-183)-EDTA, had the EDTA molecule derivatized 
near the carboxy terminus (Figure 14C). To provide a site of attachment for the 
EDTA near the carboxy terminus, the sequence of y8 (141-183) was altered. At 
position 183, the asparagine, which is found in the native molecule, was 
replaced by a lysine, whose E-amino group provided the point of attachment 
for the EDT A molecule. Attachment of the EDT A molecule near the carboxy 
terminus of the protein was accomplished by an orthoganol synthetic scheme 
that combined the use of tBoc and Fmoc protection (Figure 15) (Mack, et al., 
1990; Sluka, et al. , 1990). The N-E-Fmoc-protecting group on the lysine on 
position 183 was removed selectively from the side chain using piperidine and 
DMF. The tricyclohexal ester of EDTA was then attached to the side chain via 
an HOBt ester. The remaining portion of y8 (141-183)-EDTA was then 
synthesized using standard tBoc chemistry. The fourth y8 resolvase derivative 
that was synthesized, EDTA-y8 (141-183)-EDTA, contained two EDTA's 
attached at discrete positions within the peptide. The first EDTA was attached 
adjacent to the carboxy terminus on the E-amino group of lysine 183, and the 
second EDTA molecule was attached to the amino terminus of the protein at 





























Figure 14 a) The 43 amino acid DNA-binding domain of yo resolvase. 
Underlined regions are possible a-helices assigned according to a secondary 
structure predicting algorithm (Garnier, et al., 1978). In this structure helices 2 
and 3 would form the helix-turn-helix unit of the protein, with helix 3 
representing the recognition helix. b) The analog with EDTA attached to the 
amino terminus, EDTA-y8(141-183). c) The analog with EDTA attached near 
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Figure 15 The synthetic scheme for the attachment of the tricyclohexal ester of 
EDTA to the £-amino group of Lys183, on P-methylbenzylhydrylamine resin. 
DCC = dicyclohexalcarbodimide, (TFA) = trifluoroacetic acid; Bzl represents 
benzoyl and chex = cyclohexyl. 
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Following synthesis the proteins were deprotected and cleaved from the resin 
using HF treatment (prior to HF treatment the histidine-protecting, 
dinitrophenyl, was removed by thiolysis, and terminal t-Boc groups were 
removed with trifluoroacetic acid). The proteins were purified on a C8 reverse 
phase HPLC column using a 0-60% acetonitrile gradient. Sequences of the 
proteins were confirmed, using amino acid analysis and Edman degradation. 
Footprinting and affinity-cleaving patterns obtained with these four peptides 
were used to evaluate the orientation and binding characteristics of yo 
resolvase. 
Table 1. Overall Yields for the Synthetic Peptides Based on the DNA-




















Footprinting. Footprinting studies of the synthetic protein yo (141-183) 
demonstrated that at 2.0 ~concentrations the 43-mer binds to all six half sites 
contained within the res binding sites (Figures 16 and 17). At each half site the 
yo (141-183) protects a twelve base pair region of DNA centered on the 9 base 
pair consensus sequence (Figures 16 and 17). These observations are consistent 
with DNAse footprinting studies (Abdel-Meguid, et al., 1984) and ethylation 
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Figure 16 An autoradiogram of a high-resolution denaturing polyacrylamide 
gel containing 32P-end labeled fragments from PRW80. Bars on the left 
indicate the positions of the three binding sites, I, II, III (each consisting of a 
pair of imperfectly conserved, inverted repeats or half-sites) for gd resolvase 
with res. Odd and even numbered lanes 1-12 contain 5'- and 3'-labeled DNA, 
respectively. Lanes 1 and 2 contain intact DNA, lanes 3 and 4, EDTA-y8 (141-
183) at 0.5 Jl.M concentration; lanes 5 and 6, EDTA-y8 (141-183) at 2.0 Jl.M 
concentration; and lanes 7 and 8, EDTA-y8 (141-183) at 10.0 Jl.M concentration. 
Lanes 9 and 10 are MPE footprinting lanes containing y8 (141-183) at 2.0 J1.M 
concentration. Lanes 11 and 12 are MPE•Fe control lanes. Lanes 13 and 16 are 
5' and 3' chemical sequencing G reactions, respectively (Maxam and Gilbert, 
1980); lanes 14 and 15 contain 5' and 3' chemical sequencing A reactions, 
respectively (Iverson and Dervan, 1987). 
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Figure 17 Histograms of footprinting and affinity-cleavage data from the gel 
contained in Figure 16. The sequence, left to right, corresponds to the DNA 
sequence for site I to site III (top to bottom of the gel). I, II, and III are indicated 
by brackets. Boxes represent the 9 base pair binding sites assigned for y8 
resolvase (Grindley, et al., 1982). a) bars represent the extent of protection from 
MPE cleavage in the presence of y8 (141-183) (2.0 J..LM). b) Arrows represent the 
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interference studies (Rimphanitchayakit, et al., 1989) using yo (141-183) derived 
from a chymotrypsin digest of native resolvase. This indicates that the 
synthetically derived yo (141-183), and its related EDTA containing analogs, 
should provide useful information about the orientation and binding 
characteristics of the DNA-binding domain of yo resolvase. 
Position of the Amino Terminus. Affinity-cleaving studies with Fe•EDTA-yo (141-
183) yield a 3' shifted cleavage pattern adjacent to the 3'-end of the each half site 
contained within the res DNA sequence (Figures 16 and 17). These cleavage 
patterns are located at the center of each dimeric binding site for yo resolvase. 
The 3' shift of the cleavage pattern indicates that the Fe•EDTA group attached 
to the amino terminus of yo (141-183) is located proximal to the minor groove of 
DNA near the center of the dimeric binding site (Figure 18). This is in 
agreement with the ethylation interference studies conducted by 
Rimphanitchayakit, et al (1989). Ethylation of the 3' most phosphates contained 
within the 9 base pair consensus sequence, as well as two additional 
phosphates that are positioned across the minor groove, inhibited binding of 
the 43 amino acid carboxy terminal domain of yo resolvase. Given this 
information and comparing it with other helix-turn-helix proteins, 
Rimphanitchayakit, et al., (1989) proposed a model that positioned the amino 
terminus of yo (141-183) in the minor groove adjacent to the 3'-end of the 9 base 
pair consensus sequence for binding. The affinity-cleaving studies with 
Fe•EDTA-yo (141-183) support this model by establishing the position of the 
amino terminus of the protein as proximal to the minor groove at the 3'-end of 
the 9 base pair consensus sequence. 
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Figure 18 A model for y8 (141-183) binding to site I of res. The location of the 
EDTA•Fe moiety attached to the amino terminus of y8 (141-183) was assigned 
from the affinity-cleavage patterns contained in Figure 17. Filled circles 
represent the positions of cleavage along the phosphodiester backbone. The 







The cleavage of res by Fe•EDTA-yo (141-183) at different concentrations (in the 
range of 0.5 to 10 j..!M) shows that the six half sites have different affinities for 
the DNA-binding domain (Figures 16 and 17). At 0.5 j.lM protein concentration, 
sites Il-L and III-L are cleaved. At a fourfold higher concentration (2.0 j..!M), 
cleavage at sites I-L, I-R, II-R, and III-R appear with unequal intensity (Figures 
16 and 17). If the amount of cleavage is proportional to the extent of 
occupancy, the data suggest that the relative affinities of the DNA-binding 
domain of yo is Il-L, III-L > III-R, II-R > I-L, I-R. This is somewhat different 
with the relative binding affinities assigned from footprinting studies of the 
DNA-binding domain obtained by the chymotrypsin digest. Abdel-Meguid, et 
al (1984) assigned the relative orders of affinity as Il-L, III-L, > I-R, > III-R, I-L > 
II-R. The difference in relative affinities is probably a result of the method by 
which the binding affinities were obtained. 
Position of the Carboxy Terminus. The specific cleavage patterns produced by yo 
(141-183)-EDTA•Fe are shifted to the 3' side and indicate that the EDTA•Fe, 
attached near the carboxy terminus of the putative recognition helix, is 
positioned within the yo-binding site above the major groove adjacent to the 5' 
end of the 9 base pair recognition sequence (Figures 19 and 20). In the case of 
the right half of site I, the cleavage pattern is centrally located about the 
sequence 5'-TGTGC-3' (Figure 21). An examination of the structural data 
available for prokaryotic regulatory proteins that bind DNA, using the helix-
turn-helix motif, identifies two possible orientations for the putative 
recognition helix of yo (141-183) (Figure 21). High-resolution, x-ray crystal 
structures of the 1.. repressor and 434 repressor protein-DNA complexes show 
that the carboxy termini of the recognition helices in these proteins are pointing 
toward the center of the dimeric binding sites (Jordan and Pabo, 1988; 
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Figure 19 An autoradiogram of a high-resolution denaturing polyacrylamide 
gel containing 32P-end labeled fragments from PRW80. Bars on the left-hand 
side of the gel mark the location of the three dimeric-binding sites contained 
within res. Odd numbered lanes contain 5'-end labeled DNA and even 
numbered lanes contain 3'-end labeled DNA. Lanes 1 and 2 contain intact 
DNA; lanes 3 and 4 contain 10 ~ Fe•EDTA-y8(141-183); lanes 5 and 6 contain 
10 J.l.M y8(141-183)-EDTA•Fe; lanes 7 and 8 contain 10 J.l.M Fe•EDTA-y8 (141-
183)-EDTA•Fe; lanes 9 and 10 are A-specific cleavage lanes. 
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Aggarwal, et al., 1988). The second possible orientation is obtained from NMR 
studies of the lac repressor headpiece bound to its operator DNA (Boelenes, et 
al., 1987). The studies show that the putative recognition helix from lac 
repressor is oriented with the carboxy terminus in the opposite direction, 
pointing away from the center of the dimeric-binding site. When the position 
of the EDT A • Fe attached to the E amino group of lysine 183 is considered for 
each possible orientation, relative to the cleavage data, a better fit is obtained 
with the orientation shown in Figure 21A. This orientation is similar to the 
orientation of the recognition helix of f... and 434 repressors obtained from 
crystal structures (Aggarwal, et al., 1988; Jordan and Pabo, 1988). This 
orientation is also similar to that assigned for the 52 residue DNA-binding 
domain of Hin recombinase (Mack, et al., 1990). It is opposite to the orientation 
assigned to the lac repressor headpiece recognition helix by affinity-cleaving 
techniques (Shin, et al., 1991). The fact that the cleavage pattern is seen 
predominantly on one, but not on both, minor grooves adjacent to the major 
groove location of the helix-turn-helix motif suggests that the EDTA •Fe moiety 
(and hence the putative reocgnition helix of yo (141-183)) is not positioned 
symmetrically in the major groove. These data would be consistent with the 
carboxyl end of the recognition helix projecting outward from the floor of the 
major groove and tilting away from the center of the inverted repeat-binding 
site. Clearly, refinement of these models must await more definitive x-ray 
crystallographic and NMR analysis of the protein-DNA complex.In controls, yo 
(141-183) equipped with EDTA at both the amino and carboxyl termini, 
Fe•EDTA-yo (141-183)-EDTA•Fe produces a cleavage pattern consistent with 
the combination of patterns from Fe•EDTA-yo (141-183) and yo (141-183)-










Figure 21 A schematic representation of the two models of yo (141-183)-
EDTA • Fe bound to the right half of site I. Sites of DNA cleavage along the 
helix are marked by dots, the sizes of the dots correspond to the magnitude of 
cleavage at that position. a) The orientation of the putative recognition helix 
based on 434 and A.-repressor DNA co-crystals. b) The orientation of the 
putative recognition helix based on lac repressor NMR studies. Model A seems 
to provide the best fit with the experimental cleavage data. 
the EDTA•Fe derivatized analogs of y8 (141-183) remain unchanged whether or 
not EDTA • Fe is present or absent at other positions in the molecule suggests 
that the structure of y8 (141-183) is not significantly perturbed by the 
attachment of EDTA•Fe at position 141 or position 183. 
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Conclusions . MPE•Fe(II) footprinting studies have shown that the synthetic 
protein, yo (141-183), protects a twelve base pair region of DNA centered on the 
yo recognition sequence. Affinity-cleavage studies with EDTA on the amino 
terminus have located the amino terminus of yo (141-183) in the minor groove 
at the center of each dimeric binding site. Cleavage studies with EDTA 
attached at the caboxy terminus of yo (141-183) reveal that the putative 
recognition helix is in the adjacent major groove, oriented (N to C) toward the 
center of each binding site. The binding model for yo (141-183), which is similar 
to that proposed for Hin (139-190) (Sluka, et al., 1987, 1990; Mack, et al., 1990), 
places the helix-turn-helix motif of the protein in the major groove with 
residues at the amino terminus extending across the DNA phosphodiester 
backbone and making specific contacts on the same face of the helix to the 
adjacent minor groove. This model for yo (141-183) binding is consistent with 
methylation and ethylation interference studies, using the native resolvase 
(Falvey and Grindley, 1987) and ethylation interference studies using yo (141-
183) obtained from a chymotrypsin digest (Rimphanitchayakit, et al., 1989). yo 
and Hin DNA-binding domains may be examples of modular DNA and 
protein interactions with two adjacent DNA sites, major and minor grooves, 
bound on the same face of the helix by two separate parts of the protein. 
The Effects of Amino Acid Substitution on DNA-Binding Specificity. 
Experiments performed by Wharton, et al (1984) and Wharton and Ptashne 
(1985) have shown that by changing the amino acid composition of the 
recognition helix from a protein that binds DNA using the helix-turn-helix 
motif can alter its DNA binding specificity. The study performed by Wharton, 
et al (1984) involved the proteins 434 repressor and 434 cro. Through the use of 
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sequence homologies, the putative recognition helices in each of these proteins 
were identified and aligned. Comparison of the putative recognition helices 
from 434 cro and 434 repressor showed that they differed in only 5 amino acids. 
A "helix switch" was performed by substituting the recognition helix of 434 
repressor with the recognition helix of 434 cro. The resulting hybrid protein 
was named repressor*. Repressor* possesed the same sequence-specific DNA 
contacts and binding characteristics as the 434 cro protein (Wharton, et al., 
1984). Exchanging the recognition helices had succeeded in changing the 
DNA-binding characteristics of the protein. 
In a second experiment, Wharton and Ptashne (1985) were able to alter the 
binding specificity of 434 repressor by replacing only the amino acids on the 
solvent-exposed surface of the recognition helix. By aligning and 
superimposing the sequences of 434 and P22 repressors with the helix-turn-
helix unit observed in the x-ray crystal structure of A.-repressor, the residues on 
the solvent-exposed, or DNA contact, surface of the recognition helices were 
identified. The sequence of 434 repressor was then mutated to incorporate 
these residues from P22 repressor. The resulting hybrid molecule possessed 
the DNA-binding specificity of P22 repressor. In order to determine which 
portion of the recognition helix was responsible for determining DNA-binding 
specificity, the recognition helix was divided into three segments. The first 
segment, the amino terminal end of the recognition helix contained three 
"contact residues," the second segment, the center of the recognition helix 
contained one "contact residue," and the third segment, the carboxyl end of the 
recognition helix contained one "contact residue." Amino acid substitution 
within the carboxy segment of the recognition helix was found to have no effect 
on the DNA-binding specificity of the hybrid protein. Simultaneous 
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substitution of the three "contact residues" in the amino segment of the 
recognition helix produced a protein that showed no binding specificity 
towards either 434 or P22 binding sites. Substitution of only the contact residue 
in the central segment of the recognition helix also produced a protein that 
showed no binding specificity towards either 434 repressor or P22 repressor 
binding sites. Only simultaneous substitution of all the "contact residues" 
located in the amino and center segments created a protein that exhibited 
sequence-specific DNA binding. Since the amino segment of the recognition 
helix contained three "contact residues" that were always substituted 
simultaneously, it was impossible to determine if all three of these residues are 
involved in DNA binding. A systematic study that would examine all possible 
single and multiple amino acid exchanges between the contact surfaces of two 
helix-turn-helix proteins might provide further insight into the molecular basis 
of protein-DNA recognition by helix-turn-helix proteins. 
"Helix Switch" studies using y8 (141-183) and Hin(139-190). yo resolvase and Hin 
recombinase are both thought to bind to DNA, using the helix-turn-helix motif 
(Abdel-Meguid, et al., 1984; Sluka, et al., 1987). Hin recombinase and yo 
resolvase show a 35% homology of amino acid composition (Simon, et al., 
1980). Both proteins contain two functional domains, an amino-terminal, 
catalytic domain and a carboxy terminal DNA-binding domain (Abdel Meguid, 
et al., 1984; Sluka, et al., 1987). The carboxy terminal DNA-binding domains, yo 
(141-183) and Hin (139-190), are synthetically accessible, using solid-phase tBoc 
peptide synthesis (Sluka, et al., 1987; Graham and Dervan, 1990). Affinity-
cleaving studies have demonstrated that the amino and carboxy termini of 
these proteins share similar orientations with respect to their DNA-binding 
sites (Sluka, et al., 1987, 1990; Mack, et al., 1990; Graham and Dervan, 1990). 
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The model for DNA-binding by both of these includes a helix-turn-helix motif 
in the major groove with residues at the amino terminus extending across the 
DNA phosphodiester backbone and making specific contacts on the same face 
of the helix to the adjacent minor groove (Sluka, et al., 1987, 1990; Mack, et al., 
1990; Graham and Dervan, 1990; Glasgow, et al., 1989; Bruist, et al., 1987; 
Rimphanitchayakit, et al., 1989; Falvey and Grindley, 1987).While the 
orientation of the proteins relative to their DNA-binding sites is similar and 
while they possess a high degree of amino acid sequence homology, their 
DNA-binding sites are significantly different in the 5' region (Figure 22). 
Methylation interference studies have demonstrated that the major groove in 
this region is involved in protein binding (Falvey and Grindley, 1987; 
Rimphanitchayakit, et al., 1989; Glasgow, et al., 1989; Bruist, et al., 1987). The 
models for DNA binding by y8 resolvase and Hin recombinase position the 
recognition helices of the proteins in the major groove in this region of the 
recognition sequence. This indicates that the recognition helix from y8 
resolvase is designed to bind to the sequence 5'-TGTCC-3', while the 
recognition helix from Hin recombinase is designed to bind 5'-TTCTY-3'. 
Consequently, it is not surprising that these two peptides show little cross 
reactivity towards each other's binding sites (Figure 23 and 24). The 
combination of synthetic accessibility, similar DNA binding orientations, and 
low cross reactivity for DNA binding sites make y8 (141-183) and Hin(139-190) 
excellent candidates for a systematic helix-switch experiment. Experimental 
Design . A sequence alignment of the helix-turn-helix region from A.-cro, 
Hin(139-190), and y8 (141-183) is shown in Figure 25. Sequence alignment was 
made based on the residues that are thought to control the packing (and 
therefore the three-dimensional structure) of the helix-turn-helix unit, and not 
on the residues that contact the DNA. This type of sequence alignment makes 
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Figure 22 The recogniton sequences of the half sites bound by Hin(139-190) a) 
and yo (141-183) b). In all cases the DNA sequences are written in the 5' to 3' 
direction. The consensus sequences are derived from comparison of the 
sequences from the individual half sites. N =any base. Y =pyrimidine. 
it possible to indentify differences in amino acid composition at positions in the 
recognition helix that are thought to be in contact with the DNA. These 
differences in amino acid composition may be responsible for producing the 
differences in DNA-binding specificity observed between the proteins. Based 
on this alignment the sequences of the helix-turn-helix regions of yo (141-183) 
and Hin (139-190) were superimposed upon the a carbon backbone of A.-cro, 
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Figure 23 An autoradiogram of a high-resolution gel containing 32P-end 
labeled fragments of DNA from the Sal !/Hind III fragment from PRW80 
containing res. Lanes 1 through 5 contain 5'-end labeled DNA, lanes 6 through 
10 contain 3'-end labeled DNA. Lanes 2 through 9 are affinity-cleavage lanes. 
Lanes 2 and 9 contain EDTA•Fe(II)-y8 (141-183) at 2.0 J.lM concentration. Lanes 
3 and 8 contain EDTA•Fe(II)-Hin(139-190) at 40.0 J.lM concentration, lanes 4 
and 7 contain EDTA•Fe(II)-Hin(139-190) at 20.0 J..1M concentration, lanes 5 and 
6 contain EDTA•Fe(II)-Hin(139-190) at 10.0 J.lM concentration. Lanes 1 and 10 
contain A-specific cleavage lanes (Iverson and Dervan, 1987). 
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Figure 24 An autoradiogram of a high-resolution gel containing 32P-end 
labeled fragments of DNA from Xbal/EcoRI fragment of PMFb36 containing 
the Hin recombinase binding sites, Hix R and Hix L. The DNA is 3'-end 
labeled. Lanes 1 through 4 are affinity-cleavage lanes. Lanes 1 through 3 
contain EDTA•Fe(II)-yo (141-183) at 10, 20,40 J.!M concentrations, respectively. 
Lane 4 contains EDTA•Fe(II)-Hin(139-190) at 2.0 J.!M. Lane 5 is a G-specific 
chemical-sequencing lane (Maxam and Gilbert, 1980). 
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Figure 25 An alignment of the amino acid sequences in the helix-turn-helix 
domain of A cro hidden recombinase and yo resolvase. Residues contained 
within boxes are thought to provide the protein-protein contacts that define the 
helix-turn-helix motif. Amino acids shown in bold in the recognition helix are 
thought to contact the DNA based on the crystal structure of A cro. The circled 
























































































































































































































































































































































































































































and the amino acid side chains that were located on the DNA contact face of 
the putative recognition helices were identified. Residues at six points along 
the recognition helix were found to have side chains that were positioned in a 
way that they could make contact with DNA. The amino acids at four of these 
positions were different in the sequences of yo resolvase and Hin recombinase 
(Figure 25). 
The fifteen yo (141-183) analogs, containing single- or multiple-point mutations 
from the exchange of DNA "contact residues" with those found in the putative 
recognition helix from Hin (139-190), are shown in Figure 26. It should be 
noted that the proteins are designated by which amino acids are present at the 
four DNA contact positions that are variant between Hin and yo. For example, 
natural yo (141-183) contains an arginine, lysine, asparagine, and glutamic acid 
at these positions. Under this nomenclature the designation for this protein 
would be RKNE. If the first position is substituted with valine, which is found 
in Hin(139-190), the designation would become VKNE. If the first two variant-
contact residues are substituted for valine and arginine, respectively, which are 
present in Hin(139-190), the name of the protein becomes VRNE. This 
nomenclature continues for substitution at any one of the four variant 
positions. The fifteen hybrid proteins in yo resolvase represent all possible 
permutations of amino acid composition at these four variant positions. By 
examining all possible combinations, it is hoped that we can identify specific 
amino acid and DNA interactions that determine specificity. 
Results. A systematic helix-switch experiment between Hin(139-190) and yo 
(141-183) was conducted to determine the requirements to convert yo (141-183) 
into a protein that was capable of recognizing DNA sequences bound by 
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Hin 
v s T L y R y F p A 
y8 
R s T v y K v I N E 
Hybrids 
s T v y v I 
R R p A 
v R p A* 
R K p A 
v K p A 
R R N A 
v R N A 
R K N A 
v K N A 
R R p E 
v R p E 
R K p E 
v K p E 
R R N E 
v R N E 
v K N E 
Residue 
Number 172 177 180 181 
Figure 26 The amino acid sequences of the recognition helices from Hin, yo, 
and the hybrid peptides resulting from single or multiple substitutions of 
amino acids within the recognition helix of yo (141-183). In the sequences, 
letters shown in bold represent putative contact residues. The sequence of the 
hybrid proteins at the variant residues is used to name, or identify, the protein. 
The sequence listed with an asterisk corresponds to a complete exchange of 
amino acid residues between Hin and yo resolvase. The designation for yo 
resolvase under this nomenclature would be RKNE. 
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Hin(139-190). Since the amino acid composition of the DNA contact face of the 
putative recognition helices for ya (141-183) and Hin(139-190) differed at four 
positions, 15 hybrid proteins of ya resolvase were synthesized that contained 
one or more of the amino acids found in Hin recombinase. All 15 of these 
proteins were synthesized, using solid-phase tBoc methodology. EDTA was 
attached to the amino terminus of each of these peptides. Synthetic yields are 
reported in Table 2. Derivatization of the proteins with EDTA allowed the use 
of affinity cleaving to report both the location and the strength of protein 
binding. Following synthesis, the proteins were deprotected and cleaved from 
the resin using HF treatment (prior to HF treatment, the histidine-protecting, 
dinitrophenyl was removed by thiolysis, and terminal t-Boc groups were 
removed with trifluoroacetic acid). The proteins were purified on a C8 reverse 
phase HPLC column using a 0-60% acetonitrile gradient. Sequences of the 
proteins were confirmed, using amino acid analysis and Edman degradation. 
The DNA-binding properties of the 15 hybrid peptides were examined and 
compared to those of ya (141-183) and Hin(139-190) on both the Hind III/Sal I 
fragment of PRW 80 containing res, and the Xba 1/Eco RI fragment of pMF B36, 
containing the Hin recombinase-binding sites Hix Land Hix R. 
Binding of Helix-Switch Hybrid Peptides to the Hind III/Sal I Fragment from PRW 
80 containing Res . The affinity-cleavage patterns produced by the EDTA-
labeled, helix-switch hybrid proteins, EDTA-ya (141-183) EDTA-Hin(139-190) 
when bound to the Hind III/Sal I fragment from PRW 80, which contains res , 
are shown in the autoradiogram contained in Figure 27. A summary of the 
strength and location of protein binding determined by densitometric 
analysis of the affinity-cleavage patterns from the autoradiogram in Figure 27 
is found in Table 4. Examination of the data in Table 4 shows that the hybrid 
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Table 2. Synthetic Yields for the Proteins Used in Helix-Switch 



























































Table 3. Retention Times for the Purified Helix-Switch Hybrid Proteins. A 
Brownlee Cs Reverse Phase Column was used for the chromatography. It 
was eluted with a 0-60% acetonitrile gradient containing 0.1% 


































proteins could be divided into four classes. 
The first class of proteins shows a strong affinity of yo resolvase-binding sites, 
but no affinity for additional sites. These proteins are RKPE, RKNA, and 
RKPA. The only other protein that exhibits identical binding characteristics is 
the native peptide EDT A-yo (141-183), or RKNE, using the same nomenclature. 
Comparison between these three hybrid proteins and yo (141-183) shows that 
only Arg 172 and Lys 177 are invariant. The other two positions, 180 and 181, 
are totally variable, with all possible permutations being expressed. This seems 
to indicate that Arg 172 and Lys 177 are required for the recognition of yo 
resolvase-binding sites. 
The second class of proteins shows strong binding to the yo resolvase sites, plus 
affinity for additional new sites. These proteins are RRNE, RRPE, RRP Aa,b and 
RRNA. They bind all six half sites contained within res , plus a new site 
designated NI. The sequence of NI is 5'-TT A TTCA TT A-3'. The 5' regions of NI 
and Hix L (R), which is the site of the major groove contacts between the 
protein and the putative recognition helix, are highly homologous. The 
binding sequence for Hix L (R) is 5'-TTATCAAAAA-3'. When we examine the 
proteins that bind this series of sites, we see once again conservation of amino 
acids at positions 172 and 177, with variability at positions 180 and 181. In this 
~ase, positions 172 and 177 are both arginine. Apparently, Arg 177 does not 
affect the protein's ability to bind yo resolvase-binding sites, but imparts an 
ability to bind additional sites that are more "Hin"-like such as site NI. It is 
interesting to note that EDTA-Hin(139-190) is also capable of binding the site 
NI. 
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Figure 27 An autoradiogram of a high-resolution denaturing polyacrylamide 
gel containing s·-32P-end labeled fragments from PRW80. Bars on the left 
indicate the position of the three binding sites I, II, and III (each consisting of 
imperfectly conserved inverted repeats) for yB resolvase within res, Lane 1 
contains control DNA. Lanes 2 through 18 are affinity-cleavage lanes 
containing 2.0 ~ EDT A • Fe(II) amino-labeled proteins. The sequences of the 
proteins are written above each lane. Lane 19 contains a G-specific cleavage 
lane (Maxam and Gilbert, 1980) and lane 20 contains an A-specific lane (Iverson 
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The next class of proteins consists of those that possess a weak binding affinity 
for y8 resolvase sites, but a strong affinity for additional sites, specifically a 
strong affinity for site NI. These proteins are VRNA, VRNE, VRPA, and EDTA-
Hin(139-190). It should be pointed out that EDTA-Hin(139-190) has the same 
DNA contact pattern of amino acids as the hybrid protein VRPA. However, 
these proteins differ in that one is a Hin recombinase, and the other is a y8 
resolvase hybrid. Examination of these proteins shows once again that 
positions 172 and 177 are invariant within the class. In this case, position 172 is 
always valine and position 177 is always arginine. The other two positions, 180 
and 181, are more variable. 
The fourth class of proteins consists of those that retain little or no binding 
affinity for y8 resolvase-binding sites and express no affinity towards any 
additional sites, including site NI. These proteins are VKNE, VKP A, VKPE, 
VKNA, and VRPE. For the most part, all of these proteins possess a valine at 
position 172 and a lysine at position 177. The other two amino acids found at 
positions 180 and 181 are completely variable. The only exception to this is the 
protein VRPE. By analogy with the other hybrid proteins, you would expect 
this protein to show a binding affinity for site NI but weak or no affinity for any 
of the y8 resolvase-binding sites, because of the presence of a valine at position 
172 and an arginine at position 177. However, the protein VRPE, for some as 
yet unknown reason, possesses no ability to bind DNA specifically. 
Binding of Helix-Switch Hybrid Peptides to the Xba 1/EcoRI Fragment from pMFB 
36, which contains the Hin Recombinase Sites Hix Land Hix R.. Affinity-cleavage 
patterns produced by the EDTA-labeled, helix-switch hybrid proteins, EDTA-y8 
(141-183) and EDTA-Hin(139-190), when bound to the XBA I/EcoRI fragment 
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of pMFB 36 containing Hix L and Hix R, are shown in the autoradiogram 
contained in Figure 28. A summary of the strength and location of protein 
binding determined by densitometric analysis of the affinity-cleavage patterns 
for the autoradiogram in Figure 28 is found in Table 5. An examination of the 
data contained in this table reveals that the binding characteristics of the 
proteins fall into three major categories. 
The first category is proteins, which possess no binding affinity for Hin 
recombinase-binding sites, but show affinity for a novel site recognized by 
EDTA-y8 (141-183). These proteins are RKPE, RKNA, RKPA, RRNE, RRPE, 
RRP Aa,b, and RRNA. While these proteins were unable to recognize any of the 
Hin recombinase sites found in this restriction fragment, they were able to 
recognize a sequence that was also bound by EDTA-y8 (141-183). Analysis of 
the affinity-cleavage patterns has identified the sequence as 5'-CGCTTTTCT-3'. 
Within the 5'-region of this sequence, there is reasonable homology to the 5'-
region of site IlL from res. It is not surprising that these proteins would bind a 
novel site recognized by EDTA-y8 (141-183) because all of them have retained 
strong binding affinities for the y8 resolvase-binding sites contained within res. 
The second category of proteins includes those that contain no binding affinity 
for Hin recombinase-binding sites or novel sites within the restriction fragment. 
These proteins are VKNE, VKP A, VKPE, VKN A, and VRPE. These are the 
same five proteins that showed no binding specificity or affinity for sites 
contained within res. It is possible that they may not be competent to bind 
DNA specifically. Once again, with the exception of VRPE, they possess a 
valine at position 172 and a lysine at position 177. 
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Figure 28 An autoradiogram of a high-resolution denaturing polyacrylamide 
gel containing s·-32P-end labeled fragments from PMFb36. Bars on the left 
indicate the position of the Hin recombinase binding sites. Lane 1 contains 
control DNA. Lanes 2 through 18 are affinity cleavage lanes containing 2.0 j..iM 
protein with EDTA•Fe(II) attached to the amino terminus. The sequences of 
the proteins are written above their corresponding lanes. Lane 20 is an A-
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The final category of proteins is proteins possessing some binding specificity 
for Hin recombinase-binding sites. Three proteins fall into this category, 
VRNA, VRNE, and VRPA. It is important to note that these are the same three 
proteins that possessed Hin-like binding characteristics when the binding of the 
hybrid proteins to res was examined. Generally, while these proteins are 
capable of recognizing Hin recombinase-binding sites, they do it at a lower 
affinity than the native Hin recombinase. Additionally, they fail to recognize 
all the sites that are recognized by Hin recombinase. The protein VRNA shows 
weak affinity for the Hin recombinase secondary L and some binding in the 
region of Hix R. It is important to note that because of limitations in gel 
resolution, binding in the region of Hix R was not fully characterized, so an 
assignment of a binding site is not possible; therefore, these data should not be 
weighed as heavily as other binding sites. The protein VRP A, in which the 
amino acid composition of the contact face of the putative-recognition helix is 
identical to that of Hin recombinase. It is capable of binding weakly the Hin 
site secondary, R, which is equivalent to Hix R (L). This protein also 
demonstrates a weak binding in the region of Hix R. The remaining protein, 
VRNE, is more Hin-like in its binding characteristics. It possesses a weak 
affinity for the sites Hix L (L), Hix L (R), and secondary L. It shows a strong 
affinity for the site secondary R, which is equivalent to Hix R (L). In light of 
this, it is not surprising that the protein also shows a strong affinity in the 
region of Hix R. 
Conclusions. While the helix-switch experiment between Hin recombinase and 
yo resolvase failed to produce a hybrid protein that converted yo resolvase into 
a protein with solely Hin recombinase DNA binding specificity, it did provide 
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useful insights into the DNA recognition of both of these proteins. Generally, it 
was found that DNA-binding specificity is insensitive to the amino acids found 
at positions 180 and 181 in the recognition helix; this is proximal to the carboxy 
end of the recognition helix. Positions 172 and 177, which are proximal to the 
amino end of the recognition helix, however, had a significant impact on the 
DNA-binding specificity of the proteins. This is consistent with the results 
obtained by Wharton and Ptashne, 1985, in their studies examining a helix-
switch experiment between 434 repressor and P22 repressor. Generally 
speaking, arginine at position 172 is required to impart y8 resolvase-binding 
specificity on the hybrid proteins. The substitution of the lysine at position 177 
with arginine will create a class of proteins that are capable of recognizing 
sequences in addition to those bound by native y8 resolvase. Placing a valine at 
position 172, followed by a lysine at position 177, tends to create proteins that 
show weak binding specificity for any given site. Placing a valine at position 
172, followed by an arginine at position 177, tends to create proteins with more 
"Hin-like" DNA-binding specificity. The only exception to this is the protein 
VRPE, which expresses no binding specificity at all. It is possible that this 
combination of amino acids disrupts the secondary structure of the helix-turn-
helix motif in such a way that it is no longer competent to bind DNA. 
The failure of this helix switch to produce a protein with completely altered 
DNA binding specificity is not totally unexpected. The experiments conducted 
by Wharton and Ptashne, 1985, and Wharton, et al., 1984, which successfully 
produced hybrid proteins with fully altered DNA-binding specificity, were 
performed using proteins that showed some cross-reactivity. Our experiments 
used Hin recombinase and y8 resolvase, which were demonstrated to possess 
no cross-reactivity. 
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The availability of additional information has refined our view of helix-turn-
helix proteins from the time when these experiments were initially conceived. 
Examination of the high-resolution, crystallographic data available for helix-
turn-helix protein-DNA complexes (Anderson, et al., 1987; Aggarwal, et al., 
1988; Otwinoski, et al., 1988; Jordan and Pabo, 1989) in addition to low-
resolution, crystallographic structures or NMR studies (Wolberger, et al., 1988; 
Anderson, et al., 1981; McKay and Steitz, 1981; Kaptain, et al., 1985) have 
demonstrated that the helix-turn-helix units of the different DNA-binding 
proteins have extremely similar structures. Typically, the a-carbon backbones 
from the helix-turn-helix units can be superimposed with an average deviation 
of less than 1.1 A per a-carbon (Steitz, et al., 1982; Ohlendorf, et al., 1983). The 
general structure of the protein-DNA co-crystals also possess some degree of 
similarity. Generally, the recognition helix of the helix-turn-helix unit is 
positioned in the major groove with the first helix of the unit lying across the 
major groove and the recognition helix. 
Closer examination of the structures, however, discloses interesting differences 
in the way the proteins utilize the helix-turn-helix unit to recognize DNA. 
Several different mechanisms have been identified by which helix-turn-helix 
proteins recognize DNA. There is direct hydrogen bonding, as in the case of A-
repressor or engrailed, direct hydrogen bonding in combination with 
alterations in DNA conformation, as in the case of 434 repressor and CAP, and 
water-mediated hydrogen bonding in combination with changes in structural 
conformation of both the protein and DNA, as in the case of Trp repressor. It 
has become apparent that even if the same mechanism of sequence-specific 
recognition is used, for example, direct hydrogen bonding in the case of A-
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repressor and engrailed, variations in the relative positioning of the protein and 
DNA can significantly alter the amino acid side chains that are positioned to 
interact with the DNA. 
The result of these "subtle differences" is that it is difficult to use the contacts 
for one helix-turn-helix protein to predict the pattern of side chain base 
interactions for another helix-turn-helix protein (Sauer, et al., 1990). There is, in 
effect, no simple recognition code that determines which side chains of a helix-
turn-helix will interact with a particular base pair (Sauer, et al., 1990). In light 
of this it is easy to understand how the amino acid substitutions between Hin 
and y8 resolvase might fail to produce a protein of completely altered DNA-
binding specificity. 
Experimental 
General. Nuclear Magnetic Resonance spectra were recorded on a JEOL GX 400 
MHz NMR and are reported as parts per million downfield from 
tetramethylsilane. Ultraviolet-visible spectra were recorded on a Beckman 
model 25 spectrophotometer, a Perkin Elmer 'A 4C spectrophotometer, or a 
Hewlett Packard model 8451A spectrophotometer. Mass spectrometry was 
performed by the Regional Mass Spec Facility at the University of California at 
Riverside. Laser densitometry of gel autoradiograms was performed on an 
LKB Ultrascan XL densitometer. Tribenzyl EDTA GABA (BEG) was 
synthesized using published protocols (Sluka, 1988; Sluka, et al., 1990). 
Synthesis of t-Boc-y-aminobuteric acid: t-Boc-GABA. 20.6 g (200 mmoles) of y-
aminobuteric acid was dissolved in 800 ml of a 2:1:1 mixture of 
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dioxane:water:l.O N NaOH. The mixture was cooled to 0 °C in an ice bath. 48.0 
g (250 mmoles) of di-t-butyldicarbonate were dissolved in 20 ml of dioxane, 
and this solution was added to the reaction mixture over a period of 30 min. 
Following the addition, the reaction was stirred for 60 min at 0 oc. Then it was 
allowed to warm to room temperature over a period of 90 min. The dioxane 
was then removed from the reaction under reduced pressure, using a rotary 
evaporator. The remaining aqueous solution was placed in an ice bath and 
cooled to 0 °C. 400 ml of ethylacetate were added and the water:ethylacetate 
mixture was mixed vigorously, using a vortex mixer. To this vigorously 
stirring solution, enough 2 M KHS04 was added to adjust the pH of the 
aqueous phase to 1.6. The ethylacetate was then removed, and the aqueous 
layer was extracted two additional times with ethylacetate (300 ml). The 
organic layers were pooled, extracted once with water (400 ml) and once with a 
saturated NaCl solution (400 ml). The ethylacetate solution was concentrated 
to a volume of approximately 50 ml, using a rotary evaporator. The resulting 
clear liquid was kept at 4 °C overnight. The following morning, the flask was 
full of white crystals and a small portion of liquid. The solution and crystals 
were taken up in approximately 200 ml of cold hexane and filtered through a 
glass frit. The resulting crystals were washed two times with hexane (50 ml). 
After drying under high vacuum, 33.1 g of t-Boc-GABA in an 82% yield were 
obtained. 1H NMR (400 MHz CD CL3) 8 5.61 (bd, s, 1H), 4.69 (bd, s, 1H), 3.20 
(m, 2H), 2.40 (t, 2H, J =6Hz), 1.85 (m, 2H), 1.40 (s, 9H). 
Synthesis of TricyclohexalEDTA(TCE). 20.56 g (68 mmoles) of EDTA-tetra acid 
and 4 ml of H2S04 were added to a flask containing 145ml of cyclohexanol. 
The resulting mixture was stirred at 105 °C for 12h, at which time most of the 
EDTA had dissolved. The mixture was cooled to room temperature, dumped 
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into 300 ml of water and adjusted to pH 4 with the addition of saturated 
NaHCl3. The resulting aqueous solution was extracted three times with diethyl 
ether (500 ml). The ether extracts were pooled and the diethyl ether was 
removed under vacuum with the use of a rotary evaporator. This afforded us 
with approximately 200 ml of a solution that contained traces of ether and 
residual cyclohexanol. The remaining cyclohexanol and any traces of ether 
were removed under vacuum distillation at 80 °C. The resulting yellow gum 
was placed on the vac line for 3 days to remove any additional cyclohexanol. 
This material was then purified via silica gel chromatography 
(methanol:CH2Cl2 3.1:100). 8.65 g of TCE were obtained as a yellow oil in a 
23.6% yield. 1H NMR (400 MHz DMSO-d6) o 4.65 (m, 3H), 3.50 (s, 4H), 3.49 (s, 
2H), 3.36 (s, 2H), 2.71 (s, 4H), 1.21-1.78 (m, 30H). Mass Spectroscopy +ve FAB 
CH2Cl2/NBA Observed MH+ at M/Z 539.33 (539.33 calculated for C28 H47 08 
N2). 
Peptide Synthesis. The synthesis of yo resolvase and the related mutant peptides 
was carried out, using a combination of manual peptide synthesis procedures 
and automated synthesis performed on an ABI model 430A Peptide 
Synthesizer. Manual peptide synthesis was carried out in a 20 ml vessel fitted 
with a coarse glass frit, as described by Kent (1988). Automated syntheses were 
performed on an ABI 430A Synthesizer, modified by the removal of in-line 
filters to the top and bottom of the reaction vessel, using a 20-ml teflon/KLF 
reaction vessel (Kent, et al., 1984; Kent and Clark-Lewis, 1985). The automated 
synthetic protocols used were developed at the California Institute of 
Technology (Kent and Clark Lewis, 1985), and the manual protocols used were 
a modification of those described by Kent (Kent, 1988). All protected amino 
acid derivatives were purchased from Peninsula Laboratories, with the 
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exception of Boc-L-his (DNP), which was obtained from Fluka and N-a-t-Boc-
N-e-Fnoc-L-lysine, which was obtained from Chemical Dynamics Corporation 
(S. Plainfield, NJ). PAN resin with N-a-t-Boc-L-asparagine was purchased 
from Applied Biosystems and p-BHA resin was purchased from United States 
Biochemical Corporation. Dichloromethane (DCM) methanol (MeOH) and 
diethyl ether were purchased from Mallincroft. Trifluoroacetic acid (TFA) was 
purchased from Halocarbons. 1,4-butandithiol and anisol were purchased 
from Aldrich. Dimethylformamide (DMF), diisopropylethylamine (DIEA), 
dicyclohexalcarbodiimide in dichloromethane (DCC), and N-
hydroxybenzotriazol in DMF (HOBt) were pruchased from Applied 
Biosystems. All other chemicals were purchased from Aldrich. N-a-Boc-L-
amino acids were used with the following side chain protecting groups, Arg 
(Tos), Asp (OBzl), Glu (OBzl), His (DNP), Lys (Cl-Z), Ser (Bzl), Trp (formyl), 
Thr (Bzl), and Tyr (Br-Z). 
The automated synthesis of proteins was conducted on the model 430A as 
follows. Double couplings were performed for every amino acid. The tBoc 
groups were removed from the amino or the resin-bound amino acid with 
100% TFA. Following tBoc removal, the deprotected peptide resin was 
neutralized by 10% diisopropyl ethyl amine in DMF. Amino acids, with the 
exception of Asn, Gin, and Arg, were coupled to the free amino group as 
symmetric anhydride. Asn, Gin, and Arg were coupled as HOBt esters. In the 
first coupling, the symmetric anhydride was formed in an activating vessel 
with DCC and DCF. The dicyclohexalurea was removed by filtering the 
solution into the concentrating vessel; the volume of dichloromethane was 
decreased by approximately 50% and replaced with DMF. This solution was 
then transferred to the reaction vessel, which contained resin that had been 
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previously deprotected and neutralized. Prior to the second coupling, the resin 
was rinsed with dichloromethane and DMF and neutralized a second time with 
10% diisopropyl ethyl amine in DMF. The symmetric anhydride was formed as 
described before, filtered into the concentrator and then added directly to the 
reaction vessel. DMF was added at a midpoint through the coupling cycle. In 
the case of amino acids that were coupled as HOBt esters, initially DCC and 
HOBt were added to the activator; they were allowed to mix for a period of 
approximately 15 min, at which time the amino acid, which had been dissolved 
in DMF, was added to the solution. Following activation, the solution was 
transferred into the concentrator, and the dichloromethane was removed and 
replaced with DMF. This solution was transferred to the reaction vessel, which 
contained previously deprotected and neutralized peptide resin. Prior to the 
second HOBt ester-mediated coupling, the peptide resin was rinsed with DMF 
and neutralized with OlEA in DMF. The activation of the HOBt ester was the 
same for the first coupling. At the end of the second coupling cycle, a sample 
resin was taken from the reaction vessel, and the coupling yield for the double 
coupling was determined by quantiative ninhydrin monitoring (Sarin, et al., 
1981). 
The coupling cycles used for manual synthesis of peptide are described below. 
Initially, the resin is washed with approximately 10 vessel volumes of 
dichloromethane. The next step is the removal of the tBoc group. This is 
accomplished by mixing the resin with 65% TFA/DCM. Initially, the reaction 
vessel is filled with 65% TFA/DCM and mixed for 1 min. The vessel is then 
drained and refilled with 65% TFA/DCM and mixed for 15 min. At this time, 
the TFA/OCM is drained from the reaction vessel, and the vessel is rinsed with 
10 volumes of dichloromethane. 10% DIEA/DCM is then added to the reaction 
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vessel, and the vessel is mixed for 1 min. The DIEA/DCM is drained from the 
vessel; the resin is washed with 4 vessel volumes of dichloromethane, and 
refilled with 10% DIEA/DCM and mixed for another minute. The DIEA/DCM 
solution is then removed, and the vessel and resin are rinsed with 10 volumes 
of dichloromethane. At this point the resin is ready for the first coupling cycle. 
Two coupling cycles are used, a symmetric anhydride cycle for all residues 
except Asn, Gin, and Arg, and a HOBt ester-coupling cycle, which is used for 
Asn, Gin, and Arg. For amino acids that are coupled with the symmetric 
anhydride procedure, the following is done. Prior to rinsing the resin with 
dichloromethane, the desired tBoc amino acid is dissolved in a separate vessel 
in a minimum of dichloromethane. To this solution half an equivalent of DCC 
in dichloromethane is added. This solution is allowed to set at room 
temperature for approximately 15-20 min, the typical time for deprotection and 
neutralization of the resin. Typically, a precipitate of dicyclohexalurea forms in 
the vessel containing the amino acid and DCC after about 15 min. After the 
resin is neutralized, the dicyclohexalurea is removed by filtration, and the 
symmetric anhydride is added to the peptide resin complex. After 30 min a 
sample of resin is taken and a yield for the coupling is determined by 
quantitative ninhydrin monitoring (Sarin, et al., 1981). If the coupling yield is 
satisfactory, > 99.7% at the beginning of the synthesis falling off to 
approximately 99% near the end of a 43 amino acid peptide, the resin and 
reaction vessel will be rinsed with dichloromethane, and the cycle will be 
restarted with tBoc removal and activation of the next amino acid. If the 
coupling yield is not satisfactory, the following steps are taken. The same 
amino acid is dissolved in a minimum of dichloromethane and half an 
equivalent of DCC in dichloromethane is added. This mixture is allowed to sit 
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at room temperature for approximately 15 min, or until dicyclohexalurea 
precipitates. The reaction vessel is then drained and the resin and vessel are 
rinsed with 5 volumes of DMF. A solution of 10% DIEAin DMF is then added 
to the reaction vessel, and it is mixed for a period of 1 min. The reaction vessel 
is then drained, and the resin and vessel are rinsed with 5 volumes of DMF. 
The dicyclohexalurea is then removed from the symmetric anhydride solution 
by filtration, and the symmetric anhydride is added to the reaction vessel, and 
the vessel is topped with DMF. The vessel is mixed for 45 min, at which time a 
sample of resin is taken for quantitative anhydrin monitoring. If the yield is 
satisfactory, the cycle is restarted with tBoc removal; if the yield is not 
satisfactory, a third coupling may be performed by repeating the steps used for 
the double coupling. 
In the case of amino acids that are coupled by HOBt esters, the following 
procedure is used. 30 min prior to the start of deprotection of the peptide resin 
complex, one equivalent of DCC in dichloromethane and one equivalent of 
HOBt in DMF are mixed together. At this time one equivalent of the desired 
amino acid is dissolved in a minimum volume of DMF. After 10 min, the 
DCC/HOBt mixture is added to the dissolved amino acid, and this solution is 
allowed to sit at room temperature for approximately 40 min. At this time the 
peptide resin complex will have completed deprotection and neutralization. If 
a precipitate has formed in the HOBt/DCC/amino acid mixture, it is removed 
by filtration prior to addition of the mixture to the vessel containing 
deprotected, neutralized peptide resin. Once the HOBt amino acid complex 
has been added to the resin, the vessel is topped off with DMF, and the 
contents are mixed for 60 min. At this time a sample of resin is taken for 
quantitative ninhydrin monitoring. If the coupling yield is acceptable, a new 
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cycle is started with deprotection of the peptide resin complex; if the yield is 
unacceptable, a second HOBt ester coupling is performed. The DCC and HOBt 
solutions are mixed together and allowed to react for 10 min, at which time the 
amino acid dissolved in DMF is added. This mixture is allowed to sit at room 
temperature for 40 min. When the end of the 40 min time period is 
approaching, the reaction vessel is drained, and the peptide resin and reaction 
vessel are rinsed with 5 volumes of DMF. The vessel is then filled with 10% 
DIEA in DMF and mixed for 1 min. The vessel is drained and the peptide resin 
and vessel are rinsed with 5 volumes of DMF. The HOBt/DCC/amino acid 
solution is filtered if needed and added to the reaction vessel. After 2h a 
sample of resin is taken for quantitative ninhydrin monitoring. If the coupling 
yield is satisfactory, a new cycle will be started by tBoc removal and resin 
neutralization, followed by coupling of the next amino acid; if the yield is 
unsatisfactory, a third coupling can be performed using an HOBt ester (in the 
case of Arg, additional couplings can be performed using the symmetric 
anhydride method). 
BEG and TCE Coupling to the Amino Terminus of Resin Bound Peptides. 
Approximately 200 mg of resin bound peptide (this equals approximately 20 
J..lmoles of peptide) were placed in a 12X80 mm reactor. The resin and vessel 
were washed with 5 volumes of dichloromethane, the terminal tBoc protecting 
group was removed, and the resin was neutralized using the previously 
described protocols. 30 min prior to the deprotection and neutralization of the 
peptide, 250 J..lmoles of HOBt in DMF and 250 J..lmoles of DCC in DCM were 
mixed together. This mixture was allowed to sit at room temperature for 10 
min, at which time 250 J..lmoles of either TCE or BEG dissolved in DMF were 
added (total volume for the solution is approximately 1.2 ml). After 20 min, the 
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deprotection and neutralization of the resin-bound peptide was initiated. After 
the peptide was neutralized, the solution containing the activated TCE or BEG 
was added to the reactor. The reactor was topped off with DMF and mixed for 
2h. At this time a resin sample was taken for quantitative ninhydrin 
monitoring. If the coupling yield was< 99%, an additional250 ~moles of TCE 
or BEG were activated as before, and the resin-bound peptide was 
reneutralized using standard procedures. The activated BEG or TCE was 
added to the reactor; the reactor was topped with DMF, and mixed for 2h. A 
sample of resin was taken for quantative ninhydrin analysis, and no additional 
couplings were performed. 
Coupling of TCE to the E-NH2 Side Chain of a Lysine Residue at the Carboxy 
Terminus of a Resin-Bound Peptide. N-a-tBoc-Ne-FMOC-L-Lysine was coupled 
to a growing peptide, using the symmetric anhydride protocol with the 
substitution of DMF for DCM. Following this coupling, the resin-bound 
peptide and vessel were washed with 10 volumes of DMF. The Ne-FMOC 
group was removed from the lysine side chain by treating the resin-bound 
peptide with 20% piperidine in DMF (a 1 min treatment was followed by a 15 
min treatment). Following the removal of the Ne-FMOC group, the resin-
bound peptide and vessel were rinsed with 5 volumes of DMF. A solution of 
DMF and DCM containing 4 equivalents of activated TCE-HOBt ester was 
added to the reactor, and the reactor was topped with DMF. The reactor was 
mixed for 2h at room temperature, at which time a sample of resin was taken 
for quantitative ninhydrin analysis. In all cases the coupling yield was >99.8%, 
so no additional coupling was performed. The activated TCE-HOBt ester was 
formed by first mixing equal molar amounts of DCC dissolved in DCM and 
HOBt dissolved in DMF. The DCC/HOBt mixture was allowed to sit for 10 
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min at room temperature, at which time an equal molar amount of TCE 
dissolved in DMF was added, and the resulting mixture was allowed to sit for 
40 min at room temperature. 
Peptide Deprotection and Purification. 200 mg of resin bound peptide 
(approximately 20 J.lmoles) were placed in a 20x80 mm reaction vessel. The 
resin-bound peptide was rinsed with 5 volumes of DCM. The histidine-
protecting group, dinitrilephenyl, was removed at 25 °C, using a 20% J3-
mercaptaethanol and 10% DIEA solution in DMF. The reactor was filled with 
this solution and mixed for 30 min, at which time it was drained and refilled 
and mixed for another 30 min. Following this treatment, the resin was rinsed 
with 5 volumes of DMF and 5 volumes of DCM. Next, the N-a-tBoc group was 
removed with a 1 min treatment with 65% TFA/OCM solution followed by a 15 
min treatment with the 65% TFA/DCM solution. The resin was then rinsed 
with 10 vessel volumes of DCM and neutralized by two 1 min treatments with 
10% DIEA/DCM. Following the neutralization with the OlEA solution, the 
resin-bound peptide and reaction vessel were rinsed with 10 volumes of 
dichloromethane, 5 volumes of 1:1 DCM:MeOH, 10 volumes of methanol and 
dried for 15-30 min with an aspirator. All other side chain protecting groups 
were removed, and the peptide-resin bond was cleaved using anhydrous HF 
(10 ml) in the presence of anasil (1.0 ml) and 1,4-butanedithiol (0.5 ml) as 
scavengers. The HF, and resin-bound peptide were mixed together vigorously 
for 60 min at 0 °C. The HF was removed under vacuum. The crude protein 
was precipitated with diethyl ether, collected on a fritted funnel, dissolved with 
5% acetic acid, and washed through, leaving only the resin on the frit. 
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A small sample of the 5% acetic acid solution containing the peptide was 
removed, filtered, and subjected to analytical HPLC (Brownlee, 25 em X 4.6 mm 
C8 column, 0-60% acetonitrile, 0.1% trifluoroacetic acid over 60 min). The 
remaining solution was frozen and lyophilized. The residual DMP groups 
were removed from the resulting crude peptide by treatment in 4 M 
guanadidium HCL, 40 mM tris, pH 8.5, and 20% ~-mercaptaethanol for 1 hat 
50 °C (Kent, 1988). This solution was filtered and injected directly onto a semi-
preparative C8 HPLC column (25X1 em). The column was flushed with water 
containing 0.1 % trifluoroacetic acid until the guanadidium and ~­
mercaptaethanol had eluted. A gradient from 0-60% acetonitryl, 0.1% 
trifluoroacetic acid was run over 240 min and fractions were collected. Pure 
peptide fractions were identified by analytical HPLC. Sequencing by Edman 
degradation and amino acid analysis of the purified peptide were used to 
confirm the sequence composition. Protein concentrations were assayed based 
on a calculated OD275 (e = 6,950 based on 1 tyrosine and 1 tryptophan). 
Purified proteins were lyophilized for storage. 
Labeling of the Hind III/Sal I Restriction Fragment from Plasmid PR W 80. Plasmid 
PRW 80 (Abdel-Meguid, et al., 1984) containing two copies of Res was digested 
with the restriction endonuclease Hind III to produce two fragments, 30 and 5 
kilobase pairs in size. Labeling at the 3' end was accomplished using a_32p_ 
dATP with the Klinow fragment of DNA polymerase I. 5'-end labeling was 
accomplished by dephosphorylation of the 5'-DNA termini with calf alkaline 
phosphatase, followed by rephosphylation of the hydroxyl ends using y-32p_ 
ATP and T4 polynucleotide kinase. Following end labeling, the fragments were 
cleaved with the restriction endonuclease Sal I. This yielded three different 
sized end-labeled fragments . The smallest fragment, 240 bp long, contained the 
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intact Res site. This fragment was isolated by non-denaturing polyacrylamide 
gel electrophoresis, using a 15 em X 2 mm 5% polyacrylamide gel. 
Labeling of the Xbai/EcoRI Restriction Fragment from pMFB36. The plasmid 
pMFB36 (Bruist, et al., 1987) was restricted with the endonuclease Xbal. 
Labeling at the 3'-end was accomplished with a.32P-dATP, using the Klinal 
fragment of DNA polymerase I. The 5'-end was labeled with 32p by 
dephosphorylation with calf alkaline phosphatase, followed by treatment with 
y_32P-ATP and P4 polynucleotide kinase. Cleavage with the restriction 
endonuclease EcoRI yielded two fragments. The smaller 557 bp fragment was 
isolated by polyacrylamide gel electrophoresis, using a 10 em x 2 mm 5% non-
dena turing gel. 
MPE Footprinting Reactions. MPE footprinting reactions were performed in a 
buffer containing 20 mM NaCl, 100 J..lM in base pair calf thymus DNA, 20 mM 
tris, pH 8.0, and 32P-end-labeled DNA. The reactions contained MPE•Fe(II) 
(lOJ..lM), OTT (5 mM), and y8 (144-183) (2.0 J..lM). For footprinting reactions, y8 
(141-183) was added to the buffer and allowed to equilibrate with the DNA for 
15 min. MPE • Fe(II) was subsequently added and allowed to equilibrate for 5 
additional minutes. The reaction was then initiated by the addtion of OTT. 
After 10 min at 25 °C, the reaction was stopped by ethanol precipitation. 
Comparisons were run between MPE cleavage reactions in the presence of 
absence of y8 (141-183). 
Affinity-Cleavage Reactions Using EDTA Tagged yo (141-183) Peptides and Related 
Mutants. Affinity-cleavage reactions were performed in a buffer containing 20 
mM tris, pH 8.0, 20 mM NaCl, 100 JlM in base pair calf thymus DNA, 32P-end-
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labeled DNA, 1 mM dithiothreatol (OTT) and 0.5, 2.0, or 10.0 Jl.M Fe(II)•EDTA 
protein. The proteins were allowed to equilibrate with the DNA for 15 min at 
25 °C.; cleavage was then initiated with the addition of OTT and allowed to 
proceed for 45 min at 25 °C. The reaction was stopped by ethanol precipitation. 
The 32P-labeled DNA products were analyzed by 8% denaturing 
polyacrylamide gel electrophoresis followed by autoradiography. 
Densitometric analysis of the gel autoradiogram and comparison of the 
individual lanes with sequenced marker lanes allowed assignment of DNA 
cleavage to nucleotide resolution. 
Sequence-Specific Marker Lanes. Sequence-specific marker lanes were used to 
identify the location of affinity-cleavage sites on the labeled restriction 
fragments. Two types of marker lanes were used. A-specific cleavage lanes 
were performed using the protocol of Iverson and Dervan (Iverson and Dervan, 
1987). G-specific cleavage lanes were produced using the original protocol of 
Maxam and Gilbert (Maxam and Gilbert, 1980). 
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Chapter II: 
Design of a Sequence-Specific DNA Cleaving Metalloprotein 
Ni(II) GGH-y8 (141-183). 
Introduction 
The design of sequence-specific DNA cleavage molecules typically involves the 
creation of a molecule with two functional domains, one that recognizes a 
specific sequence of DNA and another that cleaves, or cuts, the DNA (Dervan, 
1986). This typically involves the covalent attachment of "non-natural" metal 
chelator to a naturally occurring DNA binding molecule (Dervan, 1986; Sigman 
and Chen, 1990). With this type of bifunctional molecule, a specific sequence of 
DNA is initially recognized, bound and, subsequently, DNA cleavage occurs 
via oxidation of the DNA sugar phosphate backbone mediated by the action of 
the metal chelator. Examples of this include attachment of EDTA to drugs such 
as distamycin (Youngquist and Dervan, 1985) oligonucleotides (Moser and 
Dervan, 1987; Iverson and Dervan, 1987b) and proteins (Sluka, et al., 1987). In 
other examples, different metal chelators, such as copper phenanthroline, have 
been successfully used to create sequence-specific DNA-cleaving molecules 
(Sigman and Chen, 1990). Until recently, a sequence-specific cleaving molecule 
comprised of totally natural components was not available (Mack, et al., 1988; 
Mack and Dervan, 1990). 
The design of a sequence-specific DNA cleaving protein consisting wholly of 
naturally occurring a-amino acids requires the combination of a protein-DNA 
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binding domain with a protein-DNA cleaving domain. The first example of 
this was the attachment of the tripeptide Cu-binding domain, Gly-Gly-His 
(GGH), to the amino terminus of the DNA-binding domain from Hin 
recombinase (Hin 139-190) to create a new 55 residue protein GGH (Hin 139-
190) (Mack, et al. , 1988). This protein is capable of binding DNA at 413 base 
pair sites recognized by Hin recombinase. GGH (Hin 139-190) in the presence 
of Cu (II), hydrogen peroxide, and sodium ascorbate cleaved DNA 
predominantly at one of the four Hin binding sites (Mack, et al., 1988). A 
marked change in the sequence specificity and efficiency of DNA cleavage by 
GGH (Hin 139-190) occurred when the conditions were altered (Mack and 
Dervan, 1990). When the protein was loaded with Ni (II) instead of Cu(II), and 
cleavage was initiated by monoperoxyphthalic acid in place of the hdyrogen 
peroxide and ascorbate, the protein, Ni•GGH (Hin 139-190), cleaved the DNA 
at all four of the Hin binding sites. The nickel monoperoxyphthalic acid-
mediated cleavage was more efficient and rapid than the Cu hydrogen 
peroxide, ascorbate-mediated cleavage DNA. The Ni-mediated cleavage 
occurred predominantly at a single deoxyribose position adjacent to each Hin 
binding site (Mack and Dervan, 1990). This suggested that cleavage was 
mediated by some non-diffusible species (Mack and Dervan, 1990). 
Gly-Gly-His . GGH was initially designed as a mimic for the Cu (II) transport 
site found in serum albumin (Camerman, et al., 1976; Lau, et al., 1974). The 
histidine containing tripeptide was found to be capable of binding both Cu(II) 
and Ni(II) (Camerman, et al., 1976; Lau, et al., 1974; Bryce, et al., 1966). X-ray 
diffraction analysis showed GGH bound to Cu(II) in a square-planar complex 
with coordination from an imidizole nitrogen, two deprotonated peptide amide 
nitrogens, and the terminal amino group (Camerman, et al., 1976). Although 
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the crystal structure of Ni(II) bound to GGH is not available, several lines of 
evidence indicate that its complex is also square-planar, as shown schematically 
in Figure 1. First, the crystal structures of tetraglycine with Cu(II) or Ni(II) 
indicate that the metal ions were bound by peptide ligands in a similar fashion; 
both complexes are square-planar with coordination from the terminal amino 
groups and three deprotonated peptide amide nitrogens (Freeman and Taylor, 
1965; Freeman, et al., 1968). Further support for the square-planar nature of the 
Ni(II) complex with GGH is provided by an analysis of the reaction kinetics of 
this complex with acids and triethyl tetra amine (Bannister, et al., 1982) and 
analysis of the cyclic voltammetry for the Ni(III) I (II) redox couple for this 
complex (Bossu and Margerum, 1977). 
H 
NR 
Figure 1 A model for the GGH ligand bound to Ni(II) in a square-planar 
complex. 
The tripeptide, Gly-Gly-His, when complexed with Ni(II) was found to mediate 
several different types of reactions. The first type of reaction identified 
involved the auto oxidation of Ni (II) Gly-Gly-His with molecular oxygen 
(Sakurai and Nakahara, 1979; Paniago, et al., 1971). NMR studies of the 
products of this reaction demonstrated that the histidine in the GGH complex 
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had undergone an oxidative decarboxylation. The rate of this reaction was 
found to be greatly enhanced by the addition of oxidizing agents such as IrC162-
(IV) , H202 or S20s2- (Sakurai and Nakahara, 1979). The Ni (II) complex of 
GGH was also found to mediate the epoxidation of olefins in the presence of 
iodosylbenzene (Mack, 1990). Reactions of this type have been observed in 
Ni(II) cyclam complexes (Kinneary, Albert, et al., 1988; Kinneary, Wagler, et al., 
1988). Recently Ni(II) GGH and other Ni complexes were found to catalyze the 
oxidative cleavage of DNA (Chen, et al., 1991; Mueller, et al., 1992). These 
studies showed that Ni(II) GGH and other square-planar Ni complexes in the 
presence of oxidants such as monoperoxyphthalic acid would readily catalyze 
the oxidation and strand scission of DNA at looped-out, unpaired guanine 
residues. Interestingly, DNA bases engaged in normal Watson-Crick base 
pairing were found to be unreactive to this complex. Cleavage at the unpaired 
guanine residues was found to require a piperidine treatment and is thought to 
involve the formation of an 8 oxo guanine (Mueller, et al., 1992). 
Studies report here the design and chemical synthesis of a new sequence-
specific, DNA-cleaving 46 residue metalloprotein, GGH (y,o 141-183). This 
protein combines the DNA binding domain from y,o resolvase, (y,o 141-183), 
with the transition metal-binding domain, GGH (Figure 2). 
Ni(II) GGH-yo(141-183) Cleavage of DNA 
Synthesis. The 46 residue protein was synthesized by stepwise, solid-phase 
methods (0.5 mM scale) with optimized manual protocols (Kent, 1988), on 
phenylacetamidomethyl(P AM) resin substituted with tBoc-asparagine. Each 






















































































































































































































































1981), and couplings were repeated until the yield was maximal for each step 
(99.7% early in the synthesis, decreasing to 98% near the end). The overall yield 
for the synthesis of GGH-y,8 (141-183) was 73.7%. Approximately 200 mg of the 
resin bound peptide were deprotected and purified in the following manner. 
The histidine protecting group, dinitrophenyl (DNP) was removed at 25 °C 
using 20% 2-mercaptoethanol and 10% DIEA in DMF; this treatment was 
repeated twice for a period of 30 min. The final N-a-tBoc group was removed 
with 60% TFA in dichloromethane; the resin was neutralized with 10% DIEA in 
dichloromethane, rinsed, and dried. All the other side chain protecting groups 
were removed and the peptide-resin bond was cleaved, utilizing anhydrous HF 
in the presence of anisole and 1,4-butanedithiol as scavengers. The HF was 
removed under vacuum. The crude peptide was precipitated with diethyl 
ether, collected on a fritted funnel, dissolved with 5% acetic acid, and washed 
through the funnel, leaving the resin on the frit. This solution was frozen and 
lyophilized. The residual DNP groups were removed from this crude peptide 
by treatment in 4 molar guanadium HCL, 50 millimolar tris pH 8.5, and 20% 2-
mercaptoethanol for one hat 50 °C (Kent, 1988). The crude synthetic peptide 
was purified by reverse-phase preparative HPLC using a Brown-Lee C8 
column and an acetonitrile water gradient. This afforded approximately 8 mg 
of pure synthetic peptide, GGH-y,8 (141-183) (Figure 2). The sequence of the 
protein was confirmed by Edman degradation, amino acid analysis and mass 
spectrometry (these analyses were performed by the microsequencing facility 
at the California Institute of Technology). 
Footprinting. MPE • Fe(II) footprinting (Figure 3) reveals that the synthetic 
peptide GGH-y,8 (141-183) at 2.0 j..tM concentrations binds all six y,f~resolvase 
half-sites contained in Res (lanes 7 and 8, Figure 3). Comparison of the 
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Figure 3 An autoradiogram of a high-resolution denaturing gel containing 32p_ 
end labeled DNA fragments from the Hind III/Sal !/restriction fragment of 
PRW80 that contains res. The bars on the left-hand side of the gel indicate the 
location of the y8 resolvase-binding sites. Odd number lanes contain 5'-end 
labeled DNA and even numbered lanes contain 3'-end labeled DNA. Lanes 1 
and 2 contain intact DNA. Lanes 3 and 4 contain MPE•Fe(II) cleavage in the 
absence of protein. Lanes 5 and 6 are MPE•Fe(II) footprints in the presence of 
2.0 J.lM y8 (141-183). Lanes 7 and 8 are MPE•Fe(II) footprints in the presence of 
2.0 J.lM GGH y8 (141-183). Lanes 9 and 10 are MPE•Fe(II) footprints in the 
presence of 2.0 J.lM Ni•GGH y8 (141-183). Lanes 11 and 12 are A-specific 
cleavage lanes (Iverson and Dervan, 1987). 
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footprinting pattern from y,8 (141-183) (lanes 5 and 6, Figure 3) and that of 
GGH-y,8 (141-183) (lanes 7 and 8, Figure 3) reveal that the addition of GGH to 
the amino terminus of the DNA-binding domain from y,8-resolvase does not 
alter the peptide's binding specificity. In addition, comparison of the MPE 
footprint of GGH-y,8 (141-183) in the absence and presence of Ni (0Ac)2, 
reveals that the presence of Ni (II) does not alter the binding specificity of the 
synthetic protein Oanes 9 and 10, Figure 3). A schematic representation of the 
footprint produced by all three of these proteins is found in Figure Sa. 
Nickel-Mediated Cleavage Reactions . GGH-y,8 (141-183) at 2.0 j.lM concentrations 
in the presence of one equivalent of Ni (0Ac)2 and one equivalent of 
monoperoxyphthalic acid cleaves the DNA restriction fragment containing Res 
at all six resolvase binding sites (Figure 4, lanes 7 and 6). Control lanes (lanes 1-
6) demonstrate that cleavage requires the presence of nickel, GGHy8 (141-183) 
and monoperoxyphthalic acid. The cleavage patterns are strong and 
predominate with one-base specificity located 3' to each nine base pair 
consensus sequence bound by y8 resolvase (Figure Sb). The location of this 
cleavage is consistent with the location of the amino terminus of y8 (141-183) in 
the minor groove at 3'-end of each recognition sequence, as determined by 
Fe(II)-EDTA-mediated affinity cleaving (Graham and Dervan, 1990) (Figure 6). 
Several items should be noted concerning cleavage by GGH y8 (141-183). The 
cleavage mediated by hydrogen peroxide occurs at a much lower efficiency by 
that produced by monoperoxyphthalic acid. Second, when the d-isomer of 
histidine is substituted for the [-isomer of histidine in the metal-binding region 
of the peptide, a peptide that produces the same cleavage pattern is created. 
However, the peptide GGdH y8 (141-183) cleaves DNA with an approximately 
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Figure 4 An autoradiogram of a high-resolution denaturing gel containing 32p_ 
end labeled DNA fragments from the Hind III/Sall/restriction fragment of 
PRW80 that contains res. The bars on the left-hand side of the gel indicate the 
location of the y8 resolvase-binding sites. Odd number lanes contain 5'-end 
labeled DNA, and even numbered lanes contain 3'-end labeled DNA. Lanes 1 
and 2 contain 2.0 J..LM monoperoxyphthalic acid and 2.0 J..LM Ni(OAc)2. Lanes 3 
and 4 contain 2.0 J..LM GGH y8 (141-183) and 2.0 J..LM Ni(OAc)2. Lanes 5 and 6 
contain 2.0 J..LM GGH y8 (141-183) and 2.0 J..LM monoperoxyphthalic acid. Lanes 
7 and 8 contain 2.0 J..LM GGH y8 (141-183), 2.0 J..LM Ni(0Ac)2. and 2.0 J..LM 
monoperoxyphthalic acid. The DNA in lanes 1 through 8 was subject to base 
treatment with 0.1 N-butylamine for 30 min at 90 °C. Lanes 9 and 10 are A-
specific cleavage lanes (Iverson and Dervan, 1987). 
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Figure 6 A schematic representation of the model for the designed 
metalloprotein Ni•GGH y8 (141-183) bound to res site I. Brackets indicate the 
location of the 9 bp y8 resolvase-recognition sequences. Dots indicate the 
location of DNA cleavage. Putative a-helices are shown as cylinders with 
arrows pointing from the amino to carboxyl terminus. The orientation of the 
helices is based upon affinity-cleavage data (Graham and Dervan, 1990). 
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10-fold lower efficiency than the peptide containing the native [-isomer of 
histidine, GGH y8 (141-183) (data not shown). This indicates that the reaction 
may be susceptible to positional effects relative to the DNA. Finally, it is 
important to note that while the initial peptide synthesized by Mack, et al. 
(1988) was capable of cleaving DNA in the presence of Cu(II), cleavage by GGH 
y8 (141-183) was never observed in the presence of copper. 
End Product Analysis. Knowledge of the type of DNA termini produced by a 
DNA-cleavage reaction can provide insight into the nature of the cleavage 
reaction. The type of DNA termini produced by the Ni(II), peroxide-mediated 
cleavage of DNA by GGH y8 (141-183) was examined by high-resolution 
denaturing gel electrophoresis. The electrophoretic mobility of DNA on a 
denaturing polyacrylamide gel is affected not only by the length of the DNA, 
but by the nature of its termini (Tapper and Clayton, 1981). In a DNA fragment 
50 base pairs long, the removal of a phosphate from either the 5' or 3'-terminus 
causes a reduction in the electrophoretic mobility of the DNA strand on a 
denaturing polyacrylamide gel equivalent to approximately one half a 
nucleotide. Changes in gel mobility have been successfully used to investigate 
the nature of 5' and 3' DNA termini created by bleomycin- (Kross, et al., 1982) 
and MPE- (Hertzberg and Dervan, 1984) mediated cleavage of DNA. In the 
case of bleomycin-mediated cleavage of DNA, comparison of the 
electrophoretic mobility of 3'-end labeled DNA fragments with and without 
alkaline phosphatase treatment identified the 5'-terminal product as phosphate 
(Kross, et al., 1982). When the same type of analysis was performed using 3'-
end labeled fragments of DNA generated by MPE cleavage, the 5'-termini was 
again found to be phosphate (Hertzberg and Dervan, 1984). The nature of the 
3'-DNA termini producted by bleomycin- and MPE-mediated cleavage of DNA 
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was investigated, utilizing 5'-end labeled fragments and T4 kinase. T4 kinase 
possesses a 3' phophotase activity and can selectively remove 3' phosphates 
from DNA fragments (Cameron and Uhlenbeck, 1977). The results of this type 
of analysis demonstrated that DNA cleavage mediated by bleomycin produced 
fragments whose 3'-terminus was not a simple phosphate (Kross, et al., 1982) 
but rather a 3'-phosphoglyocolate (Giloni, et al., 1981). Analysis of the 3'-
termini generated by MPE-mediated cleavage of DNA demonstrated that there 
were two products, 3'-phosphate and 3'-phosphoglycolate (Hertzberg and 
Dervan, 1984). In either case, the products of cleavage were consistent with the 
oxidative degradation of the deoxyribose ring of the DNA backbone (Hertzberg 
and Dervan, 1984; Kross, et al., 1982). 
5'-A ATT T TGCAA C CGTCCGAAA T A TT AT AAA TT A TCGCA C ACA T AAAAACA-3' 
Y~TAAAACGTTG CAGGCTTTATAATATTTAATAGCGTGT TATTTTTGT-~ 
Figure 7 The sequence of the synthetic oligonucleotide duplex containing site I 
from res. Boxes define the location of the 9 bp recognition sequences for yo 
resolvase binding. 
To determine the nature of the DNA termini produced by Ni(II) peroxide 
mediate cleavage of DNA by GGH yo (141-183), the oligonucleotide shown in 
Figure 7 and its complementary strand were synthesized. To examine the 
nature of the 5'-termini produced by DNA cleavage, the top strand of the 
duplex was labeled at the 3'-end, using a 32P-ddATP. In a separate experiment, 
the 3'-termini were examined, utilizing the same duplex, with the top strand 
labeled on the 5'-end. Since the same strand of DNA is utilized for both the 5' 
and the 3'-end product analysis, the termini on either side of the same lesion 
were examined. 
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5'-End Products. The DNA cleavage product produced when the 3'-end labeled 
oligonucleotide duplex was treated with Ni(II)•GGH yo (141-183) in the 
presence of peroxide comigrates with the DNA cleavage product produced by 
MPE•Fe(II)-mediated cleavage of the duplex (Figure 8). When the cleavage 
product produced by Ni(II)•GGH yo (141-183) and peroxide is treated with calf 
alkaline phosphatase, its electrophorectic mobility is reduced by approximately 
one-half base pair. These observations are consistent with the presence of a 
phosphate group at the 5'-termini of the DNA cleavage site. 
3 '-End Products. The DNA fragment produced when the 5'-end labeled 
oligonucleotide duplex is treated with Ni(II)•GGH yo (141-183) and peroxide, 
comigrates with a 3'-phosphate cleavage product from the MPE•Fe(II) 
mediated cleavage of the 5'-labeled duplex (Figure 9). When the DNA 
fragment is treated with T4 kinase under conditions used to remove 3' 
phosphates from DNA (Cameron and Uhlenbeck, 1977), the electrophoretic 
mobility of a portion of the band on the gel is reduced. These results indicate 
that at least a portion of the 3'-termini generated by Ni(II)•GGH yo (141-183) 
and peroxide are 3'-phosphate. The composition of the 3'-termini of the DNA 
fragments that comprise the portion of the band whose electrophoretic mobility 
was unaffected by kinase treatment is unknown. It is possible that these 3'-
termini are phosphate and that the kinase reaction failed to go to completion; 
however, it is likely that these termini are not phosphate but are some other 
type of 3'-termini that are unaffected by kinase treatment, like 3'-
phosphoglycolate. 
Summary of End-Product Analysis. Analysis of the DNA termini produced by 
Ni(II) GGH yo (141-183), peroxide-mediated cleavage of DNA has shown the 
120 
Figure 8 An autoradiogram of a high-resolution denaturing gel used for 
analysis of the 5'-end products produced by Ni(II) GGH y'& (141-183)-mediated 
cleavage of DNA in the presence of hydrogen peroxide. Lanes 1 and 2 contain 
G+A and G sequence-specific chemical marker lanes, respectively (Maxam and 
Gilbert, 1980). Lane 3 contains a DNA control. Lanes 4 and 5 were subject to 
treatment with Ni(II) GGH y'& (141-183) and hydrogen peroxide. Lane 4 was 
subsequently treated with calf akaline phosphotase to remove phosphates from 
the 5'-end of cleavage fragments. Lane 6 is an MPE cleavage lane. 
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Figure 9 An autoradiogram of a high-resolution denaturing gel used for 3'-end 
product analysis of Ni(II)•GGH y'fJ (141-183)-mediated cleavage of DNA in the 
presence of hydrogen peroxide. Lane 1 is an MPE • Fe cleavage lane containing 
DNA fragments that end in 3' phosphate and 3' phosphoglycolate (Hertzberg 
and Dervan, 1984). Lane 2 is a DNAse I cleavage lane containing DNA 
fragments ending in 3' hydroxyl. Lanes 3 and 4 contain DNA fragments 
produced by Ni(II)•GGH y'fJ (141-183) cleavage of DNA. Fragments in lane 4 
were treated with T4 kinase to remove the 3' phosphate from the DNA 
fragment. Lane 5 contains a DNA control. Lanes 6 and 7 are G and G+A 
sequence-specific chemical cleavage lanes, respectively (Maxam and Gilbert, 
1980). 
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5'-end product and a fraction of the 3'-end products to be phosphate. The 
identity of a portion of the 3'-end products is uncertain; it could be either 
phosphate or a product like phosphoglycolate. This ~et of end products is 
consistent with DNA cleavage produced by oxidative degradation of the 
deoxyribose backbone. DNA termini consistent with oxidation of the 
deoxyribose were also observed for cleavage produced by the peptide GGH-
Hin (139-190) (Mack, et al., 1988; Mack and Dervan, 1990). When DNA was 
cleaved using GGH-Hin (139-190) and copper, the resulting 3'- and 5'-termini 
were found to be phosphate. In the case of cleavage by this peptide in the 
presence of nickel, initially the 5'-end product was found to be phosphate, and 
the 3'-end product was found to be a mixture of phosphate and some other, 
unidentified product. However, when the DNA cleavage fragments produced 
by GGH-Hin (139-190) were treated with butylamine prior to end-product 
analysis, the only products identified were 5'-phosphate and 3'-phosphate 
(Mack and Dervan, 1990). 
Cleavage Conditions . In order to more thoroughly characterize DNA cleavage by 
GGH y8 (141-183) in the presence of Ni(II) and peroxide, a series of studies 
were conducted to examine the effect of oxidant concentration, protein 
concentration, time, and pH on the efficiency of the reaction. These studies 
were conducted using 5'-end labeled oligonucleotides, and except where noted, 
analyzed using a Molecular Dynamics Phosphorimager. The studies were 
conducted using both hydrogen peroxide and monoperoxyphthalic acid as 
oxidants. 
Concentration Studies. The cleavage of DNA as a function of 
monoperoxyphthalic acid concentration is graphically represented in Figure 
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lOa-c. The first feature that becomes apparent from an examination of these 
graphs is that at approximately 10 j..lM concentration, maximal cleavage is 
reached, regardless of the concentration of Ni(II)-GGH-y8 (141-183). Significant 
cleavage above background occurs with as little as 0.01 j..lmole of 
monoperoxyphthalic acid. Comparison of cleavage with and without 
butylamine treatment shows that incubating the cleavage reactions for 30 min 
at 90 °C in the presence of 0.1 normal butylamine can produce a 20-25% 
increase in cleavage. By comparing graphs a through c directly it becomes 
apparent that the extent of cleavage is dependent on the concentration of Ni(II)-
GGH-y8 (141-183). It is interesting to note that this relationship does not appear 
to be linear, at least between 0.5 and 2 j..lM. 
Examination of Figure lOc and d shows the marked difference between the two 
oxidants, monoperoxyphthalic acid and hydrogen peroxide. 
Monoperoxyphthalic acid proves to be an effective oxidant at micromolar 
concentrations. However, hydrogen peroxide requires concentrations in the 
millimolar range even to produce detectable cleavage. On this basis alone it 
appears that monoperoxyphthalic acid is a 1,000 times more effective oxidant 
than hydrogen peroxide in this system. In other systems that use Ni(II)-GGH 
to cleave DNA, the same relative effectiveness of these two oxidants is also 
observed (Chen, et al., 1991; Mack, 1991). The effect of butylamine treatment on 
DNA cleavage mediated by hydrogen peroxide and Ni(II)-GGH-y8 (141-183) 
was not examined, because butylamine treatment of DNA following exposure 
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Figure 10 DNA cleavage produced by Ni(II)•GGH y8 (141-183) as a function of 
monoperoxyphthalic acid (A-C) or hydrogen peroxide concentration (D). The 
concentration of Ni(II)•GGH y8 (141-183) present in the reactions was 0.5 JlM 
(A), 1.0 JlM (B), and 2.0 J..LM (C and D). Reactions containing hydrogen peroxide 
were allowed to proceed for 90 min prior to precipitation; those containing 
monoperoxyphthalic acid were allowed to proceed for 10 min prior to ethanol 
precipitation. The reactions were treated with butylamine as noted. The extent 
of DNA cleavage in A-C was determined in phosphorimager analysis and in D 
by densitometric analysis. 
Time Courses. Time courses of DNA cleavage produced by Ni(II)-GGH-y8 (141-
183) in the presence of monoperoxyphthalic acid or hydrogen peroxide are 
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shown in Figures lla and b. The time courses were run over a period of 120 
min. The time point at 0 minutes represents the simultaneous addition of 
oxidant and quenching agent to the reactions. Examination of the time course 
for cleavage in the presence of monoperoxyphthalic acid shows that the 
reaction is complete within less than 10 minutes. In fact, even when the oxidant 
and quenching agent are simultaneously added to the reaction, cleavage 
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Figure 11 Time course of DNA cleavage by 2.0 ~ Ni(II)•GGH y8 (141-183) in 
the presence of 1.0 1-lM monoperoxyphthalic acid (A) or 10.0 mM hydrogen 
peroxide (B). Reactions were stopped by ethanol precipitation. The zero time 
point represents simultaneous addition of oxidant and precipitation. Reactions 
containing monoperoxyphthalic acid were treated with 0.1 normal butylamine 
for 30 min at 90 °C prior to electrophoresis. The extent of DNA cleavage was 
determined by phosphorimager analysis. 
Cleavage mediated by monoperoxyphthalic acid is so rapid that an accurate 
measurement cannot be obtained under the system that we are currently using. 
When the cleavage of DNA in the presence of hydrogen peroxide is examined 
as a function of time, a much different picture appears. When oxidant and 
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quenching agent are simultaneously added to the reaction, there is detectable 
cleavage above the background. The reactions must be incubated for at least 
five minutes before significant cleavage occurs. At this point, cleavage 
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Figure 12 pH profiles of DNA-cleavage reaction mediated by Ni(II)•GGH y8 
(141-183) in the presence of 1.0 !J.M monoperoxyphthalic acid (A) and 10.0 j.l.M 
hydrogen peroxide (B). Reactions containing monoperoxyphthalic acid were 
allowed to proceed for 10 min prior to ethanol precipitation, and reactions 
containing hydrogen peroxide were allowed to proceed for 90 min prior to 
ethanol precipitation. Reactions containing monoperoxyphthalic acid were 
treated with 0.1 N-butylamine for 30 min at 90 °C prior to analysis. The extent 
of DNA cleavage was determined by phosphorimager analysis. 
pH Profiles. The effect of pH on DNA cleavage by Ni(II)-GGH-y8 (141-183) in 
the presence of monoperoxyphthalic acid and hydrogen peroxide is shown in 
Figure 12 a and b. The pH of the phosphate reaction buffer was varied from 5.8 
in 2/10ths of a pH unit up to 8.0. When DNA cleavage as a function of pH is 
examined with monoperoxyphthalic acid as the oxidant, a relatively flat profile 
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is obtained. Maximum cleavage seems to occur between the range of pH 6.8 
and 7.4. Below pH 6.6 the amount of cleavage drops steadily to pH 5.8, where 
the last measurement was taken. At the high end of the curve, from pH 7.8 to 
8.0, cleavage also appears to drop. When cleavage is examined in the presence 
of hydrogen peroxide, a different profile is obtained. From pH 5.8 to 6.6 very 
little cleavage is observed. From pH 6.6 to 7.2, a slight increase in cleavage is 
observed. Above pH 7.2 there is a sharp increase in DNA cleavage with a 
maximum occurring at about pH 7.6. From pH 7.6 to pH 8.0, the amount of 
cleavage declines. These pH profiles are unlike the sigmoidal curves obtained 
when Ni(II)-GGH-Hin (139-190) cleavage in the presence of 
monoperoxyphthalic acid and hydrogen peroxide was studied as a function of 
pH (Mack, 1991). The differences in the pH profiles obtained from Ni(II)-GGH-
y8 (141-183) and those reported by Mack (1991) may be a result of several 
factors. The first may be differences in data collection; the studies conducted 
by Mack (1991) contained only five data points, while these contained twelve 
data points over a slightly wider pH range. A second factor is the change in the 
DNA-binding domain from Hin(139-190) to y8 (141-183). The ability of these 
two proteins to bind DNA as a function of pH may be somewhat different. It is 
possible that the differences in cleavage observed between these two different 
proteins may not be a function of reaction mechanism, but rather a function of 
DNA-binding. A somewhat more puzzling observation is the difference in the 
pH profiles for monoperoxyphthalic acid and hydrogen peroxide with the 
same protein Ni(II)-GGH-y8 (141-183). A possible explanation came when the 
pH of the stock solutions of oxidants used to initiate the reactions was 
examined. In the case of monoperoxyphthalic acid, a final concentration of 1 
J..LM per acid was present in each of the reactions, and the pH of the stock 
solution used to achieve this was 6.2. However, in the case of hydrogen 
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peroxide, 10 millimolar peroxide was the final concentration in each of the 
reactions, and the pH of its stock solution was 5.2. It is possible that the low pH 
of the hydrogen peroxide stock solution in combination with the large amount 
of peroxide added to the reaction overloaded the 20 millimolar phosphate 
buffer that was used to maintain the pH of the reaction. 
ESR Studies of Ni(II) GGH and Ni(III) GGH. The oxidation state of nickel peptide 
complexes has been studied extensively, using ESR spectroscopy (Sugiura and 
Mino, 1979; Bossu and Margerum, 1977; Bossu and Margerum, 1976). The 
Ni(II) complexes of tripetides are a low-spin, square-planar d8 species, which 
are ESR-inactive. When the nickel in these complexes is oxidized to Ni(III), a 
tetragonal d7 nickel complex is formed (Bossu and Margerum, 1976; Bossu and 
Margerum, 1977; Sugiura and Mino, 1979). The ESR spectrum of these trivalent 
nickel complexes obtained at liquid-nitrogen temperatures is similar to the 
spectra obtained for many Ni(III) tetraza-macrocycle complexes (Olson and 
Vasilevskis, 1969; Gore and Busch, 1973), with a G perpendicular greater than a 
G parallel. This type of ESR spectrum is consistent with an unpaired electron in 
the dz2 orbital for d7 Ni(III). If the conditions used to promote DNA cleavage 
in the presence of Ni(II)-GGH-yo (141-183) generated a Ni(III)-GGH metal 
complex, we would expect ESR spectra with an anisotropic G tensor with 
values corresponding roughly to the values of Gx=2.256, Gy=2.278, and 
Gz=2.015, which are observed for GGH•Ni(III) (Lappin, et al., 1978). If the 
oxidizing conditions used created a ligand-centered radical, the paramagnetic 
product would be a nitrogen- or carbon-centered radical complex of Ni(II). 
Such a species would exhibit a dramatically different ESR spectrum; the G 
tensor would be isotropic with all three G values close to the spin-only value of 
2.002 (Drago and Baucom, 1972; Barefield and Mocella, 1975). 
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The ESR spectrum of the nickel complex of GGH was examined in the presence 
and absence of oxidants at -50 °C. The peptide-nickel complex was dissolved in 
20 millimolar phosphate buffer at pH 7.5, and the solutions were subject to 
several round of freeze/thaw degassing prior to measurement of the ESR 
spectrum. As expected, the Ni(II) complex of GGH showed no paramagnetic 
signal. When this complex was oxidized using IrC162-(IV), the characteristic 
ESR spectrum of Ni(III) was obtained (Figure 13). This spectrum showed the 
anisotropy characteristic of Ni(III) peptide complexes. Initially, when the EPR 
spectrum of the Ni(II)-GGH complex was measured in the presence of 
hydrogen peroxide, no paramagnetic signal was observed. To obtain a 
paramagnetic signal, a large excess of hydrogen peroxide had to be added to 
the complex; the final concentration in the ESR was 2.5 molar. This is 
approximately 500 times more hydrogen peroxide than is required to observe 
DNA cleavage in the presence of Ni(II)-GGH-yo (141-183). When the ESR 
spectrum of a solution containing SmM GGH-Ni(II) and 2.5 M H202 (the 
hydrogen peroxide was pH adjusted to 7.0) was measured, the spectrum 
shown in Figure 14 was obtained. This spectrum lacked the characteristic 
signals observed for a Ni(III) peptide complex. The spectrum showed three 
signals with G values of 2.1965, 2.0492, and 2.0059. While it is not possible to 
identify the radical species or specie responsible for this spectrum, it is 
apparent that Ni(III) is not formed under these conditions and is apparently not 
responsible for the Ni-GGH-yo (141-183)-mediated cleavage of DNA. This 
observation was confirmed when Ni(II)-GGH-yo (141-183) failed to cleave DNA 
in a sequence-specific manner in the presence of IrC162-(IV) (data not shown). 
Recently, an extensive ESR study was conducted, utilizing the Ni(II) complex of 
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confirms our observation that Ni(III)-GGH is not formed in the presence of 
hydrogen peroxide. By using a series of spin traps, this ESR study revealed 
that hydroxyl radical adducts are produced by the decomposition of hydrogen 
peroxide in the presence of Ni(II)-GGH (Inoue and Kawanishi, 1989). Their 
results indicate that either an oxo-Ni(IV) complex or a Ni(III)-peroxide complex 
is formed under these conditions. 
Kinetic Isotope Studies of the Mechanism of DNA Cleavage by Ni(ll) GGH-
y8 (141-183). 
The type of DNA termini produced by Ni(II)-GGH y 8 (141-183) in the presence 
of oxidant are consistent with DNA cleavage via the oxidative degradation of 
the deoxyribose ring of the DNA backbone. Since DNA cleavage occurs 
exclusively at one nucleotide, this oxidizing species is highly localized, unlike 
the diffusable oxidizing species generated during EDTA•Fe-mediated cleavage 
of DNA. These observations are consistent with results obtained from a 
different sequence-specific, DNA-cleaving metalloprotein, Ni(II) Hin (139-190) 
(Mack and Dervan, 1990). 
In order to gain insight into the nature of this highly localized, or more 
probably, bound oxidizing species, ESR studies were conducted utilizing Ni(II)-
GGH. Under the conditions used to produce DNA strand scission, ESR 
provided no evidence for the formation of Ni(III), nor did they indicate the 
formation of a ligand radical. However, they did not preclude the formation of 
some type of activated metal-oxidant complex that would be capable of 
oxidatively cleaving DNA. ESR spin-trapping studies examining the 
decomposition of hydrogen peroxide in the presence of Ni(II)-GGH indicate 
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that in the presence of peroxide the tripeptide-nickel complex is capable of 
forming either a Ni(IV) oxo or a Ni(III)-peroxide complex (Inoue and 
Kawanishi, 1989). Further support for the generation of a GGH Ni(IV) oxo or 
GGH Ni(III)-peroxide complex is provided by the observation that in the 
presence of iodosylbenzene Ni(II)-GGH will epoxidize olefins (Mack, 1991; 
Mack and Dervan, 1990). Mechanistic studies of olefin epoxidation catalyzed by 
other Ni(II) complexes utilizing 180-labeling have demonstrated that the 
oxygen in the epoxide is entirely derived from the oxidant (Kinneary, et al., 
1988). This indicates olefin epoxidation by Ni(II) complexes is mediated by 
some type of bound-metal oxidant species analogous with the Ni(IV)oxo or 
Ni(III)-peroxide complex detected by ESR spin-trapping studies. In order to 
improve our understanding of how the activated Ni-GGH y 8 (141-183) 
mediates DNA cleavage, a kinetic isotope experiment was conducted in which 
the effect of deuterium incorporation at discrete positions within the 
deoxyribose ring on the rate of DNA cleavage was examined. 
Kinetic isotope experiments of this type have provided useful insight into the 
mechanisms of DNA cleavage by the drugs neocarzinostatin and bleomycin 
(Kappen, et al., 1990; Frank, et al., 1991; Kappen, et al., 1991; Wu, et al., 1983; 
Kozarich, et al., 1989). In the case of neocarzinostatin, kinetic isotope effects 
have been useful in identifying the mechanism of cleavage at both major and 
minor sites (Frank, et al., 1991; Kappen, et al., 1991; Kappen, et al., 1990). The 
predominant type of DNA damage produced by neocarzinostatin is strand 
breaks at thymidilate and deoxyadenilate residues, resulting in DNA cleavage 
products with termini consisting of a 5'-phosphoaldehyde and a 3'-phosphate 
(Kappen, et al., 1982; Kappen and Goldberg, 1983). When the formation of 
these DNA strand breaks was investigated, using C4' deuterated and C5' 
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dideuterated thymidines, a kinetic isotope effect was observed at both positions 
with kH/kD = 2.4-5.5 and 1.0-2.6, respectively (Frank, et al., 1991). Close 
examination of the kinetic isotope data showed that at certain positions 
cleavage was strongly sensitive to deuterium substitution at the C4' position, 
and much less sensitive to deuteration at the C5' position. However, at other 
cleavage sites the situation was reversed, and sensitivity to 5'-deuteration was 
observed, while no evidence of sensitivity to deuteration at the 4' position was 
observed. Analysis of the end products of DNA cleavage at sites that were 
sensitive to deuteration at the 5' position showed that cleavage yielded 3'-
phosphate termini, while at sites that were sensitive to 4' deuteration cleavage 
yielded 3' termini consisting of a modified abasic carbohydrate and 
phosphoglycolate. In a subsequent experiment, it was observed that the 
proportion of DNA cleavage resulting from hydrogen abstraction at the 4' or 5' 
position could be shifted as a result of isotope-selection effects (Kappen, et al., 
1991). Kinetic analysis of neocarzinostatin cleavage at the minor sites, the 
deoxycytidylate residues in AGC sequences, demonstrated a third type of DNA 
cleavage chemistry for neocarzinostatin (Kappen, et al., 1990). At these sites, 
DNA cleavage appears to be mediated by C1' hydrogen bond cleavage. When 
the C1' position of deoxycysteine residues located at these cleavage sites was 
deuterated, a kH/kD of 3.3-4.2 was observed, confirming the location of 
hydrogen-atom abstraction as at the C1' position. Bleomycin, like 
neocarzinostatin, oxidatively cleaves DNA by a degradation of the sugar 
phosphate backbone. In the presence of metal ions such as Fe(II) or Cu(II) and 
oxygen, bleomycin cleavage of DNA yields free nucleic acid bases, base 
propenal, and DNA termini consisting of 5' phosphates and 3' 
phosphoglycolates. The first kinetic isotope study to examine the mechanism 
of bleomycin cleavage of DNA measured the effect of tritium selection on 4'-
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hydrogen abstraction (Wu, et al., 1985). Under the conditions used for this 
study, kH/kD for 4' hydrogen abstraction was found to range from 7.2-12.5. 
This clearly indicated that 4'-hydrogen abstraction was rate-limiting and 
provided the first direct evidence that bleomycin cleavage of DNA is a 
consequence of 4'-hydrogen abstraction. In a subsequent experiment, a kinetic 
isotope study was conducted that measured the effect of deuterium 
incorporation at the C4' position on the rate of bleomycin cleavage (Kozarich, et 
al., 1989). In this study, kH/kD for 4'-hydrogen abstraction was found to range 
between 2 and 4.5. This was consistent with the results of the earlier 
experiment using tritium selection and confirmed that bleomycin cleavage of 
DNA involves rate-limiting abstraction at the 4' hydrogen. An interesting side 
note from this experiment was that the differences in the magnitude of the 
isotope effect at different sites were reproducible and suggests that local 
variability in the DNA sequence may be important in determining the 
magnitude of the kinetic isotope effect that is observed (Kozarich, et al., 1989). 
Experimental Design . The experiment designed to determine the kinetic isotope 
effect for Ni(II)-GGH yo (141-183) is shown schematically in Figure 15. Like the 
kinetic isotope experiments examining neocarzinostatin and bleomycin, 
polyacrylamide gel electrophoresis is used in conjunction with sequence-
specific incorporation of specifically deuterated nucleotides. Since Ni(II)-GGH 
yo (141-183) cleaves at one nucleotide per binding site, a chemically synthesized 
oligonucleotide was designed that contained two binding sites arranged in a 
head-to-tail fashion . This provided two sites of DNA cleavage on the same 
oligonucleotide strand. Automated machine synthesis of this duplex allowed 
the insertion of a specifically deuterated nucleotide at a predetermined 
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Figure 15 A schematic representation of a kinetic isotope experiment using 
Ni(II)•GGH y8 (141-183). A) A representation of the cleavage products 
obtained from electrophoresis of a proteo and a deutero duplex. The bands 
used as internal references and experimentals are identified. B) The equation 
used to determine the kinetic isotope effect (.KIE). 
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was an all proteo duplex, the second set contained the specifically deuterated 
nucleotide at a single cleavage site within the duplex. Using oligonucleotides 
that are 5'-end labeled with 32p, two parallel sets of cleavage reactions are 
performed. The first one utilizes the all-proteo version of the target duplex, 
and the second one utilizes the target sequence containing a deuterated 
nucleotide. Following completion of the cleavage reactions, the DNA is treated 
with butylamine at 90 °C for 30 min to assure that all alkali labile products are 
converted to phosphate. This allows for the calculation of a kinetic isotope 
effect (KIE) based on one type of cleavage product. Following the butylamine 
treatment, the cleavage products are separated by gel electrophoresis using a 
20% denaturing gel. This produces a gel with the appearance shown 
schematically in Figure 15. In each lane of the gel there are three bands. The 
first band corresponds to uncut DNA, while the second and third bands 
correspond to sequence-specific affinity cleavage by Ni(II)-GGH y8 (141-183) 
adjacent to each of the protein-binding sites. The first of these affinity cleavage 
sites serves as an internal reference and always contains a proteo 
oligonucleotide. The second cleavage site is the experimental case; in the 
proteo duplex this site contains a proteo nucleotide, and in the deuterium 
duplexes this site contains a site-specific deuterated nucleotide. After 
electrophoresis, the intensity of the bands produced by affinity cleavage is 
measured, using a Molecular Dynamics Phosphorimager. These measurements 
are then used to calculate a KIE, using the formula found in Figure 15. Within 
each lane of the gel a ratio is first taken between the experimental case and the 
internal reference. This normalizes the value observed for the experimental 
band and serves to correct it for experimental error that might result from 
differential loading of DNA onto lanes of the electrophoretic gel, or for minor 
differences in the magnitude of affinity cleavage between individual reactions. 
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The kinetic isotope effect is then calculated by taking the ratio of this 
normalized value for the proteo case over the normalized value for the deutero 
case. 
It is important to make note of the cleavage conditions used for the kinetic 
isotope experiment. The reaction conditions chosen produced approximately 
1% total cleavage of the DNA after butylamine treatment. The choice of 
conditions that produce a low amount of cleavage is important for several 
reasons. First, it is important to maintain conditions where the DNA duplex is 
cleaved only once. At cleavage greater than 4-5%, a significant number of 
double cleavage events occur. It is important to avoid double-cleavage events 
because of the use of gel electrophoresis to isolate and quantitate the cleavage 
products. Gel electrophoresis separates DNA on the basis of size and charge. 
However, only the fragment of DNA that is 32P-end labeled is detected. Thus, 
in the case of double-cleavage events, only the event closest to the label is 
detected. In the experimental design used to measure the isotope effect, 
double-cleavage events would lead to an error in reporting of the KIE. 
Availability of Hydrogens for Abstraction. Affinity-cleaving studies have located 
the amino terminus of y 8 (141-183) in the minor groove at the center of each 
resolvase-binding site (Graham and Dervan, 1990). The location at which DNA 
cleavage occurs using Ni(II)-GGH-y8 (141-183) and monoperoxyphthalic acid is 
consistent with this assignment for the position of the amino terminus of the 
peptide y 8 (141-183). As a consequence of this, one would expect the DNA-
cleaving moiety Ni(II)-GGH to be positioned in close proximity with the minor 
groove, limiting the availability of hydrogens for abstraction to those that are 
found within the minor groove. By examining the major and minor grooves of 
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a) Stereo view from the minor groove 
b) Stereo view from the major groove 
Figure 16 A stereo view of the sugar phosphate backbone of DNA from the 
minor (a) and the major (b) groove. Hydrogen atoms exposed to the 
corresponding grooves are shown in black. 
duplex DNA (Figure 16), we see that only certain hydrogens are available for 
abstraction within each of these groups. Within the minor groove we see that 
hydrogens attached to carbons C1', C2', C4', and CS' of the deoxyribose are 
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available for abstraction; while within the major groove hydrogen atoms 
attached to the carbon atoms C2', C3', and CS' of the deoxyribose are available 
for abstraction. Since the Ni(II)-GGH is located in close proximity to the minor 
groove, it would be expect that DNA cleavage might involve hydrogen-atom 
abstraction from positions C1', C2', C4', and/or CS' of the deoxyribose ring. If 
the abstraction of hydrogen by the activated form of Ni(II)-GGH y 8 (141-183) is 
the rate-limiting step in DNA cleavage, then deuterium incorporation at one or 
more of these positions may produce an observable kinetic isotope effect and 
may thereby identify positions that are involved in the cleavage of DNA. An 
important assumption in this interpretation is that isotopic substitution does 
not affect the extent of strand breakage at any other step than the initial 
reaction with the activated Ni(II)-GGH yo (141-183). 
Results of Kinetic Isotope Studies 
Synthesis . Figure 17 shows the sequence of the synthetic oligonucleotide used 
for the kinetic isotope experiments, as well as the structures of the site-specific 
deuterated thymidines. The syntheses of the deuterated thymidines are shown 
in Schemes I-V. 
Synthesis of the C1 '-deuterated thymidine involved initial reduction of the 
tribenzoyl ribolactone, using deuterated disiamylborane. Following reduction 
of the lactone, the 1-0-acetyl compound (2) was synthesized by reaction with 
acetic anhydride. In the presence of the Lewis acid SnC14, (2) was reacted with 
the bis(O-trimethylsilylthymidine) forming the tribenzoylated methyluridine 
(3). The benzoyl groups were then removed and the 3' and 5'-alcohols were 
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5'-T TAA TG,TGT CT AT T A'* AA T~TGTC TAT TAlA AA TGA AT CA-3' 
3'-AA T T ACA CAGA T AA TT TT A CACAGA T AA T TTGC T T ACT-S' 
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Figure 17 The sequence of a synthetic oligonucleotide duplex used for kinetic 
isotope experiments. Boxes indicate the 9 bp yo resolvase binding sites. The 
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Scheme I. Synthesis of C1'Deuterated Thymidine. a) Disoamylborane, THF; b) 
Ac20, pyridine, 80 C; c) Bis(O-trimethylsilyl)thymine, SnCl4. CH2Cl2, 0 C; 
d) NH3 MeOH; e) 1,3-dichloro-1,1,3,3,-tetraisopropyldisiloxane, pyridine; 
f) Phenylchlorothionoformate, DMAP, CH3CN; g) BU3SnH, toluene, 75 C; 
h) Bu4NF, THF; i) DMTCl, pyridine. 
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protected as the tetraisopropyldisiloxane. The 2'-alcohol was then removed 
using the deoxygenation methodology of Robins, et al (1981). Following 
deoxygenation and removal of the silyl protecting group, a DMT group was 
attached to the 5' alcohol. The overall synthetic yield for seven sets was 12.2%, 
with a deuterium incorporation measured by mass spectrometry of 92.5%. 
The synthesis of the 2'-dideutero thymidine is shown in Scheme II. In a one pot 
synthesis, ribose is cyclized to form the 1-0-methyl compound and protect it at 
the 3- and 5'hydroxyls as the diisopropyltetrasilyl. This compound is then 
oxidized via Swern oxidation to form the ketone, 10. The ketone is then 
reduced with NaBD4, producing a mixture of the 2-deutero-arabino and ribo 
diestereomers in a 10:1 ratio. The arabino isomer was found by mass 
spectrometry to have 100% deuterium incorporation. This isomer was then 
deoxygenated, using the method of Robins, et al (1981) and the second 
deuterium was incorporated from tributyltindeuteride. This isotopic 
incorporation as determined by FAB mass spectrometry of the resulting 
dideuterodeoxyribose derivative (13) was 2% 01 and 98% 02. The a-chloro 
sugar was then synthesized, using the method of Hoffer (1960) and 
subsequently coupled with bis-0-trimethylsilylthymidine under the conditions 
of Hubbard, et al (1984). This afforded 76.4 mg of the desired J3-isomer 15. 
After ammonolysis, the deuterium incorporation of the resulting 2',2'-
dideuterothymidine, as measured by DEI mass spectroscopy, was 2% 01 and 
98% 02. Following attachment of the dimethoxytrityl group to the 5'-hydroxyl, 
37 mg of the pure 2',2'-dideutero-5'-0-(4,4'-dimethoxytrityl)-thymidine was 
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Scheme II. Synthesis of C2'Dideuterated Thymidine. a) HCl, MeOH, OC; b) 
1,3-dichloro-1,1,3,3,-tetraisopropyldisiloxane, pyridine; c) oxalyl chloride, 
DMSO, Et3N, CH2Cl2, -78 C; d) NaBD4, EtOH; e) Phenylchlorothionoformate, 
DMAP, CH3CN; f) Bu3SnD, toluene, 75 C; g) BU4NF, toluene; h) TolCl DMAP, 
CH3CN; i) HCl Acetic Acid; j) Bis(O-trimethylsilyl)thyrnine, CHCl3; k) NH3 
MeOH; l) DMTCl, pyridine. 
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Scheme III. Synthesis of C3'Deuterated Thymidine. a) Cr03, pyridine, 
acetianhydride CH2Cl2; b) NaBD4, EtOH 
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The synthesis of the 3'-deuterothymidine is shown in Scheme III. 5'-DMT 
protected thymidine is subject to chromium oxidation, forming the ketone 18. 
The resulting ketone was then reduced, using sodiumborodeuteride, producing 
two isomers. The overall yield for two steps of the desired riboisomer was 
8.5%. FAB mass spectroscopy showed the percent deuterium incorporation to 
be 97%01. 
The synthesis of the C4'-deuterothymidine is shown in Scheme IV. 1-0-acetyl-
4-bromo-2,3,5-tri-0-benzoyl-13-ribofuranose was prepared by the method of 
Ferrier, et al (1984). This compound was subsequently deuterated at position 4 
by reaction with the tributyltindeuteride. After isolation of the desired isomer, 
the 1-0-acetyltribenzoylribose was subsequently converted to the 
corresponding tri-0-benzoyl-methyluridine by reaction with bis(O-
trimethylsilyl)thymidine in the presence of SnCl4 (13). Following ammonolysis 
and protection of the 3' and 5'-hydroxyls as the tetraisopropyldisiloxane, the 2' 
position was deoxygenated, using the method of Robins, et al (1981). The 
disiloxane-protecting group was subsequently removed, and the 5' position 
was protected as the dimethoxytrityl. The overall synthetic yield for seven 
steps was 2.3%, with a deuterium-isotope incorporation of 94.5% as measured 
by FAB mass spectroscopy. 
The synthesis of the 5-dideuterated thymidine is shown in Scheme V. Initially, 
the 5'-hydroxyl is oxidized to the corresponding acid and then converted into 
the 0-methylester. The 3' hydroxyl group is then protected as the 
dimethylisopropylsilanol to improve the solubility of the molecule. Following 
protection of the 3'-hydroxyl, the 5'-methylester is reduced to the 5'-alcohol, 
using LiAlD4. The protecting group on the 3'-hydroxyl is subsequently 
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Scheme IV. Synthesis of C4'Deuterated Thymidine. a) Bu3SnD, toluene, 75 C; 
b) Bis(O-trirnethylsilyl)thyrnine, SnCl4. CH2Cl2, 0 C; c) NH3 MeOH; d) 1,3-
dichloro-1,1,3,3,-tetraisopropyldisiloxane, pyridine 30 C; e) Phenylchloro-
thionoforrnate, DMAP, CH3CN; f) Bu3SnD, toluene, 75 C; g) BU4NF, THF; h) 
DMTCl, pyridine. 
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Scheme V. Synthesis of C5'Dideuterated Thymidine. a) Pt02, 02, H20, 75 °C; 
b) MeOH, H2S04, reflux; c) tBuMe2SiCl imidazole, DMF, 25 C; d) LiAlD4, 
THF, 0 C; e) Bu4NF, THF; f) DMTCl, pyridine. 
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removed by reaction with tetrabutylammoniafluoride, and the 5'-hydroxyl is 
then protected, using DMT chloride. This produced the desired 5'-dideutero 
DMT-protected thymidine (32) in a 27% overall yield for five steps. Deuterium 
incorporation based on FAB mass spectroscopy was found to be 1.5% D1 and 
98% D2. 
Measurement of Kinetic Isotope Effects. Each of the six oligonucleotides 
(containing C1'-, C3'-, C4'-deuterated or C2'-, C5'-dideuterated, or all-proteo 
thymidine at the experimental position) was specifically labeled with 32p at the 
5'-end. The resulting labeled oligonucleotides were hybridized with the 
complementary strand and gel-purified, providing the duplex DNA used for 
the kinetic isotope experiments. Ni(II)-GGH yo (141-183) in the presence of 
monoperoxyphthalic acid was allowed to react with the DNA to produce a total 
of 1% strand scission after treatment with butylamine. Figure 18 contains a gel 
that shows cleavage with each one of the specific deuterated or the all-proteo 
nucleotide by Ni(II)-GGH yo (141-183) in the presence of monoperoxyphthalic 
acid. Examination of this gel shows that the protein cleaves the DNA 
specifically at only one nucleotide adjacent to the binding site. The site of 
cleavage at the experimental site occurs at the point in the DNA sequence 
where the specific mono- or dideuterated thymidines were incorporated. 
A close examination of lane #9, which contains the 5'- dideuterated thymidine 
at the experimental site reveals the existence of an additional cleavage band 
adjacent to the site at which the 5'-dideuterated nucleotide was incorporated. 
This band migrates approximately one-half base pair slower than the cleavage 
band, placing its electrophoretic mobility in between that of DNA fragments 
ending in phosphate resulting from DNA cleavage at the site of deuterium 
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Figure 18 An autoradiogram of a high-resolution denaturing polyacrylamide 
gel containing 32P-end labeled fragments from the oligonucleotide duplex in 
Figure 17. Lanes 1 and 2 are A and T specific chemical sequencing lanes. Lane 
3 contains control DNA. Lanes 4 through 9 are affinity-cleaving lanes 
containing 1.0 J.l.M Ni(II)•GGH y8 (141-183), and 0.05 Jl.M monoperoxyphthalic 
acid. All reactions were subject to treatment with 0.1 N-butylamine for 30 min 
at 90 oc. The reference-cleavage position and experimental-cleavage position 
are indicated on the right-hand side. Lane 4 contains all-proteo duplex. Lane 5 
contains a duplex with a C1'-deuterated thymine at the experimental position. 
Lane 6 contains a duplex with a C2'-deuterated thymine at the experimental 
position. Lane 7 contains an oligonucleotide duplex with a 3'-deuterated 
thymine at the experimental position. Lane 8 contains an oligonucleotide 
duplex with a 4'-deuterated thymine at the experimental position. Lane 9 






incorporation and the 3'-adjacent nucleotide. Out of 1,200 cleavage 
experiments that were performed during the course of the kinetic isotope 
studies, this slower-moving band was observed in only 50 of them, and it was 
always observed to occur adjacent to a site at which the 5'-dideuterated 
thymidine had been incorporated. The existence of a DNA fragment whose 
migration does not correspond to a phosphate termini is very surprising 
because all the reactions were treated with butylamine to eliminate any alkali 
labile end products. It is possible that this band may represent some as of yet 
unidentified "non-alkali labile" DNA end product resulting from oxidative 
cleavage of DNA. Additionally, since the occurrence of this uncharacterized 
band is always coincident with the incorporation of 5'-dideuterated thymidine, 
the possibility must be considered that deuterium incorporation at the 5' 
position alters the mechanism by which oxidative DNA cleavage occurs. 
The relative intensities of the cleavage band produced by Ni(II)-GGH y 8 (141-
183) in the presence of monoperoxyphthalic acid from the gel in Figure 18 are 
shown graphically in Figure 19. Panel A, which contains data from an 
oligonucleotide, which contains only proteo thymidine, shows that the 
intensity of cleavage at the experimental and control sites is approximately 
equal, as one would expect. Panel C, which contains data taken from cleavage 
of an oligonucleotide that has 2'-dideuterated thymidine incorporated at the 
experimental site, again shows no apparent difference between cleavage 
intensities at the experimental or reference site, which indicates that there 
should be no kinetic isotope effect with C2'-deuterated thymidine. Panels B 
and D, which contain information derived from duplexes that contain 
thymidine deuterated at the 1' and 3' positions, respectively, show a slightly 
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Figure 19 A graphic representation of the cleavage intensities at the reference 
(R) and experimental sites (E) obtained from phosphorimager analysis of the 
gel shown in Figure 18. A) Proteo thymine is incorporated at the experimental 
site. B) C1'-deuterated thymine is incorporated at the experimental site. C) C2'-
dideuterated thymine is incorporated at the experimental site. D) C3'-
deuterated thymine is incorporated at the experimental site. E) C4'-deuterated 
thymine is incorporated at the experimental site. F) C5'-dideuterated thymine 
is incorporated at the experimental site. 
This would be consistent with the observation of a small kinetic isotope effect. 
Examination of Panel E, which contains data derived from an oligonucleotide 
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duplex with C4'-deuterothyrnidine incorporated at the experimental site, shows 
a much larger difference in cleavage intensity between the experimental and 
reference site. The higher intensity in cleavage observed at the reference site 
would indicate incorporation of deuterium at a C4' position should produce a 
significant kinetic isotope effect. The data in Panel F, which are derived from 
the cleavage of an oligonucleotide that contains CS'-dideuterated thymidine at 
the experimental cleavage position, show a significantly higher intensity of 
cleavage at the experimental site relative to the reference site. This type of 
result would indicate a negative, or inverse, kinetic isotope effect. 
Quantitation and Statistical Analysis of Kinetic Isotope Effects. For each 
oligonucleotide duplex that contained thymidine with deuterium incorporated 
at a unique position, five gels containing ten experimental reactions and ten 
proteo control reactions were run. (Five gels containing ten experimental 
reactions using oligos in which no deuterium had been incorporated and ten 
proteo-control reactions were also run to serve as a control and to verify that 
kH/kH = 1.) Each gel produced one set of ten normalized-cleavage intensities 
for the experimental case (10 ko's and 10 normalized-cleavage intensities for 
the control 10 kH's) . (The normalized-cleavage intensities for each gel are 
contained in Appendix II.) Since a total of five gels were run for each site of 
deuterium incorporation, we had collected fifty observations of ko and fifty 
observations of kH. Unfortunately, calculation of KIE (kH/ko) was not as 
simple as determining fifty ratios and taking their mean because of two 
complicating factors. First, analysis of variance showed that the values of ko or 
kH obtained from different gels could not be pooled. This meant that KIE, or 
the ratio of kH/ko, had to be determined prior to pooling the data from 
different gels. The second complication arose from a problem with the 
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experimental design. We had not conducted the experiment in a way that 
would produce paired values of kH and ko. This meant that values of KIE 
calculated by pairing the values of ko with values of kH from the same gel 
were not statistically meaningful. To overcome this problem, KIE was 
calculated, using values of kH and ko that were randomly generated and 
paired from the sets of ten observations using a resampling method called 
"Bootstrap Technique" (Fleiss, 1986; Dunn and Clark, 1987). With this 
technique, a value was selected from the sets of kH's and the sets of ko's. 
These values were used to calculate a KIE and then replaced into the respective 
data sets. This cycle was repeated until ten KIE's were calculated. The groups 
of ten KIE's from each of the five gels that contained the same deuterated 
nucleotide were pooled and used to calculate a mean value of KIE for the site of 
deuteration (Table 1). For the purposes of statistical analysis, 420 of these sets 
of fifty KIE's were generated for each site of deuteration and the control using 
the "Bootstrap Technique." Student's T tests were then performed to determine 
if there was a significant difference in the mean between the experimental 
group and the control group for each of the 420 data sets. Results of the 
statistical analysis showed that the KIE was significantly larger when 
deuterium had been incorporated at position C4' relative to the control in all 
420 data sets (at the 95% C.I.). The value of KIE in the control was significantly 
higher than the value observed when deuterium had been incorporated at 
position C5' (with or without the inclusion of the extra, unidentified cleavage 
product in the calculation) in all 420 data sets (at the 95% C.I.). When the 
values of KIE obtained when deuterium were incorporated at positions C1' and 
C3' were compared with the value of KIE for the proteo control, they were 
found to be significantly higher than the control group in all420 data sets. The 
P value for these two sites of incorporation is slightly larger, although the data 
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are still significant at the 95% confidence intervaL When the value of KIE 
obtained with deuterium incorporated at the C2' position was compared with 
the value of KIE from the proteo control, significant differences were obtained 
with only 30 out of the 420 data sets examined. The value of KIE obtained with 
deuterium incorporation at position C2' was therefore deemed not statistically 
different from that of a value obtained with a proteo controL 
Table 1. Kinetic Isotope effects (kHikD) for Deuterated Thymidine. Value 
Represents the Mean of Fifty Rations ± the Standard Error of the Mean 
(SEM) 
Site of Deuterium Incorporation 
C1' C2' C3' C4' C5' C5'+Ex** Control 
Mean 1.07* 1.00 1.05* 1.27* 0.64* 0.48* 0.98 
±SEM ±.01 ±.01 ±.01 ±.01 ±.01 ±.01 ±.01 
* Statistical differences from the control at the 95% confidence 
intervaL 
** Represents kH/ko, including the unidentified cleavage product. 
Interpretation of Kinetic Isotope Effects . Any interpretation of isotope effects must 
involve an understanding of their origin and magnitude. Isotope effects are 
usually divided into two categories, primary and secondary. A primary 
isotope effect results when the bond to the isotopically substituted atom is 
broken in the transition state (Richards, 1970). A secondary isotope effect 
occurs when the bond to the isotopically substituted atom is not broken, but the 
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presence of the isotopically substituted atom still produces a perturbation of 
the reaction rate. 
Primary isotope effects arising from deuterium incorporation are frequently 
discussed as a result of differences in the zero-point energy between carbon-
hydrogen bonds and carbon-deuterium bonds (Richards, 1970; Kresge, 1977; 
Melander, 1960). The difference in zero-point energy is a direct result of the 
difference in mass between hydrogen and deuterium. It is usually discussed in 
terms of the stretching frequency for a carbon-hydrogen bond and a carbon-
deuterium bond, which are 2,900 cm-1 and 2,100 cm-1, respectively. These 
vibrational frequencies correspond to zero-point energies of 4.15 kcal/mole for 
carbon-hydrogen bonds and 3.0 kcal/mole for carbon-deuterium bonds. If the 
primary isotope effects observed with deuterium incorporation were solely a 
result of the difference in zero-point energy, the maximum value of kH/ko that 
could be observed would be 6.4. However, there are many examples where 
significantly greater values of kH/ko have been observed, indicating that 
discussing deuterium isotope effects solely in terms of zero-point energy is a 
gross oversimplification (Kresge, 1977). The factors that account for the 
observation of the large primary isotope effects (isotope effects > 6.4) are 
tunneling and bending vibrations. For example, a deuterium-isotope effect 
corresponding to the complete loss of zero-point energy for one stretching 
vibration and two bending vibrations results in a kH/ko of 18 (Kresge, 1977). 
While the effects of tunneling and bending vibrations can combine with the 
normal stretching vibrations to produce extremely large kinetic isotope effects 
(kH/ko's as large as 45 have been observed by Caldin and Mateo, 1975). It is 
also possible to obtain primary kinetic isotope effects with magnitudes near 
unity (Kresge, 1977). An explanation of these small, primary isotope effects 
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was initially offered by Melander (1960) and Westheimer (1961). This 
explanation is based upon a three-centered model for the transition state of a 
hydrogen-transfer reaction and assumes that in the transition state the 
hydrogen that is being transferred is simultaneously bound by an acceptor and 
a donor. In simplest terms, this description predicts that hydrogen-isotope 
effects will be greatest when the partial bonds holding the hydrogen being 
transferred to the donor and to the acceptor are of equal strength, in other 
words, when the hydrogen is half-transferred at the center of the transition 
state (Kresge, 1977). The explanations put forth by Westheimer (1961) and 
Melander (1960) state that any deviation from this symmetric situation in either 
direction would produce a smaller isotope effect. In other words, if hydrogen 
transfer does not coincide with the energy maxima of the transition state, a 
small kinetic isotope effect will be observed. It should be noted that this 
explanation for small, primary isotope effects uses a linear model for the 
transition state. In recent years it has become apparent that bending 
frequencies and non-linear transition states can also play a role in producing 
small, primary kinetic isotope effects (Jencks, 1987). 
As previously stated, secondary isotope effects are caused by isotopic 
substitution of atoms that are not "reacting." Secondary deuterium-isotope 
effects are caused by the changes in vibrational and bending frequencies and 
zero-point energies in ground and transition states that result from isotopic 
substitution. (Jencks, 1987; Melander, 1960; Richards, 1970) Secondary effects 
have been observed with deuterium substitution both, a and f3, to the reacting 
atom. A classic example of a secondary isotope effect occurs as a result of the 
sp3 sp2 transition that occurs in carbonium ion formation. Substitution of 
deuterium a to the reacting carbon center has resulted in observed secondary 
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isotope effects in the range of 1.15 to 1.28 (Streitwieser, et al., 1958; Shiner, et al., 
1968; Shiner, 1952). Secondary isotope effects of this type are probably a result 
of the change in one of the bending frequencies that occurs as a consequence in 
the change from sp3 to sp2 hybridization. Substitution of deuterium for 
hydrogen on a carbon atom adjacent (~ substitution of deuterium) to the one 
that becomes cationic can also slow the rate of reaction (Streitwieser, 1958). 
This ~ substitution of deuterium is thought to produce a kinetic isotope effect 
because during the formation of a carbonium-ion, a partial breaking of the 
deuterium-carbon bond is thought to result from hyperconjugation with the 
vacant p-orbital of the carbonium ion carbon. This effect has been found to be 
maximal when the dihedral angle between the vacant p-orbital and the carbon-
deuterium bond in question is zero (maximal overlap) and vanishes when this 
angle becomes 90°C (Streitwieser, et al., 1958; Shiner, 1960). While carbonium-
ion formation may provide the classic examples of secondary isotope effects, it 
is important to realize that these effects occur with other types of reactions in 
which changes in hybridization from sp3 to sp2 are observed (Halevi, 1963; 
Brown and Cookson, 1965; Sunko and Borcic, 1970). It is interesting to note that 
in some circumstances secondary deuterium-isotope effects are additive. In 
other words, a greater effect is observed when two deuteriums are incorporated 
as compared with one. In other situations, particularly those involving 
hyperconjugation, this may not be so (Melander and Saunders, 1980). 
When the products from reactions involving deuterated substrates can be 
isolated, it is easy to distinguish between primary and secondary isotope effects 
because it is possible to determine if product formation involved breaking of 
the carbon-deuterium bond. However, when experimental conditions 
necessitate that reactions are run on such a scale that product isolation and 
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characterization is not possible, distinguishing between primary and secondary 
kinetic isotope effects becomes somewhat more difficult. When this situation 
exists, the distinction is usually made on the basis of the magnitude of the 
observed isotope effect. It is generally accepted that an observed isotope effect 
of > 2 is a primary effect (Richards, 1970; Shiner, 1970; Harris and Wamser, 
1976). It is also generally accepted that observed isotope effects of< 1.1 are 
typically secondary effects (Harris and Wamser, 1976). The problem comes 
with interpreting values that are intermediate, those between 1.1 and 2.0. This 
arises from the fact that there are many observed primary and secondary 
kinetic isotope effects with magnitudes that fall within this range. As a 
consequence of this, isotope effects with these intermediate values are typically 
analyzed on a case-specific basis by taking into account other factors that are 
known about the reaction mechanism in question. In light of the preceding 
discussions, an attempt will be made to interpret the kinetic isotope effects 
observed for Ni(II) GGH y B (141-183) cleavage of DNA in the presence of 
monoperoxyphthalic acid. At position C2' no isotope effect was observed. At 
positions C1' and C3', small kinetic isotope effects with values of 1.07 and 1.05, 
respectively, were observed. The small magnitude of these effects in the 
absence of contradictory information would lead to their interpretation as 
secondary isotope effects. It would be quite surprising indeed to observe a 
primary isotope effect at position C3', because the C3'-hydrogen is located in 
the major groove, and our cleaving moiety is located in the minor groove. 
These small isotope effects are likely a result of the change in carbon 
hybridization from s,P to sp2 that would occur with base release from the C1' 
position and the loss of phosphate from the C3' position. This interpretation 
might raise the question as to why a 13 secondary isotope effect was not 
observed as a result of deuterium incorporation at position C2'. There are two 
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possible explanations for this. First, hyperconjugation may not have played an 
important role in the transition states for these reactions. Second, even if 
hyperconjugation could play a role, the conformational constraints of the 
deoxyribose-ring, 2'-endo sugar pucker would orient the deuteriums in such a 
manner that their contribution to an isotope effect was minimized (Saenger, 
1984). 
At the position C4', an isotope effect of 1.27 was observed. The magnitude of 
this effect makes its interpretation exceedingly difficult because values of 
kH/kD in this range have been observed for both primary and secondary 
isotope effects. Potential explanations for a secondary isotope effect with 
deuterium incorporation at this position would include an a. effect that was due 
to opening of the deoxyribose ring, creating an sp2 center at the C4' position, or 
~ effects resulting from the loss of phosphate from either the 3' or 5' position, 
creating sp2 centers at these locations. A primary isotope effect at this position 
would result from hydrogen abstraction from the C4' carbon by the activated 
species generated from Ni(II) GGH yo (141-183) in the presence of 
monoperoxyphthalic acid. Hydrogen-atom abstraction at this position would 
be consistent with the oxidative nature of the DNA cleavage observed. 
Neocarzinostatin and bleomycin, which cleave DNA in an oxidative manner, 
have been found to produce DNA cleavage by abstraction of the C4' hydrogen 
(Kappen et al., 1991; Frank, et al., 1991; Kozarich, et al., 1989). For nickel 
monoperoxyphthalic acid-mediated cleavage by the peptide GGH-Hin (139-
190) Mack and Dervan (1990) have reported a kinetic isotope effect of 1.6 
resulting from deuterium incorporation at the C4' position. If this is, indeed, a 
primary kinetic isotope effect, there are several explanations for its small 
magnitude. Two explanations that immediately come to mind, as previously 
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discussed, would be the effects resulting from either an asymmetric, or non-
linear, transition state. While these classical explanations for small-magnitude, 
primary kinetic isotope effects would be more than adequate to account for our 
experimental observation, it should be pointed out that in other experiments 
that examined kinetic isotope effects on the cleavage of DNA, there was found 
to be a sequence variability in the magnitude of the isotope effect that was 
observed (Kozarich, et al., 1989; Kappen, et al., 1991; Frank, et al., 1991). In the 
kinetic isotope effect studies examining neocarzinostatin-mediated cleavage of 
DNA, primary isotope effects for 5' hydrogen abstraction in the range of 1.3 
were observed (Frank, et al., 1991). Since the DNA cleavage observed is 
oxidative in nature and presumably involves hydrogen abstraction and no 
other larger kinetic isotope effects are observed, the isotope effect occurring at 
position C4' is probably a primary kinetic isotope effect with a small magnitude 
as a result of either characteristics of the reaction's transition state and/ or 
effects of the DNA sequence that is cleaved. 
The isotope effect observed at position CS' is probably the most diffult to 
explain rationally. The kH/kD observed for this position is 0.64. This is a 
negative, or inverse, kinetic isotope effect. In the system we are studying, there 
are three possible explanations for the occurrence of this type of effect. The first 
is that incorporation of deuterium at position CS' somehow alters the pathway 
by which the activated deoxyribose undergoes rearrangement, leading to 
strand scission. The second possibility is that we have observed a negative, 
primary isotope effect. And the third possibility is that we have observed a 
negative, secondary isotope effect. 
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The first one of these possibilities that we will deal with is that deuterium 
incorporation somehow alters the mechanism by which the deoxyribose 
rearranges prior to producing strand scission. This possibility is supported by 
the observation of an additional cleavage product when 5'-dideuterated 
thymidine is incorporated into the oligonucleotide duplex. This cleavage 
product is present even though all the cleavage reactions were subject to base 
workup using butylamine, indicating that it is some type of non-alkali, labile 
cleavage product. Inclusion of this addtional product in the calculation of the 
isotope effect for C5' deuteration leads to a significantly more negative effect of 
0.48 . The idea of an altered rearrangement mechanism, or change in 
partitioning of the rearrangement mechanism used by deoxyribose to lead to 
DNA strand scission, is highly attractive since a non-alkali, labile end product 
was not previously observed in DNA cleavage mediated by Ni(II) GGH y o 
(141-183) in the presence of monoperoxyphthalic acid. This hypothesis could 
be readily tested by examining the profile of DNA cleavage products that are 
produced both in the presence and absence of deuteration at the CS' position, 
with and without butylamine treatment. Careful characterization of these 
products and identification of the unknown, non-alkali labile product may 
provide support for this interpretation. This interpretation would still be 
consistent with the assignment of the effect at C4' as a primary isotope effect. 
The two alternate explanations for the effect observed at C5' would require us 
to have observed a negative secondary, or primary, kinetic isotope effect. There 
are examples of both negative secondary and primary kinetic isotope effects in 
the literature. It has been found that a negative secondary kinetic isotope effect 
can occur as a result of the change in carbon hybridization from sp2 to s p3 
(Brown and Cookson, 1965). This explanation for the observation of a negative 
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kinetic isotope effect as a result of deuterium incorporation at position CS' 
would be consistent with the mechanism for DNA cleavage, which first 
involved hydrogen abstraction from the C4' position to generate an sp2 center, 
followed by a reaction of either a radical or cation at this position with oxygen 
or water, respectively. When the C4' position would react with oxygen or 
water, it would undergo a transition from sp2 to sp3 and the deuteriums 
present at the CS' position would be responsible for producing a negative p 
secondary isotope effect. o18 incorporation studies of bleomycin-mediated 
cleavage of DNA have shown that the radical generated at position C4' as a 
result of hydrogen abstraction can readily incorporate molecular oxygen and 
that a cation generated as a result of electron transfer from this radical can 
readily incorporate water at the C4' position (McGall and Stubbe, 1991; Rabow, 
et al., 1990; McGall, et al., 1992). These observations support our interpretation 
of the negative isotope effect at position CS' as being an inverse P secondary 
isotope effect resulting from a change in hybridization from sp2 to sp3. 
The remaining possibility for the negative kinetic isotope effect observed with 
deuterium incorporation at position CS' would be a primary, negative kinetic 
isotope effect. It is important to point out that if a negative, primary kinetic 
isotope effect was observed at this position, our interpretation of the isotope 
effect at C4' should be changed to that of a secondary isotope effect to be 
mechanistically consistent. Inverse primary kinetic isotope effects have been 
observed in the reduction of sterically hindered ketones by LiAl (0Bu-t)3D 
(Wigfield, et al., 1975), the formation of allylic-insertion products by carbenes 
(Baldwin and Andrist, 1971) and in the hydrogen-transfer reaction involved in 
the addition of hydrogen bromide to alkenes (Pasto, et al., 1974). In the 
hydrogen-transfer reactions involving hydrogen bromide and alkenes, kinetic 
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isotope effects in the range of 0.48 to 0.63 were observed. The magnitude of 
these observed inverse kinetic isotope effects is consistent with the transfer of a 
hydrogen ion from a species having a lower vibrational frequency than that of 
the hydrogen bond that is being formed (Pasto, et al., 1974). In simple terms, an 
inverse kinetic isotope effect of this type is thought to occur as the result of 
transferring hydrogen from a species having a weaker bond to the hydrogen to 
one that has a stronger bond to the hydrogen. Interestingly, our observed 
inverse kinetic isotope effects for deuterium incorporation at position CS', with 
or without the inclusion of the extra cleavage product, fall within the range 
observed for this type of effect. If the negative kinetic isotope effect observed 
as a result of deuterium incorporation at position CS' was a primary effect of 
this type, the mechanism of DNA cleavage would involve hydrogen 
abstraction, or transfer, from the CS' position and the subsequent formation of a 
bond between this hydrogen and the activated nickel species that is stronger 
than a carbon-hydrogen bond. Currently, there is no evidence to support the 
existence of such an intermediate. 
Conclusions. The metallopeptide GGH y a (141-183) in the presence of nickel 
and monoperoxyphthalic acid produces highly specific cleavage of DNA 
adjacent to sites bound by y a (141-183). This DNA cleavage occurs at one 
nucleotide, indicating that it is mediated by some type of non-diffusible species. 
The nature of the cleavage is oxidative, producing phosphate termini on both 
the 5'- and 3'-ends. The results of ESR spectroscopy, using the tripeptide GGH 
and Ni(II) indicate that Ni(III) is not the active species that mediates this 
cleavage of DNA. Presumably then, DNA cleavage is mediated by some high-
valent form of the nickel-peptide complex, presumably a nickel-peroxy or 
nickel-oxo species. Studies examining the effect of deuterium incorporation at 
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specific positions within the deoxyribose ring indicate that DNA cleavage may 
involve abstraction of the hydrogen at the C4' position. Currently, further 
studies are needed to elucidate the mechanistic details by which Ni(II) GGH y 8 
(141-183) cleaves DNA in the presence of monoperoxyphthalic acid. 
Experimental 
General. UV vis spectra were recorded on a Perkin Elmer Lambda 4C 
spectrophotometer or a Hewlett Packard model 8451A diode array 
spectrophotometer. Proton, nuclear magnetic resonance spectra (1 H NMR) 
were taken on one of the following instruments: JEOL FX-90, or JEOL GX-400, 
Bruker 500 or a General Electric 300 MHz instrument. Chemical shifts (8) were 
reported in parts per million (ppm) relative to TMS. Melting points were 
measured, using a Thomas Hoover Capillary Melting Point apparatus and were 
uncorrected. Exact mass and high resolution mass spectra were obtained from 
the NSF regional mass spectroscopy facility at the University of California, 
Riverside. DNA cleavage reactions were quantitated, using a Molecular 
Dynamics Phosphorimager model #400S. All chemicals were obtained from 
either Aldrich or Sigma, with the exception of sodium borodeuteride, which 
was purchased from Cambridge Isotopes. All enzymes were purchased from 
Boehringer Mannheim. 
Peptide Synthesis and Purification. GGH-y8(141-183) was synthesized by manual 
protocols on phenylacetamidomethyl (PAM) resin, substituted with tBoc-Asn. 
Standard tBoc synthetic protocols and previously described Boc protected 
amino acids were used. The overall yield for the synthesis was 72.8%. The 
peptide was deprotected, using the previously described HF protocol and 
purified via reverse phase chromatography, using a C8 column from Brownlee. 
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The sequence of the protein was confirmed via amino acid analysis and Edman 
degradation and mass spectral analysis agreed with the expected weight of the 
protein. 
Labeling of the Hind III I Sal I Restriction Fragment from Plasmid PRW 80. Plasmid 
PRW 80 (Abdel-Maguid, et al., 1984) containing two copies of Res was digested 
with the restriction endonuclease Hind(III) to produce two fragments, 30 and 5 
kilobase pairs in size. Labeling at the 3' end was accomplished using a32p_ 
dATP with the Klenow fragment of DNA polymerase I. 5'-end labeling was 
accomplished by dephosphorylation of the 5'-DNA termini with calf alkaline 
phosphatase, followed by rephosphorylation of the hydroxyl ends using y-32p_ 
ATP and T4 polynucleotide kinase. Following end labeling, the fragments were 
cleaved with the restriction endonuclease Sal (I). This yielded three different 
sized, end labeled fragments. The smallest fragment, 240 bp long, contained 
the intact Res site. This fragment was isolated by non-denaturing 
polyacrylamide gel electrophoresis, using a 15 em X 2 mm 5% polyacrylamide 
gel. 
Ni(II) GGH y8(141-183) Cleavage Reactions. Cleavage reactions were performed 
in a buffer containing 20 mM phosphate buffer (pH 7.5) 20 mM NaCl, 100 J..LM 
in base pair calf thymus DNA , approximately 30,000 cpm of 32P-end labeled 
DNA. The reactions contained 0.5 J..LM, 1.0 J..LM, or 2.0 J..LM Ni(II) GGH yo (141-
183) as noted in the text. The protein was allowed to equilibrate with the DNA 
in the buffer solution for 15 min prior to the addition of the oxidant. The 
reactions were initiated by the addition of either hydrogen peroxide or 
monoperoxyphthalic acid at the concentrations noted in the text. The times the 
reactions were allowed to proceed are also noted in the text. Reactions were 
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terminated by ethanol precipitation and dried by lyophilization. If butylamine 
treatment is indicated, they were resuspended in 50 Jll of 0.1 normal N-
butylamine and heated at 90 °C for 30 min, then frozen and lyophilized. All 
reactions were resuspended with 10 Jll of 100 mM trisborate EDTA and 80% 
formamide solution. The resulting 32p end labeled DNA fragments were 
analyzed by denaturing polyacrylamide gel electrophoresis. The resulting 
polyacrylamide gels were analyzed either by using autoradiography and 
densitometric analysis or by imaging with a Molecular Dynamics 
Phosporimager. 
MPE Footprinting Reactions. MPE Footprinting reactions were performed in a 
buffer containing 20 mM NaCl, 100 J.!M in base pair, calf thymus DNA, 20 mM 
tris buffer (pH 8.0), and approximately 30,000 cpm 32P-end labeled DNA. The 
reactions also contained 10 J.!M MPE•Fe(II), 5 mM OTT, and 2.0 J.!M protein 
when noted. For footprinting reactions, the protein was added to the buffer 
and allowed to equilibrate for the DNA for 15 min. MPE • Fe(II) was then 
added and then allowed to equilibrate for 5 min. The reaction was then 
initiated by the addition of OTT. After 10 min at 25 °C, the reaction was 
stopped by ethanol precipitation. Comparisons were run between MPE 
cleavage reactions in the presence and absence of protein. 
Oligonucleotide Synthesis and Purification. Oligonucleotides used for end product 
analysis were synthesized on a Beckman System 1+ DNA synthesizer 
employing solid phase phosphotriester chemistry (Matteucci and Caruthers, 
1981; Beaucage and Caruthers, 1984). Oligonucleotides were cleaved from the 
solid support and deprotected by treatment with concentrated ammonia 
hydroxide at 55 °C for 20h. Following removal of the ammonia hydroxide, the 
171 
oligonucleotides were purified by preparative polyacrylamide gel 
electrophoresis. Bands containing the desired product were visualized by UV 
illumination and excised from the gel. The oligonucleotide was eluted from the 
gel slice, using a solution that contained 0.2 M NaCl and 20 mM EDTA. After 
the polyacrylamide was removed by filtration, the resulting supernatant was 
desalted, using Sephadex G60. The concentration of the oligo in solution was 
then determined using UV spectroscopy. 
5 '-End Labeling of Oligonucleotides . 20 pmoles of single-stranded 
oligonucleotide was 5'-end labeled withy 32p ATP, using T4 polynucleotide 
kinase. After the labeling reaction was complete, the solution was ethanol-
precipitated and reconstituted with 50 j..tl of STE buffer. To this solution 2 j..tl of 
solution containing 25 pmoles of the complementary strand of DNA were 
added. The mixture was heated to 90 °C and allowed to cool to room 
temperature overnight. The resulting labeled DNA duplex was purified using 
non-denaturing polyacrylamide gel electrophoresis. The labeled bands were 
visualized by autoradiography, and the desired band was excised from the gel. 
The labeled oligonucleotide was eluted from the gel slice using a buffer 
containing 0.2 M NaCl and 20 mM EDTA. After the polyacrylamide was 
removed by filtration, the solution was desalted, using Sephadex G60 and 
lyophilized. The DNA was then reconstituted with water to a concentration of 
30,000 cpm per j..tl. 
3 '-End Labeling of Oligonucleotides. 25 pmoles of single-stranded oligonucleotide 
were 3'-end labeled with a-32p ddATP and terminal transferase. After the 
labeling reaction was completed, the DNA was ethanol-precipitated and 
reconstituted with 50 j..tl of STE buffer. To this solution 2 j..tl of a solution 
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containing 25 pmoles of the complementary strand were added. The mixture 
was heated to 90 °C and allowed to cool to room temperature overnight. The 
resulting duplex was isolated, using the same procedures described above for 
5'-labeled oligonucleotides. 
Analysis of DNA Termini by Gel Electrophoresis. The analysis of DNA termini 
was conducted using 3'- and 5'-end labeled oligonucleotide duplexes. The 
conditions used for MPE•Fe(II) cleavage of the DNA were previously 
described. Ni(II) GGH yo (141-183) cleavage of DNA was performed in the 
previously described reaction buffer. These reactions contained 2.0 J.lM final 
concentration of peptide and 1.0 mM final concentration of the oxidant, 
hydrogen peroxide. Cleavage reactions were allowed to proceed for 90 min at 
25 °C prior to ethanol precipitation. The resulting DNA cleavage fragments 
were analyzed by electrophoresis, using a 20% denaturing polyacrylamide gel. 
Analysis for the presence of 5'- and 3'-terminal phosphate groups was 
conducted using the methodology described by Hertzberg and Dervan (1984). 
Electron Paramagnetic Resonance Spectroscopy (ESR) . ESR spectroscopy was 
conducted using a Varian E-Line Century Series Spectrometer. The spectra 
were obtained at -150 °C, using degassed samples. All of the samples 
contained 5 mM tripeptide nickel complex (Ni(II) GGH) dissolved in a 20 mM 
phosphate buffer adjusted to pH 7.5. When noted, IrC162- (IV) and hydrogen 
peroxide were present at final concentrations of 5 mM and 2.5 M, respectively. 
The pH of the hydrogen peroxide was adjusted to 7.0 prior to addition. 
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Sequence-Specific Marker Lanes. A-specific cleavage lanes were produced using 
the protocol of Iverson and Dervan (1987). G-specific and G+A cleavage lanes 
were produced using the protocol of Maxam and Gilbert (1980). 
Protocols Modified for Kinetic Isotope Studies 
Oligonucleotide Synthesis and Purification . Oligonucleotide synthesis was 
conducted on an Applied Biosystems model 490A DNA synthesizer, using 
Applied Biosystems reagents in all cases except for the specific deuterated 
thymidines. The standard Applied Biosystems cycle for 1.0 micromolar 
synthesis, using cyanoethyl phosphoramidites was used. The oligonucleotides 
were synthesized with the trityl group on. All couplings were done 
automatically with the exception of the couplings for the specific deuterated 
thymidines. In the case of the deuterated thymidines, couplings were 
performed manually, using the protocol described below. In all cases the 
thymidine was incorporated at base #29 on the oligo. The oligonucleotides 
differed only in the site of deuteration of the thymidine at this position. The 
DNA synthesis was allowed to proceed automatically through the completion 
of the coupling of base #28. After the coupling of base #28, the synthesis was 
allowed to continue through the detritylation and the wash steps. It was 
stopped at the eighth step for each column that was an aceytonitrile wash. The 
column was removed from the DNA synthesizer at this time. A 100 mmolar 
solution of the desired phosphoramidite was then made by adding 150 
microliters of dry acetonitrile to 15 micromoles of phosphoramidite. To this 
solution, 99 microliters of 500 nmolar tetrazole were added. This mixture was 
flushed over the column for a period of not less than 4 min., using two oven-
dried glass syringes. After this step, the column was returned to the machine, 
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and the synthetic cycle was allowed to complete normally with the exception 
that at the step where a phosphoramidite would have been added to the 
column, only acetonitrile was added. The synthesis was completed, using 
standard ABI coupling procedures. Upon completion of the synthesis, the 
columns were removed from the machine and dried on a lyophilizer overnight. 
The oligo cartridges were then opened and the glass beads placed in a vial to 
which 2 ml of fresh ammonia hydroxide were added. The vials were tightly 
capped and heated for 24h at 55 °C in a water bath. The vials were then 
removed from the water bath and allowed to cool to room temperature. The 
vials were then uncapped, and the remaining ammonia was removed by a 
stream of argon. The beads were removed from the remaining solution by a 
filtration, using a Centrex spin column containing a 0.45 micron filter. The 
beads were rinsed two times with 1 ml of H20, which was also filtered through 
the spin column. This filtrate was aliquoted into 4 eppendorf tubes, and the 
tubes were frozen and lyophilized. 1ml of water was added to each of these 
dry tubes, and the tubes were frozen and relyophilized. 1 I 4 of each synthesis 
was then detrytilated by the addition of 300 microliters of 80% acetic acid. The 
acetic acid was added to the tube and allowed to stand for 20 min., at which 
time 300 microliters of absolute ethanol were added, and the tubes were frozen 
and lyophilized. The samples were then reconstituted with 1000 microliters of 
water and relyophilized. This step was repeated a second time. The resulting 
deprotected oligos were then purified on a 30 em X 2mm 20% denaturing 
acrylamide gel. The gel was run for 36h at 900 volts until the xylene cyanol had 
run off the bottom of the gel. Oligonucleotide bands were visualized by UV 
shadowing at 254 nm. The bands were excised from the gel and crushed. The 
oligonucleotides were eluted from the gel overnight with 4 mls of a solution 
containing 200 mM NaCl and 1 mM EDTA. The acrylamide was removed from 
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the solution, using filtration, and the solution was desalted, using Sep-pak C18 
columns. The resulting desalted oligos were frozen and lyophilized. They 
were reconstituted with a known volume of milli Q H20 and their 
concentrations were determined, using UV spectroscopy and a calculated 
extinction coefficient e260=361,368 for the experimental strand and 
£260=385,056 for the complementary strand. 
5 '-End Labeling of Oligonucleotides. 120 picomoles of single-stranded 
oligonucleotide and buffer were incubated with 50 mCi y 32p ATP(Amersham) 
and 30 units of T4 polynucleotide kinase for 20 min. at 37 °C. At this point, 15 
picomoles of cold A TP were added to the reaction, and the reaction was 
incubated for 30 additional min. at 37 °C. The reactions were cooled to room 
temperature and ethanol-precipitated. Following precipitation, 50 microliters 
of STE buffer and a 10% molar excess of the complementary strand of DNA 
were added to each tube. The tubes were heated to 90 °C and allowed to cool 
slowly to room temperature. The resulting oligonucleotide duplexes were 
purified on a 15% non-denaturing polyacrylamide gel 15 em long by 2 mm 
thick. They were electrophoresed for 5 hat 230 volts. Labeled oligonucleotides 
were then visualized by autoradiography, and bands containing 
oligonucleotide duplexes were excised, crushed and eluted into 2 mls of buffer 
containing 200 millimolar sodium chloride and 1 millimolar EDTA at room 
temperature for 24h. The acrylamide buffer slurry was filtered through a 
Quick-Sep fritted filter into a sterile centrifuge tube. The acrylamide layer was 
rinsed two times with 500 ml portions of milli Q H20. The resulting solution 
was then filtered through a 0.45 micron centrex filter. The solution was then 
desalted using a NAP 25 column and the manufacturer's procedure. The 
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resulting desalted, labeled oligonucleotides were concentrated on a speed vac 
until dryness and reconstituted with water to 25,000 cpm per~· 
T-Specific Cleavage Reactions. 1,000,000 CPM of labeled single-stranded DNA 
were dissolved in 10 microliters of milli Q water. To this were added 3 
microliters of calf thymus DNA (1.4 mM in base pair) was added. 20 J ..Ll of 20 
J..Lg/ml KMn04 were then added. The mixture was incubated for 9 min at room 
temperature, at which time 10 J..Ll of allyl alcohol were added to the solution. 
This mixture was mixed vigorously with a vortex mixer for 45 sec. It was then 
frozen and lyophilized on a speed vac lyophilizer. 150 microliters of 1M 
piperidine were added and heated at 90 °C for 30 min. The solution was frozen 
and lyophilized. 150 microliters of milli Q water added to the residue, the 
residue was redissolved, and it was lyophilized an additional time. The 
reaction was resuspended with an 80% formamide loading buffer to 60,000 
CPM/microliter. 
Conditions for Ni(II) GGH y8 (141-183) Cleavage. Conditions were chosen to give 
approximately 1% total cleavage of the DNA duplexes. All reactions were run 
in a total volume of 20.0 J..Ll. The reactions contained 20 mM NaCl, 20 mM 
sodium phosphate buffer, pH 7.5, 50 J..Lm in base pair, calf thymus DNA, 75,000 
CPM hot DNA duplex, 1.0 J..LM Ni(2)GGH (y, 8141-183) peptide-nickel complex, 
and 0.05 J..LM monoperoxyphthalic acid. To minimize the errors that were due 
to pipeting, for every ten reactions a stock solution was made up that contained 
the sodium chloride, sodium phosphate buffer, calf thymus DNA, and hot 
oligonucleotide duplex. This stock solution was then aliquoted into ten 
individual tubes. To each of these tubes, the protein-nickel complex was 
added. The protein-nickel complex was allowed to equilibrate with the DNA 
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in these tubes for 15 min, at which time the monoperoxyphthalic acid was 
added and the tubes were allowed to react for 10 min at room temperature. 
The reactions were then stopped by the addition of 2 ~of 20% sodium acetate, 
pH 5.2, and 70 microliters of absolute ethanol. The resulting mixture was 
frozen at -70 °C, and the DNA was precipitated by centrifugation. After 
removal of the supernatant, the tubes were dried on a speed vac lyophilizer for 
5 min. 50 microliters of a 0.1 M aqueous solution of butylamine were then 
added to each tube. The tubes were then heated at 90 °C for 30 min. The tubes 
were then allowed to cool to room temperature, and the aqueous butyl amine 
was removed overnight on a speed vac lyophilizer . 15 ~ of an 80% formamide 
loading buffer containing only the dye BPB were then added to each tube, and 
they were allowed to resuspend for 24 h at 4 °C. 
Gel Analysis. Reactions for kinetic isotope experiments were analyzed, using a 
25 em X 0.2 mm 20% denaturing polyacrylamide gel. Each gel contained 24 
lanes. Lanes 1 and 13 contained specific marker lanes, either an A or T lane. 
Lane 2 contained a control lane for the proteo reference duplex, and lanes 3 
through 12 contained reaction lanes for the proteo duplex. Lane 14 contained a 
control lane for the deuterated duplex, and lanes 15 through 24 contained 
reaction lanes for the deuterated duplex. All gels were run such that the 
bromophenyl blue had traveled 21 em. 
Data Collection and Workup. Five gels were run for each of the six oligos to be 
tested. The six oligos were deuterated at either C1', C2', C3', C4', CS', or not 
deuterated at all (entirely proteo). After electrophoresis, the gels were exposed 
to a Molecular Dynamics Phosphorimager plate for 10-14 h . The plates were 
then scanned, using the Molecular Dynamics Phosphorimager. On each gel 
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there were 20 lanes containing cleavage reactions, and in each of these lanes 
containing cleavage reactions, there were two sites of cleavage. For ten of the 
reaction lanes, one of these sites of cleavage contained a thymidine in which 
one of the positions on the sugar had been deuterated (this was true in all cases 
except for the control, where an entirely proteo oligonucleotide was compared 
to an entirely proteo oligonucleotide). The other ten lanes contained an 
oligonucleotide, which at both sites of cleavage contained ribose that was 
entirely proteo. When looking at one of these gels, you will see two sites of 
cleavage; in all cases the upper site of cleavage served as a reference for a given 
lane, and the lower site of cleavage was used as the experimental case. These 
cleavage sites were analyzed and integrated by volume on the 
Phosphorimager; they were corrected for background, and used as the raw data 
to calculate the kinetic isotope effects. Calculation for kinetic isotope effects 
was done as follows: A ratio was taken between the lower cleavage site (or 
experimental case) and the upper cleavage site (or reference). This ratio 
represented an observation for one given reaction. This was done for each of 
the ten experimental lanes and for each of the ten that we will call control lanes. 
To calculate a kinetic isotope effect (KIE), one would then take a ratio of these 
two previously defined ratios. So, in effect, ten lanes on each gel provided a 
measurement of reactions, in which case deuterium was present and ten lanes 
on each gel provided a measurement of a case where there was no deuterium 
present and the substrate was entirely proteo. By determining the ratio defined 
by these two sets of ten observations, you would determine ten different values 
for the KIE or kH/ko. 
Statistical Treatment and Analysis of Data. For each of the deuterated oligos plus 
the proteo control, five gels were run. Each of these gels provided ten 
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observations for the experimental case and ten observations for the control. 
This meant that there was a total of fifty experimental observations for each 
treatment and fifty associated control observations. The first issue which 
needed to be addressed was that of their gel-to-gel variability. If there was no 
gel-to-gel variability, it would mean that the observations from the five 
different gels could be pooled and could be treated as one set of fifty, as 
opposed to five sub-sets of ten with associated controls. Every set of ten 
experimental observations for each of the five deuterated oligos plus the proteo 
control was tested for normality, using Geary's test (Fleiss, 1986; Dunn and 
Clark, 1987). All of the subgroups of ten observations were found to be 
normally distributed. This meant that the data from each of the five gels for 
each deuterated oligonucleotide could be compared by an analysis of variance. 
Unfortunately, in every case comparison of the data from the five different gels 
showed that there was a gel-to-gel effect; in short, it meant that the data could 
not be pooled and had to be treated as five sets of ten observations as opposed 
to one set of fifty observations. 
The next question that was addressed was one of intragel variability, and the 
question of whether there was any rationale to pair a specific individual from 
the ten control observations with a specific individual from the ten 
experimental. A comparison of data using different groupings of individual 
lanes within a gel demonstrated that there were no lane-to-lane positional 
effects on the kinetic isotope gels. This meant that while there is a statistical 
difference between gels, there is no statistical difference between lanes on the 
same gel that contain the same oligonucleotide or experiment. This means that 
no rationale exists for matching, or pairing, individual values from the 
experimental data sets on a given gel with individual values from the control 
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data sets on the same gel. Since a given control observation and experimental 
observation cannot be matched, the ratio of observations is not statistically 
meaningful (Fleiss, 1986; Dunn and Clark, 1987). 
To obtain a statistically meaningful computation for the kinetic isotope effect 
ratio, a random sampling technique, called the Bootstrap Method, will be 
employed (Fleiss, 1986; Dunn and Clark, 1987). The Bootstrap Method for 
unpaired data involves the generation of a series of data sets based on the 
random pairing of the original observations. These data sets are, by design, the 
same size and composition as the originally collected group of observations. 
For example, for each deuterated oligonucleotide we ran five gels, and each gel 
contained ten measurements of the experimental case and ten measurements of 
the unpaired control. Our observed data set, therefore, consists of a total of 
fifty observations of KIE, ten observations from each of the five gels used to 
analyze a given deuterated oligonucleotide. Based on this, a data set generated 
using the Bootstrap Method would contain fifty ratios, or values, for KIE. This 
set of fifty ratios would comprise ten ratios from each of the five gels. The ten 
ratios from a given gel would be generated via a random pairing with 
replacement of observed values for the experimental and the control case. In 
general, several hundred data sets generated by this method would be 
compared in order to determine the statistical difference between two groups 
of data. It is generally accepted that the more random data sets that are 
compared, the more meaningful the values you get out. Typically, two 
hundred or more data sets are compared. 
In our experiments examining the effect of deuteration on Ni(II) GGH y, 8 (141-
183) mediated cleavage of DNA, the following comparisons were set up. In our 
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case we had five treatments and one control. The five treatments consisted of 
five different oligonucleotides containing a site-specifically deuterated 
thymidine at the point of DNA cleavage. The treatments are C1 ', C2', C3', C4', 
and C5'. The control case contains no deuteration at any point within the 
oligonucleotide. It will be referred to as proteo. We are interested in the 
statistical comparison between the deuterated oligonucleotides individually 
and the proteo, or control, case. Our comparison was done using the Bootstrap, 
random sampling, technique. 420 data sets of fifty ratios were computed, using 
Bootstrap sampling for each experimental and control group. Student's T tests 
were performed to see if there were significant differences in the ratio between 
the experimental group and the control for each data set. 
Chemical Synthesis of Deuterated Thymidines. All glassware was oven-dried. 
Reactions were run under an argon atmosphere, unless otherwise noted. 
Diglyme was distilled from LiAlH4. Tetrahydroforan (THF) was distilled from 
potassium and benzophenone immediately before use. Triethyl amine, 
diisopropyl ethyl amine, acetonitrile (CH3CN) and methylene chloride 
(CH2CL2) were distilled from CaH2 before use. 1,1-dichloroethane and 
toluene were distilled from P205. Pyridine, N,N-dimethylformamide (DMF) 
and dimethyl sulfoxide (DMSO) were from Fluke over molecular sieves and 
used with no further purification. Oxalyl chloride was distilled immediately 
before use. 
2,3,5-0-tribenzoylribolactone, (1). Benzoylchloride 7.8 g (55.6 mmoles) in 
chloroform, 6ml, was cooled in an ice bath. Pyridine, 8 ml, in chloroform was 
also cooled in an ice bath and then slowly added to the benzoylchloride. Solid 
ribolactone, 2g, 13.5 mM, was added over the course of 30 min. The solution 
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was allowed to warm to 25°C and stirred for 36h, at which time it was diluted 
with chloroform, 200 ml. Solid sodium bicarbonate, 8g, 0.1M, was added 
slowly to the mixture. When gas evolution ceased, the residue was dissolved in 
water, 50 ml, and the layers were separated. Organic layer was further 
extracted with water, 3 X 50 ml, washed with brine, 50 ml, and dried over 
sodium sulfate. Upon evaporation, the crystalline mass was recrystallized from 
ethanol chloroform 8:2. Melting point was 89-92 °C. Proton NMR 300 MHz in 
CDCl3. 8 7.9-8.1 (m, 6H); 7.3 -7.65 (m, 9H); 6.2 (d, 1H; J=6 Hz), 5.96 (d, 1H; J=6 
Hz); 5.08 (t, 1H; J=3 Hz); 4.7-4.8 (dd, 2H; J=3 and 14Hz). 
Preparation of deuterated diisoamylborane. The diborane generated was released 
through a side arm and bubbled through THF 40 ml at - 70°. Sodium boro 
deuteride 3.06 g (73.2 mmoles) in diglyme, 100 ml, were added over 1.5h, via an 
addition funnel to borontrifluorideetherate, 20.87 g, 146.4 mM. After the 
addition was complete, the diglyme solution was heated to 70 °C for 30 min. 
The diborane THF solution was warmed to 15 °C, and 2-methyl-2-butene in 
THF, 2M, 40 ml, were added by a syringe pump over 1h. The solution was 
then stirred for 6h at this temperature. 
1-0-acetyl-1-deutro-2,3,5-0-tribenzoyl-~-d-ribofuranose, (2 ) . 2,3,5-0-
tribenzoyllactone, 3.65 g, 9 mM, in THF, 10 ml, were added to the THF solution 
of diisoamylborane prepared above and stirred for 60 h at 25 oc. The solution 
was cooled to 0 °C and carefully quenched with water. Additional water, 5 ml, 
was added and the solution was refluxed for 1h. After removing the THF on a 
rotary evaporator, the residue was taken up in 50 ml of acetone:water (8:2), and 
cooled to 0 °C. 30% hydrogen peroxide, 1 ml, was added and the pH was 
adjusted to 7.5 with 3 N sodium hydroxide, and the solution was stirred for 10 
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min. Dimethylsulfide, 5 ml, was added and the mixture was stirred for 30 min 
before extracting with chloroform (3 X 200 ml). The crude lactol solution was 
dried over sodium sulfate and concentrated in vacuo. _The crude lactol was 
heated at 90 °C in pyridine (10 ml) and acetic anhydride (10 ml) for 4h. The 
solution was cooled to 25 °C, poured over ice, and extracted with 
methylenechloride (4 X 100 ml). The material was then dried over magnesium 
sulfate and concentrated on a rotary evaporator. Flash chromatography with 
1:4 ethyl acetate hexane, followed by recrystallization from methanol yielded 
1.79 g of 2, 40% total yield. Melting point 124-125 °C, proton NMR 300 MHz, 
CD, CL 3. Delta 7.89 (d, 2H, J= 7Hz); 7.86 (d, 1H, J=7Hz); 7.3-7.6 (m, 10 H, 5.89, 
dd, 1 H, J=5, 6Hz); 5.76 (d, 1H, J=5Hz); 4.73-4.78 (m, 2H); 4.48 (dd, 1 H, J= 5, 13 
Hz); 1.98 (s, 3H). Mass Spec +ve DCI (NH3) observed (M+ MH4)+ at M/Z = 
523.18 (523.18 calculated for C28 H27 D1 09 N1). 
1'-deutro-2',3',5'-0-tribenzylmethyluridine, (3). SnCl4, 583 mg (2.25 mM) was 
added via a gas-tight syringe to 10 ml of dichloromethane containing 1.52 g (3.3 
mM) of 2 and 1.22 g (4.5 mmoles) of bis(O-trimethylsilyl)thymidine. After 
stirring for 10h, the solution was poured into dichloromethane (100 ml) and 
washed with saturated sodium bicarbonate (50 ml) and filtered through celite. 
The organic layer was dried over sodium sulfate and concentrated in vacuo. 
Flash chromatography, ethyl acetate:methylenechloride (1:5) yielded 1.33 g, 
76% of 3 as a white crystalline solid. Melting point 158-160 °C, proton NMR 
300 MHz, CDCL3, delta 7.92-8.4 (m, 6H); 7.34-7.64 (m, 9H); 7.14 (q, 1H, J=l.3 
Hz); 5.89 (dd, 1H, J=5,6 Hz); 5.74 (d, 1H, J=6 Hz); 4.88 (dd, 1H, J=3, 13Hz); 4.69 
(dt, 1H, J=5,3 Hz); 4.63 (dd, 1H, J=3,13 Hz); 1.57 (d, 3H, J-1.3 Hz). Mass Spec 
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+ve FAB CH2Cl2/NBA observed MH+ at M/Z = 572.18 (572.18 calculated for 
C31 H26 D1 N2 09). 
1 '-deutro-3',5'-0-1,1,3,3-tetraisopropyldisyloxanernethyluridine, (4 ). 1.01 g, 
1.77 mM of 3 were dissolved in 10 ml of methanol. This solution was saturated 
with ammonia at 0 °C. The flask was stoppered and stirred for 12h at 25 °C, at 
which time the mixture was evaporated to dryness in vacuo. To remove any 
remaining traces of methanol, the residue was taken up in 15 ml of pyridine 
and evaporated to dryness in vacuo. Three such cycles were repeated. The 
residue was then taken up in 10 ml of dry pyridine and allowed to react with 
1,3-dichloro-1,1,3,3-tetraisopropyldisyloxane, 613 mg, 1.94 mM for 2h at room 
temperature. The crude mixture was poured into water (10 ml) and extracted 
with diethyl ether (3 X 25 ml). The organic layer was washed two times with 
pH 7 buffer and dried once with brine, 20 ml. The organic layer was dried over 
sodium sulfate. Flash chromatography, ethyl acetate:methylenechloride (1:3) 
yielded 728 mg, 81% of the desired product, melting point 79-81 °C. 1 H NMR 
300 MHz, CDCL3. Delta 8.3, (bd, s, 1H); 7.34 (s, 1H); 4.41 (dd, 1H, J=5,8 Hz); 
4.14 (m, 2H); 3.9804.05 (m, 2H); 2.95 (bd, s, 1H); 1.89 (s, 3H); 1.01-1.07 (m, 28H). 
Mass Spec +ve FAB CH2Cl2/NBA observed MH+ at M/Z = 502.25 (502.25 
calculated for C22 H40 01 N2 07 Si2). 
1 '-deutro-2'-0-phenylthiocarbonyl-3',5'-0-1,1,3,3-tetraisopropyldisyloxyl-
rnethyluridine, (5). 221 mg, 0.44 mM of compound 4 and 70 mg, 0.57 mM of 
DMAP were dissolved in 4 ml of acetonitrile. To this solution, 91 Mg, 0.53 mM 
of phenylthiochloroformate were added. The solution was stirred for 4h at 
room temperature. The solvent was removed on a rotary evaporator, and the 
residue was purified by flash chromatography, ethyl acetate:methylenechloride 
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(1:9). The desired product was obtained in 80% yield, 225 Mg. Melting point 
70-73 oc. 1H NMR 300 MHz, CDCL3. 88.15 (bd, s, 1H); 7.36-7.42 (m, 3H); 7.26-
7.3 (dd, 1H, J=7-8 Hz); 7.08-7.10 (d, 2H, J=8 Hz); 5.99 (d, 1H, J=6 Hz); 4.55 (dd, 
1H, J=1,6 Hz); 4.21 (d, 1H, J=13 Hz); 4.01 (m, 2H); 1.90 (s, 3H); 1.00-1.09 (m, 
28H). Mass Spec +ve FAB CH2Cl2/NBA observed MH+ at M/Z = 638.25 
(638.25 calculated for C29 H44 D1 N2 08 Si2). 
1'-deutro-3',5'-0-,1,1,3,3,-tetraisopropyldisyloxlythyrnidine, (6). 225 Mg, 0.35 
mM of 5, 123 Mg tributyltin hydride and 10 Mg AIBN were dissolved in 4 ml of 
toluene. The resulting solution was subject to three rounds of freeze/thaw 
degassing. The reaction mixture was then immersed in an oil bath at 75 °C for 
45 min. After cooling to room temperature, the toluene was removed on a 
rotary evaporator equipped with a -78 °C cold finger and evacuated with a 
rough pump. Chromatography ethyl acetate:dichloromethane (1:6) yielded 140 
Mg, 82% of 6. Melting point 148-151 °C. 1H NMR 300 MHz COCL3. Delta 7.95 
(bd, s, 1H); 7.40 (q, 1H, J=1 Hz); 4.46 (ddd, 1H, J=7,8,10 Hz); 4.08 (d, 1H, J=13 
Hz); 4.00 (d, 1H, J13 Hz); 3.72 (d, 1H, J=7 Hz); 2.43-2.49 (m, 1H) 2.22-2.26 (m, 
1H); 1.90 (d, 3H, J=11 Hz); 1.00-1.09 (m, 28H). Mass Spec +ve FAB 
CH2Cl2/NBA observed MH+ at M/Z = 486.26 (486.26 calculated for C22 H4o 
D1 N2 06 Si2). 
1'-deutrothyrnidine, (7). 140 Mg, 0.29 mM of 6 were dissolved in 5 ml of THF. 
To this, 0.9 ml of a 1.0 M solution of Bu4N+p- in THF was added. After stirring 
at 30 min at room temperature, the THF was removed on a rotary evaporator. 
Chromatography in methanol:dichloromethane (1:5) yielded 64 Mg, 91% of the 
desired product, 7. Proton NMR 90 MHz D20. Delta 7.72 (bd, s, 1H); 4.30 (d, 
1H, J=6 Hz); 3.95 (m, 1H); 3.7-3.8 (m, 2H); 2.24 (dd, 2H, J=5,8 Hz); 1.76 (s, 3H). 
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Mass Spec +ve FAB CH2Cl2/NBA observed MH+ at M/Z = 244.10 (244.1 
calculated for C10 H14 N2 D 05). Percent deuterium incorporation as 
determined by FAB mass spectroscopy 92.5% 01 and 7.5% Do. 
1'-deutro-5'-0-dimethoxytridylthyrnidine, (8 ). 63 mg (0.26 mmoles) 
deutrothymidine were taken up in pyridine, 5 ml. This was evaporated to 
dryness under vacuum three times to insure the dryness of the compound. The 
resulting residue was taken up in 2 ml of dry pyridine, blanketed under argon, 
and cooled in an ice bath. 97 mg, 0.28 mmoles of dimethoxytridylchloride were 
added and allowed to react for 6h. The reaction was quenched with methanol, 
1 ml, poured into water, 10 ml, and extracted with diethyl ether. The organic 
layers were washed twice with pH 7 buffer and once with brine, 20 ml, and 
dried over sodium sulfate. After removing the ether in vacuo, the residue was 
purified by silica gel chromatography, using ethyl acetate:hexanes:methanol 
(40:55:5). The desired product was obtained in 83% yield, 120 Mg. Melting 
point 120-122 oc. Proton NMR 400 MHz CDCL3. Delta 8.05 (bd, s, 1H); 7.18-
7.54 (m, 10H); 6.81 (m, 6H); 4.55 (m, 1H); 4.01 (m, 1H); 3.78 (s, 6H); 3.46 (dd, 1H, 
J=1,10 Hz); 3.35 (dd, 1H, J=1, 10Hz); 2.30-2.45 (m, 2H); 1.46 (s, 3H). Mass Spec 
+ve FAB CH2Cl2/NBA observed MH+ at M/Z = 545.23 (545.23 calculated for 
C31 H31 D1 N2 07). Percent deuterium incorporation as determined by FAB 
mass spectroscopy 92.5% D1 and 7.5% Do. 
1-0-methyl-3,5-0-tetraisopropyldisil yribofuranicide, ( 9 ) . 0.8 gram (22 
mmoles) of hydrogen chloride gas was dissolved in 285 g (225 ml) methanol. 
To this solution, 10 g (66 mmoles) of ribose were added. The mixture was 
stirred at room temperature for 4.5h, at which time 75 ml of pyridine were 
added to neutralize the solution. The methanol and pyridine were removed 
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under vacuum and 75 additional ml of pyridine were added to the residue, and 
it was also removed under vacuum. The residue was dissolved in 200 ml of 
dry pyridine. The flask was blanketed with argon and chilled to 0 °C. 21.8 g 
(69 mmoles) of tetraisopropyldisilychloride were added slowly via syringe. 
After 7h of stirring at 0 °C, the reaction was warmed slowly to room 
temperature, and the pyridine was subsequently removed under vacuum. The 
residue was taken up in 500 ml of dichloromethane and extracted one time with 
500 ml of 10% citric acid. The aqueous layer was back-extracted with 
dichloromethane (2 X 250 ml) . The organic layers were pooled and extracted 
with a 1:1 mixture of pH 7 buffer and saturated sodium chloride (2 X 200 ml), 
and one time with saturated sodium chloride (200 ml). The dichloromethane 
was dried with magnesium sulfate and removed under vacuum. The residue 
was purified by silica gel chromatography (ethyl acetate:hexane 1:10). This 
afforded 22.493 grams of pure material in an 84% overall yield for both steps. 
1 H NMR (300 MHz CD CL3) 8 4.83 (s, 1H), 4.52-4.48 (m, 1H), 4.06-4.00 (m, 4H), 
3.75 (t, 1H, J =9Hz), 3.32 (s, 3H), 3.0 (s, 1H), 1.10-1.02 (m, 28H). Mass Spec +ve 
FAB Observed: (M- H)+ at M/Z = 405.21 (405.21 calculated for C18 H37 06 
Si2). 
1-0-methyl-2-keto-3,5-0-tetraisopropyldisylribofuranicide, (10 ). 1.29g (1 0.0 
mmoles) of oxalochloride were dissolved in 30 ml of dry dichloromethane. The 
mixture was blanketed under argon and cooled to -78 °C. 1.66 g (21.3 mmoles) 
of DMSO were dissolved in 16 ml of dichloromethane. This was slowly added 
to the mixture at -78 °C via a syringe. This mixture was stirred for 10 min at -78 
0 C. 24 ml of dichloromethane containing 3.46 g (8.5 mmoles) of 9 were added 
slowly via syringe. Upon completion of the addition of the ribofurancide, the 
mixture was stirred for 20 min at -78 °C. A white precipitate was observed to 
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form. After the 20 min, 4.3g (42.5 mmoles) of triethylamine were added to the 
solution. The reaction was warmed to -40 °C and maintained at this 
temperature for 30 min. The mixture was subsequently added to 150 ml of cold 
diethylether and extracted with 150 ml of 10% aqueous citric acid. The citric 
acid was back-extracted with 3 portions of 50 ml of diethylether. The organic 
phases were pooled and were extracted with pH 7 buffer (3X 50 ml) and then 
extracted with brine (1 X 150 ml). The ether was then dried with sodium 
sulfate and removed under vacuum. The resulting residue was purified with 
silica gel chromatography (ethyl acetate:hexane:triethylamine 200:1000:1). This 
afforded 3.18 g of pure ketone in 92% overall yield. 1H NMR (500 MHz CD 
CL3) 8 4.69 (s, 1H), 4.59 (m, 1H), 4.09 (t, 1H, J =8Hz), 3.89 (m, 1H), 3.81 (m, 
1H), 3.45 (s, 3H), 1.09-0.98 (m, 28H). Mass Spec CI/NH3 Observed (M+NH4)+ 
at M/Z = 422.24 (422.24 calculated for C18 H4o 06 N1 Si2). 
1-0-methyl-2-deutero-3,5-0-tetraisopropyldisylarabanofuranicide, (11). 1.06g 
(25.6 mmoles) NABD4 were placed in a dry flask and blanketed with argon. To 
this 68 ml of absolute ethanol were added and 1.53 ml (20.8 mmoles) of acetone 
were added. The mixture was stirred for 30 min at room temperature. After 
this time, 2.7 g (6.7 mmoles) of ketone, 10, in 20 ml of absolute ethanol were 
added. This mixture was stirred for 14h at room temperature. At this time, the 
ethanol was removed under vacuum and the residue was taken up in 125 ml of 
ethyl acetate. The ethyl acetate was extracted with pH7 buffer (3 X 50 ml) and 
washed with brine (50 ml). The ethyl acetate was dried with sodium sulfate 
and removed under vacuum. The resulting crude material contained a mixture 
of the 2-deuteroarabino and ribodistereomers. The distereomers were 
separated and purified, using silica gel chromatography (ethyl acetate:hexane 
7:100). After chromatography, 2.17 g of the arabino isomer were obtained (79.6 
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% yield) and 204 mg of the ribo isomer (7.5% yield). The overall yield for the 
reaction was 87%, and the ratio of arabao to ribo isomers was 10:1. Only the 
arabino isomer was used in subsequent synthetic steps because it was found 
that the ribo isomer contained proteal contamination. Arabino isomer lH 
NMR (300 MHz CD CL3) 8 4.86 (s, lH), 4.33 (d, lH, J =6Hz), 4.1-4.06 (dd, lH, J 
= 10,3 Hz), 3.90-4.00 (m, lH), 3.87 (t, lH, J = 11 Hz), 3.51 (s, 3H), 2.39 (s, lH), 
1.22-1.09 (m, 28H). Mass Spec +ve FAB Observed (M-H)+ at M/Z = 406.22 
(406.22 calculated for C18 H36 D1 06 Si2). Isotopic incorporation as 
determined by +ve FAB is 100% Dl. 
1-0-rn ethyl-2-deu tero-2-0-p henythiocarbonate-3 ,5-0-tetraisopropyl disil y 
arabinofuranose, (12). 1.05g (8.6 mmoles) dimethylaminopuridine and 1.46g 
(3.6 mmoles) of alcohol, 11, were dissoved in 60 ml of dry acetonitrile and the 
flask was blanketed in argon. To this solution 865 J..Ll (6.1 mmoles) of 
phenylchlorothiocarbonate were added via syringe. The mixture was stirred 
for 48h under an inert atmosphere. The acetonitrile was removed under 
vacuum. The residue was taken up in hexane, and the insoluble material was 
filtered off. The resulting filtrate was purified by silica gel chromatography 
(benzene:hexane 1:1). This afforded 1.42 g of the desired product in a 72.1% 
yield. 1 H NMR (400 MHz, CD, CL3) 8 7.39-7.43 (m, 2H); 7.39-7.29 (m, lH); 
7.25-7.10 (m, 2H); 5.20 (s, lH); 4.74 (d, lH, J = 6 Hz); 3.94-4.02 (m, 2H); 3.85 (t, 
lH, J = 9 Hz); 3.39 (s, 3H); 1.02-1.11 (m, 28H). Mass spectroscopy +ve FAB 
CH2CL2/MBA Observed: (M-H)+ at M/Z = 542.22 (542.22 calculated for C25 
H40 D1 07 Si2 S1). 
1-0-methyl-2,2-dideutor-3,5-0-tolyldeoxyribofuranose, (13 ). 1.28 g (4.3 
mmoles) tributyltindeuteride, 1.3 g (2.4 mmoles) of compound 12 and 15 mg 
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AIBN were dissolved in 130 ml of dry benzene. The solution was subjected to 
three rounds of freeze/thaw degassing and placed under an argon atmosphere. 
The reaction was heated at 75 °C for 3h under argon, at which time it was 
removed from the heat and allowed to cool to room temperature. 10 ml of 1 
molar Bu4N+F- in THF were added to the reaction mixture and the reaction 
was stirred for 12h at room temperature. The benzene and THF were removed 
under vacuum, and the brown residue was dissolved in 20 ml of dry 
acetonitrile and the flask was blanketed in argon. 1.5 g (11.8 mmoles) of 
dimethylaminopuridine were dissolved in the solution. 940~ (7.11 mmoles) of 
toluchloride were added to the mixture via syringe. The mixture was stirred 
for 18h at which time significant starting material remained. An additional600 
microliters (4.5 mmoles) of toluchloride were added, and the reaction was 
stirred for an additional 22h. At this time, no starting material was detected. 
The acetonitrile was removed under vacuum, and the residue was dissolved in 
500 ml of diethylether. The diethylether was extracted with 250 ml of water. 
The water was back-extracted with diethylether (3 X 100 ml). The organic 
phases were pooled and extracted with saturated NaHC03 (2 X 100 ml). 
Subsequently, the organic phase was extracted with pH 7 buffer (2 X 100 ml) 
and saturated sodium chloride (150ml) and then dried with sodium sulfate. 
The ether was removed under vacuum, and the resulting residue was purified 
using silica gel chromatography (diethylether:CH2Cl2 1:100). After 
purification, 372 milligrams of the desired product was obtained. The overall 
yield for three steps was 41%. 1H NMR (400 MHz CD CL3) 8 7.97 (d, 2H, J = 8 
Hz); 7.91 (d, 2H, J = 8 Hz); 7.23 (d, 2H, J = 8 Hz); 7.21 (d, 2H, J = 8 Hz); 5.59 (d, 
1H, J = 1 Hz); 5.23 (s, 1H); 4.46-4.57 (m, 3H); 3.36 (s, 3H); 2.41 (s, 3H); 2.39 (s, 
3H). Mass spec +ve FAB CDCL3/NBA Observed: (M-H)+ at M/Z = 385.16 
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(385.16 calculated for C22 H21 D2 0). Isotopic incorporation determined by 
+ve FAB 2% D1 and 98% Oz. 
1-a-Cl-2,2-dideutero-3,5-0-tolyldeoxyribofuranose, (14 ). 278 mg (0.72 
mmoles) of compound 13 were dissolved in 1.0 ml glacial acetic acid. This was 
added to 1ml of glacial acetic acid that was saturated with hydrogen chloride 
gas. Hydrogen chloride gas was bubbled through the resulting mixture until a 
precipitate formed. The solution was filtered through a medium glass frit, and 
the precipitate was washed with 50 ml of diethylether. The precipitate was 
dried under high vacuum. This yielded 131 mg of the chloro sugar (46.7% 
yield). Note: The chloro sugar is highly unstable and must be stored under 
vacuum with an acid trap. Ideally, it should be used immediately after 
synthesis. MP 120-121 °C DC. 1 H NMR (3 MHz CD CL3) 8 8.02 (d, 2H, J = 7 
Hz); 7.92 (d, 2H, J = 7Hz); 7.25 (d, 2H, J = 7Hz); 7.23 (d, 2H, J = 7 Hz); 6.49 (s, 
1H); 5.58 (d, lH, J = 3 Hz); 4.87 (m, lH); 4.76 (dd, lH, J = 3,12 Hz); 4.69 (dd, 1H, 
J = 3, 12 Hz); 2.44 (s, 3H); 2.42 (s, 3H). Mass spec DCI/NH3 Observed: (M-Cl) 
at M/Z = 355.38 (355.37 calculated for C21 H19 02 Os). 
2',2'-dideutero-3',5'-0-tolylthymidine, (15). 228 mg thymine (1.8 mmoles) 
were refluxed overnight in a mixture of 4 ml chlorotrimethylsilene and 8 ml of 
hexamethyldisylizane. The solution was allowed to cool to room temperature, 
and the volatile material was removed on a rotovap under aspirator vacuum. 
16 ml of chloroform, CHCl3, freshly distilled from P205, were added to the 
residue. 125 mg of the chloro sugar (0.32 mmoles) were added as a solid to the 
reaction and the reaction was blanketed with argon. The mixture was stirred 
under argon for 12h. 3 ml of methanol were added to the reaction, and after 15 
min it was filtered through a fine-fritted glass funnel to remove the solid 
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material. The liquid fraction was evaporated to dryness under vacuum, and 
the residue was purified by silica gel chromatography (CH2Cl2:MeOH 100:4). 
After chromatography, 132 mg of dideuterothymidine were obtained. NMR of 
this material showed it to be a mixture between the p and a isomers and the 
enatiomeric ratio to be 3.4:1, p to a. 125 mg of this material was crystallized 
from hot ethyl acetate. After this round of crystallization, 48 mg of pure 2',2'-
dideutero-3',5'-0-tolyl-P-thymidine were obtained. The mother liquor from the 
crystallization was concentrated under vacuum. NMR of the resulting residue 
showed it to be 1:1 in P and a isomers. The residue was enriched for the 
desired P isomer, using a spinning chromatotron. The mixture was eluted from 
the chromatotron with ethyl acetate:dichloromethane 1:3, plus 0.5 ml of 
benzene for a 100 ml total of solvent. Purification using the chromatotron 
produced 35 mg of material, which contained 90% of the desired P isomer and 
10% of the a isomer. This material was crystallized from hot ethyl acetate. 
Crystallization afforded 28.4 mg of pure p isomer. In all, 76.4 mg of pure 2',2'-
dideutero-3',5'-0-tolylthymidine were obtained in a 50% overall yield. MP 196-
197 oc. 1H NMR (300 MHz CDCl3) 8 8.20 (bd, s, 1H); 7.94 (m, 4H); 7.28 (m, 
SH); 6.46 (s, 1H); 5.63 (d, 1H, J = 2Hz); 4.78 (dd, 1H, J = 3,12 Hz); 4.66 (dd, 1H, J 
= 3,12 Hz); 4.53 (m, 1H); 2.44 (s, 3H); 2.43 (s, 3H); 1.61(s, 3H). Mass spec DEI 
Observed [M-CsHsN02]+ mass minus thymidine at M/Z = 355. Percent 
deuterium incorporation determined by mass spectroscopy 2% D1 and 98% D2. 
2',2'-dideuterothymidine, (16). 67 mg (0.14 mmoles) of 15 were added to a 
pressure tube containing 10 ml of methanol. The tube was blanketed with 
argon and cooled to 0 °C. Anydrous ammonia was bubbled through the 
solution for 15 min. The pressure tube was then sealed and allowed to stir at 
room temperature for 48 h. The tube was cooled back to 0 °C, opened, and 
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allowed to warm slowly to room temperature. When the evolution of ammonia 
had ceased, the methanol was removed under reduced pressure. The residue 
was tritirated with diethylether. This yielded 34.2 mg of solid material, which 
was dried under high vacuum. The material was crystallized from hot 
methanol. Crystallization yielded 31 mg of the desired product in a 91% 
overall yield. 1 H NMR (300 MHz D20) B 7.62(m, 1H); 6.29 (s, 1H); 4.46 (d, 1H, 
J =4Hz); 4.03 (m, 1H); 3.82 (dd, 1H, J = 4,12 Hz); 3.76 (dd, 1H, J = 4, 12Hz); 1.79 
(s, 3H). Mass Spec DEI Observed: M+ 244.10 (244.10 calculated for ClQ H12 D2 
Os N2). Deuterium incorporation by DEI mass spectroscopy 2% D1 and 98% 
D2. 
2',2'-dideutero-5'-0-dimethoxytritylthymidine, (17). 25 mg (0.103 mmoles) 
2',2'-dideuterothymidine was taken up in 5 ml of dry pyridine and evaporated 
to dryness under vacuum. This was repeated two more times. The residue was 
dissolved in 1 ml of dry pyridine and 38.5 mg (0.11 mmoles) of 
dimethoxytritylchloride were added. The mixture was stirred under argon for 
12h. The pyridine was removed under vacuum, and the residue was taken up 
in 50 ml of dichloromethane. The dichloromethane was washed three times 
with pH 7 buffer (25 ml) and two times with a saturated sodium chloride 
solution (35 ml). The aqueous layers were layered and back-extracted with 
dichloromethane (2 X 30 ml). The organic layers were pooled and dried with 
sodium sulfate. The dichloromethane was removed under vacuum, and the 
residue was dried under high vacuum. The residue was crystallized from hot 
benzene. Crystallization afforded 37 mg (68%) yield of pure 2',2'-dideutero-5'-
0-(4,4'-dimethoxytrityl)-thyrnidine. 1 H NMR (400 mHz, CDCL3) B 8.22 (bd, s, 
1H); 7.58 (m, 1H); 7.21-7.38 (m, 9H); 6.82 (d, 4H, J =9Hz); 6.37 (s, 1H); 4.55 (bd, 
s, 1H); 4.05 (bd, s, 1H); 3.81 (s, 6H); 3.46 (dd, 1H, J = 1,10 Hz); 3.35 (dd, 1H, J = 
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1,10 Hz); 1.46 (s, 3H). Mass spec +ve FAB Ch2Cl2/MBA Observed M+ at M/Z 
546.23 (546.23 calculated for C31 H30 02 N2 Os). 
3'-keto-5'-0-dimethoxytritylthymidine, (18). 1.50 g (15 mmoles) Cr03 were 
dissolved in 70 ml dry dichloromethane and blanketed with an inert 
atmosphere. The reaction vessel was placed in a 20 °C water bath. 2.5 ml of 
dry pyridine were slowly added to the solution via syringe. Following the 
addition of the pyridine, 1.5 ml of acetic anhydride were added to the reaction 
mixture via syringe, and the mixture was stirred for 5 min. 2.73 g (5 mmoles) of 
5'(4,4'-dimethyoxytrityl)thymidine were dissolved in 5 ml of dry 
dichloromethane and added slowly via syringe to the reaction mixture. The 
total reaction mixture was stirred at room temperature for 45 min. At this time 
the reaction was poured into a buchner funnel containing 2.5 ml celite and 75 
ml cold toluene. The toluene was filtered through the celite, and the celite was 
rinsed with 25 additional ml of toluene. The filtrate was filtered a second time 
through celite, and the resulting filtrate was evaporated to dryness using rotary 
evaporator and high vacuum. The residue was taken up in 75 ml of cold 
toluene, and the resulting solution was evaporated to dryness again. This 
procedure was repeated three additional times. The residue was then treated 
with 50 ml of cold toluene plus 10 ml of hexane and filtered . The residue was 
washed with hexane (3 X 10 ml). The residue was then dried under high 
vacuum. The total yield of the reaction was 2.37 g of the desired ketone 
(87.4%). 
3'-deutero-5'-0-4',4'-dimethoxytritylthymidine, (19). 300 mg (7 mmoles) of 
NaBD4 were placed in a dry flask under argon. 30 ml of cold absolute ethanol 
were added and the entire mixture was cooled to 0 °C. Then 420 microliters 
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(5.7 mmoles) of acetone were added. This mixture was stirred at 0 °C for 2h. 
After this period of time, a suspension of 1.085 g (2 mmoles) of ketone, 18, in 10 
ml of absolute ethanol chilled to 0 °C were added to the reaction mixture. The 
reaction was stored at 4 °C for 22h. The resulting, green, homogeneous mixture 
was evaporated to approximately 10% of volume using a rotary evaporator and 
then taken up in 300 ml of ethyl acetate. The resulting mixture was extracted 
with 150 ml of a 1:1 mixture of pH 7 buffer and saturated sodium chloride. The 
aqueous phase was extracted with two more 300 ml portions of ethyl acetate. 
The resulting organic phases were pooled and washed with brine (2 X 150 ml) 
and then dried with sodium sulfate. The ethyl acetate was removed in vacuo 
yielding 769 mg of green foam. This foam contained a mixture of the desired 
riboisomer and a diastereomer. The foam was purified, using silica gel 
chromatography (CH2Cl2:MeOH 1,000:43). Purification resulted in 481 mg of 
an undesired isomer and 120 mg of the desired riboisomer. The riboisomer was 
recrystallized from a minimum volume of hexane. Recrystallization afforded 
112.4 mg of the desired ribo product. Total yield for the reaction was 593 mg 
(54%). The diestereo selectivity was 1:4.3. 1H NMR (400 MHz, C0Cl3) 8 8.12 
(bd s, 1H); 7.58 (s, 1H); 7.2-7.5 (m, 12H); 6.84 (m, 4H); 6.39 (dd, 1H, J = 6,7 Hz); 
4.05 (s, 1H); 3.76 (s, 6H); 3.48 (dd, 1H, J = 1,10 Hz); 3.35 (dd, 1H, J = 1,10 Hz); 
2.29-2.44 (m, 2H); 1.44 (s, 3H).Mass spec -ve FAB CH2Cl2/NBA Observed (M-
H)- at M/Z = 544.19, 545.26 calculated for C31 H31 01 N2 07). Percent 
deuterium incorporation by -ve FAB CH2Cl2/NBA 96.8% 01 and 3.2% Do. 
1-0-acetyl-4-deutero-2,3,5-tri-0-benzoyl-~ D-ribofuranose, (21). 1-0-acetyl-4-
bromo-2,3,5-tri-0-benzoyl-P-D-ribofuranose 20 was prepared by the method of 
(Ferrier, et al., 1984). 7.8 g(13.4 m) of 1-0-acetyl-4-bromo-2,3,5-tri-0-benzoyl-P-
0-ribofuranose, 7.81 g tributyltindeuteride (26.7 m) and AIBN (100 mg) were 
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dissolved in 70 ml of toluene. Argon was bubbled through the solution for 30 
min at 25° C. The solution was then immersed in an oil bath at 75 ° C for 40 
min. After removing the toluene in vacuo, the residue was crystallized from hot 
methanol. After two rounds of crystallization from methanol, 3.52g (52% yield) 
of the a-isomer were obtained. The mother liquors from the two 
crystallizations were combined and concentrated in vacuo. This afforded a 
residue now enriched in the desired, deuterated ~-D-ribofuranose, 21. The ~-D­
ribofuranose was crystallized from hot isopropyl alcohol, yield 954 mg (14%). 
MP 124-125 C. lH NMR (400 MHz, CDCl3). o 8.05 (d, 2H, J =7Hz); 7.98 (d, 
2H, J =7Hz); 7.86 (d, lH, J =7HZ); 7.30-7.60 (m, 10 H); 6.41 (d, lH, J = 1Hz); 
5.88 (dd, lH, J = 5 Hz); 5.76 (dd, lH, J = 1,5 Hz); 4.75 (d, lH, J = 12 Hz); 4.48 (d, 
lH, J = 12Hz); 1.98 (s, 3H). Mass Spec: +ve FAB CH2Cl2/NBA. MH at M/Z 
505.45 (calculated 505.4922 C5 H5 01 05. NMR for the a-isomer: lH (400 MHz, 
CDCL3). d: 7.82-8.00 (m, 6H); 7.30-7.56 (m, 10 H); 6.50 (s, lH); 6.08 (d, lH, J = 5 
Hz); 5.76 (d, lH, J = 5 Hz); 4.64 (s, 2H); 2.08 (s, 3H). 
4'-deutero-2',3',5'-tri-0-benzoyl-rnethyluridine, (22). 320 mg of SnCL4 (1.24 m 
moles) were added via a gas-tight syringe to a 0° C solution of 425mg (0.84m 
mole) of 10-acetyl-4-deutero-2,3,5-tri-0-benzoyl-~-D-ribofuranose and 0.7 g 
bis(O-trimethylsylil)thymidine (2.58 m moles) in 6 m of dichloroethane. After 
stirring for lOh, the solution was poured into dichloroethane (50 ml) and 
washed with saturated Na (25 ml) and then filtered through celite. The organic 
layer was dried over Na2S 04 and concentrated in vacuo. Silica gel 
chromatography, ethyl acetate:dichloromethane (1:5) yielded 400 mg of 3 in an 
83% yield. MP 158-160 oc lH NMR (400 MHz, CDCL3) d 7.92-8.14 (m, 6H); 
7.34-7.64 (m, 9H); 7.15 (q, lH, J = 1.3 Hz); 6.41 (d, lH, J =7Hz); 5.89 (d, lH, J = 6 
Hz); 5.73 (dd, lH, J = 6,7 Hz); 4.86 (d, lH, J = 12 Hz); 4.63 (d, lH, J = 12Hz); 1.57 
197 
(d, 3H, J = 1.3 Hz). Mass Spec: +ve FAB CH2Cl2/NBA M+ at M/Z 572.17 
(calculated 572.18 for C31 H26 01 N2 09). 
4'-deutero-3',5'-0-tetraisopropyldisilyrnethyluridine, (23), A solution of 10 ml 
of methanol and 400 mg (0.70 mmoles) of 22 was saturated with ammonia 0 °C. 
The flask was stoppered and stirred at 25 °C for 12h, after which time the 
mixture was evaporated to dryness in vacuo. The residue was dried further by 
alternate cycles of dissolving in 15 ml of pyridine and evaporating to dryness in 
vacuo. After three such cycles, the residue was taken up in 10 ml of dry 
pyridine and allowed to react with 1,3-dichloro-1,1,3,3-
tetratisopropyldisyloxane (237 mg, 0.75 mmoles) for 2h at 35 °C. The crude 
mixture was poured into water (10 ml) and extracted with diethylether (3 X 40 
ml). The organic layers were washed two times with pH 7 buffer (20 ml) and 
once with brine (20 ml) and dried over Na2S04. Flash chromatography 
(ethylacetate:CH2Cl2, 1:3) yielded 222 mg (63% yield). MP 78-80 °C. 1H NMR 
(400 MHz, C0Cl3) 8 8.3 (bd s, lH); 7.33 (q, 1H, J = 1.3 Hz); 5.68 (s, 1H); 4.40 (d, 
1H, J =5Hz); 4.09-4.17 (m, 2H); 3.98 (d, 1H, J =13Hz); 2.95 (bd s, 1H); 1.89 (d, 
3H, J = 1.2Hz); 1.01-1.08 (m, 28H). Mass Spec: +ve/FAB CH2Cl2/NBA 
observed MH+ at 502.24 (calcualted for C22 H4o 01 N2 07 Si2 502.25). 
4'-deutero-2'-0-phenylthiocarbonate-3',5'-0-tetraisopropyldisilyrnethyl-
uridine, (24). 540 mg (1.08 m moles) of compound 23 and 172 mg (1.40 m 
moles) of DMAP were dissolved in 8 ml of dry acetonitrile. To this solution 
phenylthiochloroformate 223 mg (1.3 m moles) were added slowly via syringe. 
The soluiton was stirred for 4h at 25 °C. The solvent was then removed on a 
rotary evaporator, and the residue was purified by a flash chromatography 
using ethyl acetate:CH2Cl2, (1:9). 47 mg of the desired product (68% yield) 
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were obtained. Melting point 70-72 °C. lH NMR (400 MHz COCL3) 88.02 (bd 
s, lH); 7.36-7.42 (m, 3H); 7.26-7.30 (t, lH, J =3Hz); 7.09 (d, 2H, J =8Hz); 5.99 
(d, lH, J = 5Hz); 5.89 (s, lH); 4.58 (d, lH, J = 5Hz); 4.21 (d, lH, J = 14 Hz); 4.01 
(d, lH, J =14Hz); 1.91 (s, 3H); 1.00-1.09 (m, 28H). 
4'-deutero-3',5'-0-tetraisopropyldisilythymidine, (25). 470 mg of 24 (0.74 m 
moles), 260 mg tributyltinhydride (0.89 m moles) and 10 mg AIBN were 
dissolved in 8 ml of dry toluene. The solution was subjected to three rounds of 
freeze/thaw degassification. The reaction mixture was then placed under 
argon and immersed in an oil bath at 70 °C for 45 min. After cooling to room 
temperature, the toluene was removed on a rotary evaporator equipped with a 
-78 °C cold finger and evacuated through a rough pump. Flash 
chromatography ethyl acetate:CH2Cl2 (1:6) yielded 258 mg of the desired 
product (71 % yield) . MP 149-151 °C. lH NMR (400 MHz, C0Cl3) o 7.95 (bd s, 
lH); 7.4 (d, lH, J = 1 Hz); 6.04 (dd, lH, J = 2,7 Hz); 4.47 (dd, lH, J = 7,9 Hz); 4.0 
(d, lH, J = 13 Hz); 3.99 (d, lH, J = 13Hz); 2.43-2.49 (m, lH); 2.22-2.26 (m, lH); 
1.90 (d, 3H, J =1Hz); 1.00-1.10 (m, 28H). Mass Spec +ve/FAB CH2Cl2/NBA: 
Observed MH+ at M/Z of 486.26 (calculated for C22, H40, 01, N2, Si2, 06, 
486.26). 
4'-deuterothymidine, (26). 255 mg of 25 (0.54 m mole) were dissolved in 8 rn1 
of THF. To this solution, 1.6 ml of a 1M solution of BU4N+p- in THF were 
added. After stirring for 30 min, the THF was removed on a rotary evaporator. 
The residue was purified by flash silca gel chromatography methanol:CH2Cl2 
(1:5). This afforded 115 mg of 4'-deuterothyrnidine (88% yield). lH NMR (90 
MHz, 020) o 7.70 (bd s), lH); 6.15 (t, lH, J =7Hz); 4.30 (m, lH); 3.95 (m, 2H); 
2.25 (m, 2H); 1.76 (s, 3H). 
199 
4'-deutero-5'-0-dirnethoxytritylthymidine, (2 7 ) . 115 mg of 4'-
deuterothymidine(0.47 mmole) were taken up in 5 ml of pyridine and 
evaporated to dryness. This was repeated two times. The residue was taken 
up in 3 ml of dry pyridine and allowed to react with 175 mg of 
dimethoxytritylchloride (0.51 m moles) for 6h. The reaction was quenched with 
1 ml of methanol and then poured into 10 ml of H20. The water was extracted 
with diethylether (3 x 50 ml). The organic phase was washed two times with 
pH 7 buffer (30 ml) and one time with brine (30 ml) and then dried over NA2 
SL4. After removing the ethylether in vacuo, the residue was purified by flash 
silica gel chromatography ethyl acetate:hexane:methanol (40:55:5). After 
chromatography, 190 mg of 27 were obatined in 74% yield. MP 120-122 °C. 1H 
NMR (400 MHz, CDCL3) B 8.03 (bd s, 1H); 7.55 (s, 1H); 7.37 (d, 2H, J = 7Hz); 
7.25-7.30 (m, SH); 6.81 (m, 6H); 6.37 (t, 1H, J = 6 Hz); 4.55 (t, 1H, J = 3 Hz); 3.77 
(s, 6H); 3.46 (d, 1H, J = 11 Hz); 3.34 (d, 1H, J = 11 Hz); 2.33 (bd m, 2H); 1.46 (s, 
3H). Mass Spec: +ve/FAB CH2Cl2/NBA Observed: M+ at M/Z 545.23 
(calculated for C3 1, H3 1, D1, N2, 07 is 545.23). Percent deuterium 
incorporation by mass spec using- ve/FAB CH2Cl2/NBA 94.5% D1,and 5.5% 
Do. 
Methylthymidine-5'-carboxolate, (28). 6 mg of crude thymidine (2.34 m moles) 
were refluxed in 150 ml of methanol and 0.5 ml of H2S04 for 6h. The solution 
was cooled to room temperature and neutralized with solid Na2C03. The 
solids were filtered off, and the methanol was removed in vacuo. The residue 
was purified by flash silica gel chromatography (methanol:CH2Cl2, 1:9). 
Purification yielded 586 mg of 28 (93% yield). 1 H NMR (90 MHz, 06-DMSO). 
B 8.1 (bd s, 1H); 6.31 (m, 1H); 5.82 (d, 1H, J =8Hz); 4.40 (m, 1H); 3.72 (s, 3H); 
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2.10 (m, 2H); 1.72 (s, 3H). Mass Spec: +ve FAB CH2Cl2/NBA Observed: M+ at 
M/Z 270.21 (270.24 calculated for C11, H14, N2 06). 
Methyl-3'-0-t-butyldirnethylsilylthymidine-5'-carboxolate, (29). 0.59 g of 28 
(2.17 m moles) and 0.37 g of imidizole (5.43 m moles) were dissolved in 7 ml of 
dry DMF. To this solution 0.39 g of t-butyldimethylsilylchloride (2.61 m moles) 
was added, and the solution was stirred at 37 °C for 10h. The mixture was 
taken up in 10 ml of water and extracted with diethylether (3 X 35 ml). The 
organic layers were combined, washed with pH 7 buffer (2X 20 ml) and brine 
(20 ml), and dried over MgS04. The ether was removed in vacuo and the 
residue was purified, using flash silica gel chromatography methanol:CH2Cl2 
(1:19). This afforded 460 mg of the desired product (55% yield). MP 138-140 
0 C. 1H NMR (90 MHz, CDCl3) 8 8.1 (bd s, 1H); 6.5 (dd, 1H, J = 5,9 Hz); 4.43-
4.53 (m, 2H); 3.8 (s, 3H); 2.20-2.35 (m, 2H); 1.96 (s, 3H); 0.89 (s, 9H); 0.10 (s, 6H). 
Mass spec: +ve FAB CH2Cl2/NBA Observed: MH+ at M/Z = 385.48 (385.51 
calculated for C17 H19 N2 06 Si). 
5',5'-dideutero-3'-0-t-butyldirnethylsilylthymidine, (30). 35 mg of LiAID4 (1.2 
m moles) were dissolved in 6 ml of THF and placed under an inert atmosphere 
and cooled to 0 °C. To this solution, 1 ml of THF containing 460 mg of 10 (1.2 m 
moles) was added via syringe. The reaction was stirred for 2h at 0 °C, after 
which time the reaction was quenched with the slow addition of 0.5 ml of 
water. The mixture was then concentrated on a rotary evaporator. 5 ml of 
water were added to the residue, and the mixture was extracted with 
diethylether (3 X 35 ml). The organic layers were pooled and washed with pH 
7 buffer (2 X 20 ml), brine (20 ml) and dried with Na2S04. The ether was 
removed on a rotary evaporator. The residue was purified, using flash silica 
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gel chromatography methanol:CH2Cl2 (1:19). This afforded 329 mg of the 
desired product (77% yield) as a clear oil. 1 H NMR (90 MHz, CDCL3) 8 7.33 (s, 
1H); 6.11 (t, 1H, J = 8 Hz); 3.92 (d, 1H, J = 6 Hz); 3.50 (m, 1H); 2.30 (m, 2H); 1.88 
(s, 3H); 0.85 (s, 9H); 0.07 (s, 6H). Mass spec +ve FAB CH2Cl2/NBA Observed: 
MH+ at M/Z = 359.49 (359.48 calculated for C16 H17 D2 N2 Os Si). 
5',5'-dideuterothymidine, (31). 329 mg of 30 (0.92 m moles) were dissolved in 8 
ml of THF, blanketed with an inert atmosphere and cooled to 0 °C. To this 
solution, 1.9 ml of a 1 M solution of Bu4N+p- in THF were added via syringe. 
The solution was stirred at 30 °C for 30 min, then allowed to warm to 25 °C. 
The reaction was then stirred for 3h at 25 °C. The THF was removed on a 
rotary evaporator, and the residue was purified by flash silica gel 
chromatography methanol:CH2Cl2 (1 :9). This afforded 168 mg of the desired 
product in 75% yield. 1 H NMR (90 MHz, D20) 8 7.60 (s, 1H); 6.15 (t, 1H, J = 7 
Hz); 4.3 (m, 1H); 3.89 (d, 1H, J = 4 Hz); 2.24 (dd, 1H, J = 6,5 Hz); 1.76 (s, 3H). 
Mass spec +ve FAB CH2CL2/NBA Observed: M+ at M/Z 244.10 (244.10 
calculated for C10 H12 D2 Os N2). 
5',5'-dideutero-5'-0-'dimethoxytritylthymidine, (3 2 ). 168 mg 5',5'-
dideuterothymidine (0.69 m moles) were taken up in 5 ml of pyridine and 
evaporated to dryness. This was repeated two times. The residue was taken 
up in 3 ml of dried pyridine and allowed to react with 260 mg of 
dimethoxytritylchloride (0.77 m moles) for 6h. The reaction was then quenched 
with 1 ml of methanol. The mixture was poured into 10 ml of water and 
extracted with diethylether (3 X 50 ml). The organic layers were cooled and 
washed with pH 7 buffer (2 X 30 ml) and with brine (30 ml) and dried over 
Na2S04. The ether was removed under vacuum and the residue was purified 
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by flash silica gel chromatography ethyl acetate:hexanes:methanol (40:55:5). 
Chromatography yielded 343 mg of 13 (91% yield). MP 119-121 oc lH NMR 
(400 MHz, CDCl3) 8 8.05 (bd s, 1H); 7.55 (s, 1H); 7.36-7.38 (d, 2H, J =7Hz); 7.25-
7.30 (m, 5H); 6.81 (m, 6H); 6.37 (t, 1H, J = 6 Hz); 4.55 (m, lH); 4.02 (d, 1H, J = 3 
Hz); 3.81 (S, 6H); 2.3-2.45 (m, 2H); 1.46 (s, 3H). Mass spec +ve FAB 
CH2Cl2/NBA Observed M+ at M/Z = 546.23 (546.23 calculated for 
C31H30D2N207). Isotopic incorporation based on mass spectroscopy, using 
-ve FAB CH2Cl2/NBA matrix 98% D2, 1.5% and 0.5% Do. 
Phosphitylation of Deuterated Thymidines. Typically, 25 mg (46 J.Lmoles) 
deuterated thymidine were dissolved in 0.75 ml of dry dichloromethane, 32 ).ll 
(230 ).lffioles) of freshly distilled triethylamine were added, and the flask was 
blanketed with argon. To this mixture, 16 ).ll (69 J.Lmoles) of 2-cyanoethyl N,N-
diisopropylchlorophosphoramidite were added via syringe. The mixture was 
stirred under argon for 80 min, at which time the dichloromethane was 
removed under vacuum. The residue was purified by silica gel 
chromatography (ethyl acetate:dichloromethane:triethylamine 30:70:1). Typical 
yields for the reaction range between 85 and 95%. The phosphoramidites were 
stored under vacuum and used as rapidly as possible. 
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Appendix A: Phosphorimager Data for the Ni(II) GGH y8 (141-183) 
Cleavage-Condition Studies. 
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Table I. Phosphorimager Data from the Concentration Studies of DNA Cleavage 
in the Presence of 2.0 mM Ni(II) GGH yo (141-183) and Monoperoxyphthalic Acid 
with and without Butylamine Treatment 
Monoperoxyphthalic 
Acid Concentration (mM) 
% DNA Cleavage 
w/o Butylamine 
Treatment 





































Table II. Phosphorimager Data from the Concentration Studies of DNA Cleavage 
in the Presence of 1.0 mM Ni(II) GGH y o (141-183) and Monoperoxyphthalic Acid 
with and without Butylamine Treatment 
Monoperoxyphthalic 
Acid Concentration (mM) 
% DNA Cleavage 
w I o Butylamine 
Treatment 





































Table III. Phosphorimager Data from the Concentration Studies of DNA Cleavage 
in the Presence of 0.5 mM Ni(II) GGH yo (141-183) and Monoperoxyphthalic Acid 
with and without Butylamine Treatment 
%DNA Cleavage % DNA Cleavage 
Monoperoxyphthalic w I o Butylamine with Butylamine 
Acid Concentration (m.M) Treatment Treatment 
0.00 0.00% 0.00% 
0.01 0.22% 0.31% 
0.05 0.35% 0.66% 
0.10 0.58% 0.88% 
0.50 2.63% 4.95% 
1.00 6.05% 7.87% 
2.00 13.93% 19.97% 
5.00 29.93% 36.88% 
10.00 40.87% 51.58% 
20.00 40.33% 51 .86% 
50.00 39.10% 50.20% 
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Table IV. Densitometer Data from the Concentration Studies of DNA Cleavage 









Normalized DNA Cleavage as a 








Table V. Phosphorimager Data from the Time Course of DNA Cleavage by 
Ni(II) GGH yo (141-183) in the Presence of Monoperoxyphthalic Acid or Hydrogen Peroxide 
Monoperoxyphthalic acid Hydrogen Peroxide 
time (min) % cleavage Normalized cleavage % cleavage Normalized Cleavage 
background 0.05% 0.01 0.05% 0.00 
0 3.86% 0.39 0.13% 0.00 
0.5 6.90% 0.69 0.34% 0.01 
1 7.37% 0.74 0.44% 0.01 
2 8.54% 0.84 0.91 % 0.02 
5 9.24% 0.92 1.42% 0.03 
10 9.98% 1.00 2.71 % 0.06 
20 9.93% 0.99 8.34% 0.19 
40 9.92% 0.99 15.08% 0.34 
60 9.89% 0.99 28.85% 0.65 
80 9.92% 0.99 30.41 % 0.69 
100 9.52% 0.95 44.11 % 1.00 
120 9.45% 0.94 44.19% 1.00 
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Table VI. Phosphorimager Data from the pH Profiles of DNA Cleavage by 
Ni(II) GGH yo (141-183) in the Presence of Monoperoxyphthalic Acid or Hydrogen Peroxide 
Monoperoxyphthalic acid Hydrogen Peroxide 
pH % cleavage Normalized cleavage % cleavage Normalized Cleavage 
background 0.59% 0.40 0.06% 0.03 
5.8 0.98% 0.67 0.07% 0.02 
6.0 1.05% 0.72 0.08% 0.02 
6.2 1.20% 0.82 0.10% 0.03 
6.4 1.34% 0.92 0.16% 0.04 
6.6 1.39% 0.95 0.21 % 0.05 
6.8 1.46% 1.00 0.30% 0.08 
7.0 1.43% 0.98 0.36% 0.09 
7.2 1.37% 0.94 0.60% 0.15 
7.4 1.41 % 0.97 1.77% 0.45 
7.6 1.36% 0.93 3.92% 1.00 
7.8 1.37% 0.94 3.77% 0.96 
8.0 1.17% 0.80 3.07% 0.78 
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Appendix B: Normalized Cleavage Values Used to Calculate KIE 
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Table I. Phosphorimager Data for the Kinetic Isotope Studies Examining DNA Cleavage by 
Ni(II) GGH y 8 (141-183) in the Presence of Monoperoxyphthalic Acid when the Thymidine at 
the Experimental Cleavage Site in the "Deutero Duplex" is Deuterated at Position Cl' 
Normalized Cleavage of the "Deutero Duplex" 
Containing C1' Deutero Thymidine 
Lane# Gel #1 Gel#2 Gel #3 Gel#4 Gel#5 
1 1.01 1.05 1.05 0.87 0.99 
2 1.08 1.06 1.03 0.87 1.01 
3 1.08 1.04 1.04 0.90 0.94 
4 1.01 1.02 1.04 0.89 0.91 
5 1.06 1.00 0.99 0.92 0.90 
6 1.03 0.97 1.03 0.90 0.87 
7 1.04 0.93 1.04 0.90 1.86 
8 1.03 0.97 1.05 0.90 0.86 
9 1.05 0.97 1.04 0.93 0.87 
10 1.04 0.93 1.01 0.87 0.86 
Normalized Cleavage of the All-Proteo 
Control Duplex 
Lane# Gel #1 Gel#2 Gel #3 Gel#4 Gel#5 
11 1.14 1.01 1.20 0.98 0.95 
12 1.12 1.04 1.14 1.03 0.98 
13 1.09 1.02 1.13 1.11 1.00 
14 1.11 1.01 1.16 1.00 1.03 
15 1.09 1.02 1.08 0.99 1.05 
16 1.10 0.99 1.08 0.93 0.98 
17 1.10 1.01 1.09 0.96 0.93 
18 1.08 0.98 1.09 0.98 0.93 
19 1.16 1.03 1.08 0.99 0.93 
20 1.10 0.97 1.08 0.97 0.98 
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Table II. Phosphorimager Data for the Kinetic Isotope Studies Examining DNA Cleavage by 
Ni(II) GGH yo (141-183) in the Presence of Monoperoxyphthalic Acid when the Thymidine at 
the Experimental Cleavage Site in the "Deutero Duplex" is Dideuterated at Position C2' 
Normalized Cleavage of the "Deutero Duplex" 
Containing C2' Dideutero Thymidine 
Lane# Gel#6 Gel#7 Gel#8 Gel#9 Gel #10 
1 1.05 0.96 1.10 0.92 1.15 
2 0.97 1.01 1.07 0.95 1.12 
3 1.01 1.00 1.13 0.95 1.15 
4 0.97 1.00 1.06 0.91 1.10 
5 0.96 1.03 1.08 0.93 1.08 
6 1.04 1.17 1.08 0.96 1.15 
7 0.99 1.04 1.11 0.93 1.11 
8 0.99 1.04 1.08 0.90 1.14 
9 1.05 1.03 1.08 0.88 1.14 
10 1.00 0.97 1.07 0.94 1.13 
Normalized Cleavage of the All-Proteo 
Control Duplex 
Lane# Gel #6 Gel#7 Gel#8 Gel#9 Gel #10 
11 0.97 0.96 1.11 0.96 1.20 
12 1.01 1.10 1.10 0.98 1.16 
13 1.01 0.98 1.09 1.01 1.28 
14 0.98 0.93 1.08 1.00 1.18 
15 0.99 0.89 1.11 1.01 1.16 
16 1.01 0.94 1.08 0.98 1.08 
17 1.04 0.97 1.09 0.93 1.13 
18 0.97 0.96 1.15 0.93 1.11 
19 0.98 0.95 1.06 0.92 1.14 
20 0.98 0.89 1.04 0.97 1.07 
217 
Table III. Phosphorimager Data for the Kinetic Isotope Studies Examining DNA Cleavage by 
Ni(ll) GGH yo (141-183) in the Presence of Monoperoxyphthalic Acid when the Thymidine at 
the Experimental Cleavage Site in the "Deutero Duplex" is Deuterated at Position C3' 
Normalized Cleavage of the "Deutero Duplex" 
Containing C3' Deutero Thymidine 
Lane# Gel #11 Gel #12 Gel #13 Gel #14 Gel #15 
1 0.99 1.01 0.90 1.09 1.04 
2 1.02 0.98 0.90 1.01 1.04 
3 0.98 1.02 0.89 1.07 1.06 
4 1.00 1.02 0.85 1.03 0.98 
5 0.97 0.98 0.83 1.02 0.98 
6 1.16 1.01 0.87 1.05 1.00 
7 1.02 0.97 0.88 0.94 0.95 
8 0.96 1.00 0.85 1.02 0.96 
9 0.90 1.02 0.86 1.01 1.02 
10 0.95 0.98 0.88 0.99 0.95 
Normalized Cleavage of the All-Proteo 
Control Duplex 
Lane# Gel #11 Gel #12 Gel #13 Gel #14 Gel #15 
11 1.02 1.00 0.96 1.15 1.05 
12 1.02 0.99 0.98 1.03 1.07 
13 1.03 1.01 0.97 1.09 1.02 
14 1.02 1.00 1.00 1.15 1.04 
15 1.06 1.00 0.96 1.05 1.02 
16 1.02 1.01 1.05 1.06 1.01 
17 1.03 0.98 1.01 1.05 1.00 
18 1.01 1.00 0.96 1.06 0.98 
19 1.01 1.03 1.04 1.05 1.05 
20 0.99 1.00 0.96 1.05 1.01 
218 
Table IV. Phosphorimager Data for the Kinetic Isotope Studies Examining DNA Cleavage by 
Ni(II) GGH y 5 (141-183) in the Presence of Monoperoxyphthalic Acid when the Thymidine at 
the Experimental Cleavage Site in the "Deutero Duplex" is Deuterated at Position C4' 
Normalized Cleavage of the "Deutero Duplex" 
Containing C4' Deutero Thymidine 
Lane# Gel #16 Gel #17 Gel #18 Gel #19 Gel #20 
1 0.87 0.90 0.83 0.86 0.88 
2 0.81 0.91 0.77 0.88 0.81 
3 0.80 0.88 0.80 0.86 0.83 
4 0.81 0.87 0.80 0.85 0.84 
5 0.82 0.92 0.80 0.88 0.82 
6 0.84 0.88 0.81 0.83 0.80 
7 0.82 0.80 0.87 0.84 0.89 
8 0.91 0.86 0.84 0.86 0.88 
9 0.83 0.93 0.80 0.85 0.82 
10 0.82 0.85 0.79 0.86 0.79 
Normalized Cleavage of the All-Proteo 
Control Duplex 
Lane# Gel #16 Gel #17 Gel #18 Gel #19 Gel#20 
11 1.07 1.13 0.98 1.20 1.03 
12 1.05 1.12 0.96 1.13 1.03 
13 1.04 1.13 1.04 1.18 1.00 
14 1.04 1.10 1.04 1.09 0.99 
15 1.03 1.20 1.01 1.05 1.01 
16 1.05 1.21 1.01 1.03 1.01 
17 1.06 1.22 1.00 1.05 0.99 
18 1.06 1.22 1.07 1.03 1.03 
19 1.05 1.22 1.02 1.08 1.01 
20 1.07 1.22 1.05 1.18 1.04 
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Table V. Phosphorimager Data for the Kinetic Isotope Studies Examining DNA Cleavage by 
Ni(II) GGH yo (141-183) in the Presence of Monoperoxyphthalic Acid when the Thymidine at 
the Experimental Cleavage Site in the "Deutero Duplex" is Dideuterated at Position CS' 
Normalized Cleavage of the "Deutero Duplex" 
Containing C5' Dideutero Thymidine 
Lane# Gel #21 Gel #22 Gel #23 Gel#24 Gel#25 
1 1.83 1.56 1.75 1.80 1.77 
2 1.70 1.44 1.71 1.73 1.69 
3 1.86 1.41 1.74 1.70 1.70 
4 1.90 1.52 1.73 1.79 1.73 
5 1.80 1.38 1.64 1.77 1.67 
6 1.87 1.49 1.72 1.78 1.78 
7 1.86 1.45 1.68 1.61 1.76 
8 1.75 1.37 1.68 1.71 1.68 
9 1.84 1.59 1.80 1.63 1.81 
10 1.80 1.59 1.68 1.66 1.73 
Normalized Cleavage of the All-Proteo 
Control Duplex 
Lane# Gel #21 Gel #22 Gel #23 Gel #24 Gel#25 
11 1.10 1.08 1.06 1.15 1.01 
12 1.11 1.05 1.06 1.15 1.16 
13 1.10 1.12 1.06 1.19 1.05 
14 1.09 1.06 1.05 1.13 1.01 
15 1.07 1.06 1.03 1.15 0.98 
16 1.11 1.11 1.05 1.15 1.04 
17 1.11 1.12 1.14 1.07 1.07 
18 1.12 1.11 1.08 1.04 1.04 
19 1.09 1.14 1.08 1.09 1.01 
20 1.11 1.10 1.04 1.06 0.98 
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Table VI. Phosphorimager Data for the Kinetic Isotope Studies Examining DNA Cleavage by 
Ni(II) GGH yS (141-183) in the Presence of Monoperoxyphthalic Acid when Proteo Thymidine 
is Present at Both Cleavage Positions in the Experimental and Control Duplexes 
Normalized Cleavage of the All-Proteo 
Experimental Duplex 
Lane# Gel #26 Gel #27 Gel #28 Gel #29 Gel #30 
1 1.17 1.02 1.03 1.02 1.02 
2 1.10 0.99 1.08 1.05 1.00 
3 1.08 1.03 1.05 1.10 0.99 
4 1.11 1.02 1.06 1.10 0.97 
5 1.05 1.00 1.03 1.08 0.98 
6 1.06 1.05 1.16 1.07 0.96 
7 1.04 0.99 1.12 1.05 1.09 
8 1.11 1.05 1.07 1.14 1.01 
9 1.08 0.97 1.11 1.06 1.01 
10 1.02 1.01 1.07 1.06 0.98 
Normalized Cleavage of the All-Proteo 
Control Duplex 
Lane# Gel #26 Gel#27 Gel #28 Gel#29 Gel#30 
11 1.09 1.03 1.07 1.02 0.96 
12 1.10 1.05 1.02 1.04 0.95 
13 1.04 1.10 1.05 1.02 0.94 
14 1.09 1.05 1.06 1.04 0.94 
15 1.08 1.03 1.11 1.02 0.91 
16 1.10 10.6 1.05 1.03 0.93 
17 1.09 1.06 1.06 1.05 0.97 
18 1.07 1.02 1.03 1.04 0.94 
19 1.09 1.02 1.04 1.05 0.96 
20 1.07 1.02 1.01 1.05 0.94 
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Appendix C: Mass Spectrometry of Peptides 
222 
Mass Spectrometry. The synthetic proteins used in the previously described 
studies were examined by time of flight mass spectrometry. This technique in 
addition to amino acid analysis and sequencing of the pe.ptides confirmed their 
identity as the desired y'6 resolvase analogs. Mass spectroscopy was performed 
at the micro sequencing facility at the California Institute of Technology. 
Analysis was performed on an Applied Biosystems Bio Ion 20R mass 
spectrometer using plasma desorption and 252cf as the radiation source. The 
expected and observed masses for the purified proteins is shown in Table 1. 
Table I. Mass Spectroscopy of y'6 resolvase Affinity Cleaving Peptides. 
Values are in atomic mass units and expected mass is calculated based on 
normal isotopic distributions 
Protein Ex12ected Mass Observed Mass 
y'6(141-183) 4888.6 4891.4 
EDTA-y'6(141-183) 5248.0 5259.7 
y'6(141-183)-EDTA (Asn183_ Lys183) 5245.9 5238.3 
EDTA-y'6(141-183)-EDTA (Asn183_ Lys183) 5605.2 5620.1 
GGH-y'6(141-183) 5139.9 5145.9 
Ni(II) GGH-y'6(141-183) 5198.6 5190.7 
As can be seen from Table I all of the observed masses match fairly well to 
the expected masses. The accuracy of the measurement is approximately 1% 
(SO mass units for a protein of molecular weight 5000). The differences between 
the observed and expected masses fall with in this range. The observed masses 
of the various EDT A labeled compounds are consistent with EDTA 
incorporation. 
It should be noted that mass spectroscopy of y'6 resolvase analogs was 
problematic. The proteins were not readily desorbed. They contain a high 
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number of lysines and arginines which leads to a high rate of fragmentation. 
The proteins also contain two methonines. During the course of analysis these 
methonines tended to become oxidized to their corresponding sulfoxides and 
sulfones. These factors combine to produce a low signal and distribution of 
masses that makes identification of the molecular ion peak difficult. 
